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Abstract
Embryonic stem (ES) cells are unique cells with the capacity to self-renew and
differentiate into every cell type in the body even after prolonged culture.
They provide an ideal system in which to study genetic mechanisms that
regulate differentiation along specific lineages. Further, once such
differentiation can be precisely controlled in vitro, ES cells hold great promise
for a variety of therapeutic applications. This study concerns the mechanisms
that regulate neural differentiation of ES cells, and specifically in the possible
role of Wnt signalling in this process. Wnt proteins are a large family (19
members in mammals) of signalling molecules that have well-established
roles in regulating embryonic patterning, cell proliferation and cell
determination.
Activation of Wnt signalling has previously been shown to inhibit the
differentiation of ES cells to neural precursors. Further, there is preliminary
evidence that Wnt signalling may promote the differentiation of these neural
precursors into neurons. In order to investigate how Wnt signalling affects
the differentiation of ES cells into neurons in vitro, RNA expression of all 19
Wnt genes together with two Wnt antagonists, Dkkl and sFRP2, during the
process was first determined by RT-PCR. Of 19 Wnt genes, the expression of
12 with particularly interesting patterns was subsequently analysed by
quantitative RT-PCR (qRT-PCR). Neural differentiation of ES cells was
induced through the formation of embryoid bodies (EBs) and the addition of
retinoic acid (RA). The gene expression was determined in five different
stages of the process including undifferentiated ES cells, early EBs prior to
the addition of RA, EBs in the presence of RA, attached EBs after withdrawal
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of RA and finally neuron-like cells grown on an adhesive substratum. Many
Wnt genes showed dynamic alterations in expression levels during neural
differentiation.
In order to test the effect of expressing Wnts at different stages, we
developed an inducible expression system. The system is based on a cre-loxP
strategy and allows for stimulation or inhibition of Wnt signalling at specific
steps of the differentiation process. Overexpression of Wntl-HA and Wnt3a
at early and late stages of the process in addition to constitutive expression of
these genes was carried out. Additionally, inhibition of Wnt signalling by
overexpressing Dkkl at early and late stages as well as its constitutive
expression during the differentiation process was also conducted. The effects
of altered Wnt signalling on the formation of neural precursor cells (NPCs)
and neuronal cells was analysed using specific protein markers by
immunocytochemistry and fluorescent-activated cell sorting (FACS) analysis.
It was found that overexpression of Wntl and Wnt3a at the early stages of the
differentiation process significantly reduced the formation of NPCs while
inhibition of Wnt signalling at this stage by induction of Dkkl significantly
increased the number of NPCs. A Significant increase in the percentage of
neuron formation was observed when Dkkl and Wntl were overexpressed at
early stages of the process. In contrast, overexpression of Wnt3a at this stage
significantly reduced the number of neurons.
Formation of neurons was stimulated by overexpression of Wnt3a at late
stages of neural differentiation process, whereas induction of Wntl at this
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stage enhanced the percentage of neurons in cultures. Overexpression of
Dkkl at this stage however significantly decreased the formation of neurons.
Additionally, constitutive stimulation or inhibition ofWnt signalling during
the process was observed to reduce the ability of ES to differentiate into
NPCs and neurons. These observations therefore highlight the complexity of




1.1 Embryonic Stem cells
1.1.1 Mouse Embryonic Stem (ES) Cells
At the time of implantation, the early mouse embryo is composed of three
distinct cell types termed the trophectoderm, the primitive endoderm and
the inner cell mass (ICM). Among these, the ICM will be organized into the
epiblast, which then during gastrulation develops into the three primary
germ layers (ectoderm, mesoderm and definitive endoderm), and the
extraembryonic mesoderm of the yolk sac and amnion. The primary germ
layers consist of progenitor cells which are capable to differentiate into all
types of fetal and adult tissues (Loebel et al., 2003; Eiges and Benvenisty,
2002; Wobus, 2001). At around embryonic day 3.5 (E3.5)1, the cells of the
ICM are relatively undifferentiated, pluripotent2 cells prior to differentiating
into the specific tissues. Within a few days, the embryo from the
ICM/blastocyst stage (-E5.0) develops to gastrulation (-E7.0) stage by which
point most of these pluripotent cells have differentiated (Figure 1.1, Loebel et
al., 2003; Hadjantonakis and Papaioannou, 2001; Wobus, 2001).
Understanding the basic properties of these cells, especially their capacity to
self-renew as well as to differentiate would offer a great deal of advantages
in understanding mammalian development. Therefore, it would be
advantageous to have a system that can recapitulate the proliferation and
differentiation processes of these cells in vitro. Besides having the chance to
1 E0.5 is taken as midday on the day that vaginal plug is detected.
2 The cells are able to differentiate into virtually any cell type present in the body. At this point the
cells are expressing Oct4, a marker for pluripotent cells and also Rexl, which is specifically
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study the mechanisms in a more simplified environment, the system will also
serve as an invaluable tool/model for genetic manipulation as well as
potentially providing a renewable cell source of cell-replacement therapies.
These are the cells that most people refer to as embryonic stem (ES) cells
when growing in vitro.
1.1.2 Origin and Properties of Embryonic Stem (ES) cell lines
The establishment of mouse ES cell lines by several independent groups in
the 1980s (Evans and Kaufman, 1981; Martin, 1981; Axelrod, 1984; Wobus et
al., 1984) has given us invaluable tools for the analysis of genetics and
development as well as a great model system to understand lineage
differentiation and as a source of cells for transplantation (O'Shea, 2001).
Mouse ES cells have normally been derived from either dissociated morulae
(Eistetter, 1988), intact blastocysts (Evans and Kaufman, 1981), or entire ICM
(Martin, 1981). In addition, Brook and Gardner (1997) also found a source of
ES progenitor cells in the primitive ectoderm or epiblast. In most cases, the
cells were derived from E3.5 ICM (Figure 1.1) of mouse blastocyst (O'Shea,
2001) into tissue culture and propagating them as undifferentiated cell lines
in the presence of leukemia inhibitory factor (LIF) [Smith et al., 1988] or
mouse embryonic fibroblasts (MEFs), which provide a source of LIF
(Hadjantonakis and Papaioannou, 2001). Apparently, the cells are able to
replicate unlimitedly in tissue culture without losing their pluripotency. A
characteristic that is well suited for cell genetic manipulations. Upon
withdrawal of LIF, the cells spontaneously differentiate (Li et al., 1998a;
Smith, 2001; Murray and Edgar, 2001).
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Similar to the ICM and the early epiblast, ES cells are capable to differentiate
into multiple cell types in culture (Rossant and McKerlie, 2001), in teratomas
(ref Hadjantonakis and Papaioannou, 2001), or in chimeric embryos and can
even form the entire fetus when transferred back into blastocysts of an early
embryo (Nagy et al., 1990, 1993). However, ES cells have not been
demonstrated to contribute to either the trophectoderm or visceral
endodermal lineages (Loebel et al., 2003). The cells also retain a normal,
euploid karyotype when propagated in vitro. The majority of established ES
cell lines are male (XY), since the XX karyotype seems to be unstable, and
often the X chromosome is lost (Smith, 2001). Other characteristics of
undifferentiated ES cells are high alkaline phosphatase activity, expression of
embryonic antigens SSEA-1 (Solter and Knowles, 1978; Resnick et al., 1992), a
high nucleo-cytoplasmic ratio and high telomerase activity (Thomson et al.,
1998; Burdon et al., 1999; Prelle et al., 1999).
1.1.3 Maintenance of ES cells
Two major invaluable properties of ES cells are their ability to self-renew
indefinitely in vitro and their capacity to differentiate into virtually any cell
type present in the body (pluripotent cells), even after prolonged culture
(Suda et al., 1987). Therefore, understanding the factors controlling these
mechanisms is essential in order to conclusively provide a continuous
genuine resource of embryonic stem cells in vitro with these properties
preserved. Presently, there are at least five signalling pathways that are
thought to be co-operatively involved in maintaining self renewal and
pluripotency of mouse ES cells (Nakashima et al., 2004; Temple, 2003).
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One of the key regulators of ES cell pluripotency and differentiation is Oct4
(also known as Oct3), which belongs to the POU (Pit-Oct-Unc) transcription
factor superfamily (Pesce and Scholer, 2001; Scholer et al., 1991). Oct4
appears to be exclusively expressed in ES cells and, is downregulated upon
commitment to differentiation (Fuhrmann et al., 2001). In the mouse embryo,
its expression is restricted to the ICM and downregulated in the
trophectoderm and the primitive endoderm. Mice with targeted disruption
of Oct4 produced embryos devoid of the pluripotent ICM (Nichols et al.,
1998), suggesting the importance of the gene in maintaining pluripotency.
However, Niwa and colleagues (2000) demonstrated that increased
expression of Oct4 causes ES cells to differentiate. Quantitative analysis of
Oct4 expression also demonstrated that a high and a low level of Oct4
expression directed ES cells towards the extra-embryonic mesoderm or
endoderm lineages, and trophectoderm, respectively. Nevertheless, ES cells
with normal level of Oct4 remain pluripotent (Pan et al., 2002; Niwa et al.,
2000; Niwa, 2001). In addition, these cells still require LIF for self-renewal
(Niwa et al., 2000) indicating that there is more than one regulatory element
or pathway involved in maintaining these properties of ES cells.
A major signalling pathway that sustains long term self-renewal of mouse ES
cells with maintained undifferentiated cell characteristics, pluripotency and
embryo colonization capability (Smith, 2001; Ying et al., 2003a) involves
leukaemia inhibitory factor (LIF). LIF acts by binding a heterodimeric
receptor complex comprising the LIF receptor (LIFR) and glycoprotein 130
(gpl30) (Yoshida et al., 1994; Smith 1998; Smith and Treutlien, 1998; Ernst et
al., 1999; Burdon et al., 2002). This receptor complex results in activation of
gpl30 signaling through the Janus Kinase (Jak)/signal transducer and
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activator of transcription-3 (Stat-3) pathway. Activation of the latent
transcription factor STAT3 by LIF is sufficient to maintain mouse ES cells
self-renewal in serum containing cultures (Matsuda et al., 1999; Niwa et al.,
1998). Several cytokines related to LIF bind to the LIFR/gpl30 heterodimer
and can also substitute LIF in vitro, such as ciliary neurotrophic factor,
cardiotropin 1 and oncostatin M (Hadjantonakis and Papaioannou, 2001).
Inhibition of STAT3 was also found to induce differentiation of ES cells
(Niwa et al., 1998; Ernst et al., 1999). However, in the absence of serum, LIF
alone cannot maintain the cells self-renewal; instead, they differentiate into
neural-like cells (Temple, 2003). Therefore, another factor(s), which may be
present in the serum, together with LIF must be needed in order to preserve
this invaluable property of ES cells.
This observation, thus, has led to the study of neurogenesis inhibitor element
as a target in another pathway that may be involved in maintaining self-
renewal in mouse ES cells. In the study conducted by Ying et al. (2003a), an
early embryo anti-neurogenesis factor (Wilson and Edlund, 2001; Wilson and
Hemmati-Brivanlou, 1995), bone morphogenetic protein (BMP), in
combination with LIF was found to inhibit neural differentiation, thus,
enhancing self-renewal of mouse ES cells in serum-free cultures.
Interestingly, they discovered that BMP alone neither activated STAT3 nor
modulated gpl30 signal transduction in ES cells, indicating that a BMP
signalling pathway directly contributes to the self-renewal of ES cells. Ying
and colleagues (2003a) proposed the Smad pathway as a transducer of the
self-renewal signal through activation of expression of inhibitor of
differentiation (Id) genes. Id proteins are negative regulators for basic helix-
loop-helix (bHLH) transcription factors that specify various cell lineages
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(Ying et al., 2003a; Nakashima et al., 2001). Together with LIF, overexpression
of Id has been observed to maintain undifferentiated ES cells in serum-free
medium. On the other hand, BMP alone has been discovered to promote
differentiation of ES cells to non-neural cells (ref. Ying et al., 2003a; Ying et al.,
2003b), besides being demonstrated to antagonize neural differentiation of ES
cells in serum-free cultures (Tropepe et al., 2001, Ying et al., 2003b).
Therefore, the effect on self-renewal of ES cells may be dependent totally on
co-stimulation and balancing with LIF pathway, since both pathways have
stimulatory and inhibitory effects on self-renewal of ES cells (Temple, 2003).
Even though LIF seems to be the central player in maintaining these
properties of ES cells, previous studies have shown that mutant embryos
deficient in the LIF/gpl30/Stat3 pathway formed normal ICM and LIF-
deficient mice developed normally (Stewart 1994) arguing against the
fundamental role of LIF/gpl30/Stat3 for pluripotency. As a result, the
existence of a novel pathway(s) that maintains pluripotency in both ICM and
ES cells has been proposed (Mitsui et al., 2003). Mitsui et al. (2003) and
Chambers et al. (2003) demonstrated the involvement of a divergent
homeobox transcription factor, Nanog, in maintaining self-renewal of ES
cells independently of the LIF/STAT3 pathway. Similar to Oct4, Nanog is
expressed in the ICM as well as in ES cells, and downregulated upon
differentiation of ES cells (Cavaleri and Scholer, 2003; Chambers et al., 2003).
Mitsui and colleagues discovered that nanoy-deficient ES cells lost
pluripotency and differentiated into extraembryonic endoderm lineage, and
nanog-deficient ICM failed to generate epiblast and only produced parietal
endoderm-like cells. In addition, Chambers et al. (2003) demonstrated that
overexpression of nanog cannot revert the differentiation of ES cell induced
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by downregulation of Oct4. They also discovered that Nanog was still
expressed in Oct4-deficient embryos, suggesting that Nanog and Oct4 may
be working side by side in supporting ES cells potency and self-renewal.
Stat3-activated self-renewal of ES cells was also not affected by
overexpression of Nanog. Therefore, Nanog, Oct4 and Stat3 seem to be
operating three different transcriptional pathways in maintaining self-
renewal and pluripotency of ES cells.
The other pathway, which has recently been proposed to be sufficient in
maintaining self-renewal as well as the pluripotency of ES cells, is the
canonical Wnt pathway. Wnt proteins are signalling proteins, which are
believed to participate in the control of gene expression, proliferation,
differentiation and cell polarity (Nakashima et al., 2004). In this pathway,
also referred to as the Wnt/fi-catenin pathway, the binding of Wnt to its
receptor, frizzled, results in inactivation of glycogen synthase kinase-3 (GSK-
3 fi), which then stabilizes 6-catenin and activates the transcription of target
genes (Miller, 2002). In a study conducted by Sato and colleagues (2004), the
pathway was activated by a new GSK-3-specific pharmacological inhibitor,
BIO. BlO-treated mouse ES cells were found to be morphologically and
pluripotency maintained in the absence of LIF. Therefore, activation of Wnt
pathway seems to be sufficient to sustain the self-renewal of ES cells.
Expression of known genes involved in mouse ES cells maintenance such as
zinc-finger protein Rex-1, POU family transcription factor Oct-4 and the
newly identified homeodomain protein Nanog were detected in these cells,
indicating their pluripotency property is maintained. The cells were also
able to differentiate into the expected lineages upon the withdrawal of BIO.
Earlier studies have also indicated the involvement of the canonical Wnt
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pathway in maintaining the proliferation of various multipotent stem cells
such as haematopoetic stem cells (Reya et al., 2003), neural stem cells (Chenn
and Walsh, 2002), skin stem cells (Alonso and Fuchs, 2003) as well as mouse
embryonic stem cells (Kielman et al., 2002). The observations made by Sato
and colleagues may indicate the possibility that LIF induces self-renewal of
ES cells partly through activation of the Wnt pathway. Additionally, a recent
study also has suggested the convergence of Wnt/fi-catenin and LIF
pathways on activation of STAT3 in preventing differentiation of ES cells
(Fiao et al., 2006). The study found that activation of STAT3 protein by
Wnt/S-catenin is not enough to maintain ES cells without the presence of LIF
in the culture.
1.1.4 Differentiation of ES cells
Studies with mouse ES cells have led to the successful development of many
in vitro differentiation systems. Most of them involve culturing the ES cells
as small aggregates, called embryoid bodies (EBs), in the absence of the
cytokine leukemia inhibitory factor (LIF) on a non-adhesive substratum
(reviewed in Gottlieb and Huettner, 1999). The differentiation of ES cells to
specific lineages is often directed using growth factors and/or retinoic acid
(Rohwedel et al., 1999; Lee et al., 2000a; Liu et al., 2000a; Buttery et al., 2001;
Lumelsky et al., 2001) or by blocking certain inhibitory pathways (Tropepe et
al., 2001; Gratsch and O'shea,2002). In addition, differentiation can also be
achieved by growing the cells in co-culture with various differentiated cell
types (Rathjen et al., 1999; Kawasaki et al., 2000; Wichterle et al., 2002;
Mummery et al., 2002) or by forced expression of transcription factors known
to be essential for specific differentiation lineages, such as GATA factors
toward differentiation into visceral endoderm (Fujikura et al., 2002).
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One of the in vitro differentiation systems established is the differentiation of
ES cells into early primitive ectoderm-like (EPL) cells (Rathjen et al, 1999).
The primitive ectoderm of the mouse embryo arises from the ICM between
E4.75 and E5.25 just prior to formation of the three primary germ layers
(Rathjen et al., 1999). Gene expression profiles of ES and EPL cells
recapitulate the expression of ICM and epiblast, respectively (Loebel et al.,
2003). Thus, EPL cells are believed to resemble the epiblast in the embryo.
However, unlike ES cells, these EPL cells cannot contribute to tissues in
chimeric embryos (Rathjen et al., 1999; Pelton et al., 2002). Interestingly, EPL
cell-derived EBs are predisposed to mesodermal differentiation even though
these EPL cells are a step closer to ectodermal commitment (Loebel et al.,
2003). Nevertheless, continuous exposure to conditioned medium could also
direct the EPL cells to a neural fate (Rathjen et al., 2002). Interestingly, these
cells can revert to an ES cell-like state upon withdrawal of conditioned
medium, with the ability for in vitro differentiation and contribution to
tissues in chimeric mice (Rathjen et al., 1999; Lake et al., 2000).
The foremost important contribution of ES cells is their ability to differentiate
into all primary germ layer tissues in vitro. Depending on the culture
supplements and conditions, differentiation of ES cells can be directed to
ectodermal, mesodermal and endodermal derivatives (Table 1). The
endothelial and haematopoietic cells are the earliest mesodermal derivatives
to be differentiated from ES cells in cultures. Other mesodermal derivatives
that have been differentiated in vitro are the smooth muscle cells, heart
tissues, skeletal muscles, mast cells, adipocytes, chondrocytes, osteoblasts
and osteoclasts. As for endodermal derivatives, ES cells have been
demonstrated to differentiate into pancreatic islet cells, insulin- producing
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Table 1.1: Different differentiated cell types derived from ES cells in vitro
Embryonic Germ Layer Cell Type References
Ectoderm (external layer)
Neural progenitor cells Li et al., 1998
Neurons Bain et al., 1995; Strubing et al.,
1995; Okabe et al., 1996
Cortical neurons Bibel et al., 2004
Dopaminergic neurons Lee et al., 2000a; Bjorklund et al.,
2002; Kim et al., 2003
Motor neurons Wichterle et al., 2002
Interneurons Renoncourt et al., 1998
Oligodendrocytes Brustle et al., 1999; McDonald et
al., 1999; Liu et al., 2000a
Astrocytes Billon et al., 2002; Fraichard et
al., 1995
Dendritic cells Fairchild et al., 2000
Mesoderm (middle layer)
Adipocytes Dani 1999
Cardiomycetes Wobus et al., 1991; Maltsev et al.,
1993; Wobus et al., 1997; Wobus
and Guan, 1998; Boheler et al.,
2002
Chondrocytes Kramer et al., 2000
Haematopoietic cells Wiles, 1993; Robb and Begley,
1996; Kennedy et al., 1997; Kyba
et al., 2002
Lymphoic precursors Gutierrez-Ramos and Palacios,
1992
Endothelial cells Bagutti et al., 1996, 2001;
Gualandris et al., 2000;
Yamashita et al., 2000; Feraud et
al., 2001, 2003.
Osteoblasts Buttery et al., 2001; Phillips et al.,
2001
osteoclasts Hemmi et al., 2001
Skeletal muscle cells Rohwedel et al., 1994; Ridgeway
et al., 2000
Smooth muscle cells Yamashita et al., 2000
Mast cells Tsai et al., 2000; Lindmark et al.,
2004
Endoderm (internal layer)
Pancreatic-like islets Lumelsky et al., 2001; Hori et al.,
2002
Insulin-producing cells Soria et al., 2000; Blyszczuk et al.,
2004
Hepatic progenitors Yin et al., 2002
Hepatocytes Hamazaki et al., 2001; Jones et
al., 2002
cells, hepatic progenitors and liver. For ectodermal commitment, ES cells
have been successfully differentiated into neural precursors, dendritic cells,
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various types of neurons, and glial cells both the astrocytes and
oligodendrocytes.
1.1.5 Neural differentiation of ES cells in vitro
Numerous methods have been established in order to achieve populations
enriched in neural lineage cells from ES cells in culture. Among the methods
established are treatment with retinoic acid (RA) in the presence of serum
(Bain et al., 1995), coculture with a particular stromal cell line, PA6 (Kawasaki
et al., 2000), adherent monoculture in serum-free medium with N2 and B27
supplements (Ying et al., 2003b), the use of selective medium (Okabe et al.,
1996; Tropepe et al., 2001) and the use of genetically modified ES cells and
antibiotic selection for cells expressing early neural precursor cells (Li et al.,
1998). Additionally, the use of the growth factors EGF (epidermal growth
factor) and FGF-2 together with insulin contained in N2 have been recently
shown to sufficiently sustain the specific expansion of neural stem (NS) cells
derived from ES cells (Conti et al., 2005). The study has successfully
generated NS cell lines, that only express neural genes but not of mesoderm-
and endoderm-specific genes or even of pluripotent cell-specific transcription
factors Oct4 and Nanog, derived from at least ten ES cell lines in this
condition.
The most common method used for neural differentiation of mouse ES cells
is the spontaneous formation of three-dimensional multicellular aggregates
termed embryoid bodies (EBs). Upon withdrawal of LIF, dissociated ES cells
spontaneously form EBs when grown in a non-adhesive substratum dish
(Figure 1.2). Based on gene expression analysis, the structure of EBs
recapitulates certain aspects of early embryogenesis in which lineage specific
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region similar to that found in the embryo appears (Gottlieb and Huettner,
1999; Rodda et al., 2002). Upon further culturing, differentiation in EBs
resembles the formation of egg cylinder-stage embryos which contains a
double-layered structure with an inner ectodermal layer and outer layer of
endoderm enclosing a cavity, followed by the appearance of mesodermal cell
types (Figure 1.2). However, only a small percentage of neural lineage cells
are produced by spontaneous differentiation of EBs (Strubing et al., 1995).
In order to enhance neural differentiation, a method, which was optimized
based on neuronal differentiation from teratocarcinoma cells (Jones-
Villeneuve et al., 1982), referred to as the 4-/4+ protocol (Bain et al., 1995) was
developed. In the 4-/4+ protocol, EBs are cultured for 4 days in the absence
of retinoic acid (RA), or specifically all-trans retinoic acid (ATRA), followed
by 4 days in the presence of RA. RA has been demonstrated to induce
differentiation in human teratocarcinoma (NT2) (Pleasure and Lee, 1993;
Pleasure et al., 1992), P19 embryonal carcinoma (EC) cells (Boudjelal et al.,
1997; Bouillet et al., 1996) and D3 ES cell line (Bain et al., 1995). RA is believed
to have important regulatory functions during embryonic development
(Morriss-Kay and Sokolova, 1996), although this is controversial. In vitro, RA
induces differentiation of ES cells into specific cell types in a time- and
concentration-dependent manner (Drab et al., 1997).
In the 4-/4+ protocol, the events occurring during the first 4 days in culture
are parallel to the ones occurring between embryonic days 4-6 (E4-6). One of
the major events occurring at this stage is the expression of a transcription
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expressed in undifferentiated ES cells and downregulated as the EBs mature
(Niwa et al., 2000). Its expression is also extinguished between E5 and E8
embryo as committed lineages emerge (reviewed in Gottlieb and Huettner,
1999). Based on marker expression, the outer layer of EBs also consists of
cells resembling visceral endoderm cells as found in E5 embryo (Duncan et
al., 1997) in addition to the formation of epiblast-like cells inside the EBs
(Doetschman et al., 1985). Besides these events, the cells undergoing neural
differentiation in vitro also express many regulatory genes expressed in very
early brain development, such as Wntl, MASH-1, Sox 1, Sox 2, Pax6, Pax3, and
delta 1. These events, therefore, demonstrate that the in vitro pathway of
neural development of neurons through a series of cellular progenitors may
resemble that in vivo (Gottlieb and Huettner, 1999).
Treatment with RA at early stage of EBs (on day 2 or day 4) with high
concentration of ATRA (100-1000 nM) results in almost 100% of cells in each
EBs differentiating into neural cells compared to low frequency of neural
differentiation from spontaneous differentiation (Strubing et al., 1995;
Fraichard et al., 1995). A recent study by Plactha et al., 2004 has
demonstrated that RA appears to restrict the differentiation of ES cell-
derived progenitors to a CNS fate. The finding was based on transplantation
of RA-treated EBs into a chick neural tube which resulted in the formation of
the CNS restricted neuronal cells compared to development of the CNS and
PNS restricted neuronal cells on the untreated neural tube. RA-treated EBs
also generate various type of neural cells including excitatory and inhibitory
neurons and glial cells (Bain et al., 1995, 1996; Fraichard et al., 1995; Strubing
et al., 1995; Finley et al., 1996).
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A posteriorising effect of RA during neural development in vivo and in vitro
has been suggested (Blumberg et al, 1997; Maden, 2002; Barberi et al, 2003;
Du and Zhang, 2004-references therein) even though there is little evidence
to prove that RA is actually inducing neural specification from ES cells. RA
indeed has been shown to be required for differentiation of EBs into spinal
motorneurons (Wichterle et al., 2002) and neuronal cell types characteristic of
ventral CNS; somatic motorneurons, cranial motorneurons and interneurons
(Renoncourt et al., 1998). On the other hand, Bibel and colleagues (2004) have
managed to differentiate RA-treated EBs into Pax6 positive radial glial cells
which leads to generation of a defined neural lineage characteristic of cortical
pyramidal neurons. These findings therefore imply that treatment with RA
could generate various types of neurons within the CNS.
1.2 Wnt Signalling Pathways
1.2.1 Wnt Genes
In 1982, a signalling molecule, the proto-oncogene Int-1, correlated with
development of mammary tumours in mice was discovered by Nusse and
Varmus (Nusse and Varmus, 1982). Not long after the discovery its homolog
was then identified in Drosophila Wingless (Wg) which plays an important
role in segment polarity (Cabrera et al., 1987). Interestingly, the Int-1 protein
was later discovered to be required for midbrain and cerebellar development
(McMahon and Bradley, 1990; McMahon et al., 1992). Consequently, the
amalgamation of Wg and Int led to the name Wnt. Wnt proteins are now
recognized as one of the important signalling molecules, together with other
families such as the fibroblast growth factors (FGFs), the transforming
growth factors (TGFs), the bone morphogenetic proteins (BMPs) and
hedgehog (HH) proteins that have been implicated in a wide variety of
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biological processes. With its pleiotropic signals, Wnt has been seen to be
involved in regulating embryonic patterning, cell proliferation and cell
differentiation (Brown and Moon, 1998; Wodarz and Nusse, 1998; Logan and
Nusse, 2004). Wnt genes encode a large family of secreted glycoproteins
varying between 350-440 amino acids in length with all proteins have highly
conserved spacing of 23-24 cysteine residues (Figure 1.3), suggesting that the
protein folding may depend on the formation of multiple intramolecular
disulfide bonds (Miller, 2001).
Once secreted, Wnt proteins associate with glycosaminoglycans in the
extracellular matrix (ECM) and bind tightly to the cell surface (Bradley and
Brown, 1990; Reichsman et al., 1996). It is also possible to collect active Wnt
protein from the medium of cultured cells [Wnt3a conditioned medium
(CM): Shibamoto et al., 1998; Wg CM: VanLeeuwen et al., 1994] even though
they are found in tight association with the plasma membrane.
Unfortunately, they are notoriously insoluble to be purified in active form,
hence hampering attempts on protein characterization. Studies by Willert
and colleagues (2003), however have finally managed to unravel the mystery
of the insolubility of Wnt proteins. They found Wnt proteins to be
unexpectedly hydrophobic and post-translationally modified by
palmitoylation, which was found to be on a conserved cysteine residue.
Palmitate was found to be critical for signalling. They also discovered that
different results were obtained when haematopoietic stem cells (HSCs) were
treated with purified Wnt3a protein compared to treatment with Wnt3a CM
suggesting that the presence of other factor in the medium might have
underscored the function of Wnt protein in the medium. The availability of
purifiedWnt proteins will therefore be useful in determining the role of each
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Figure 1.3: A) Structure of Wnt showing 23-24 cysteine residues with their
spacing conserved. B) Structure of Frizzled (Fzd) showing cysteine rich
domain (CRD) for Wnt binding and the seven transmembrane domains with
cytoplasmic carboxyl domain (CD). C) Structure of secreted frizzled
related proteins (sFRP) showing CRD that is 30-50% sequence homology
with CRD with Fzd. D) Dkk structure showing the two cysteine-rich
domains (Cys-1 and Cys-2). Diagrams are adapted from Miller, 2002, and
Kawano and Kypta, 2003.
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Wnt genes as well as otherWnt signalling components during development.
The transduction ofWnt signals involves post-translational modification and
secretion of Wnts, binding to transmembrane receptors, activation of
cytoplasmic effectors, and transcriptional regulation of target genes. Most
information on Wnt signalling is based on genetic studies in Drosophila and
Caenorhabditis elegans, ectopic gene expression in Xenopus, and gene
knockouts in the mouse (Wodarz and Nusse, 1998). Presently, in vertebrates:
16 members have been found in Xenopus, 11 in chick, 12 in zebrafish, 19 in
mouse and humans, while in invertebrates: 7 members have been found in
Drosophila, 5 in Caenorhabiditis elegans and 1 in hydra. More specific
information and updates on Wnt genes including Wnt mutant phenotypes
can be obtained from Roel Nusse's webpage:
http://www.stanford.edu./~rnusse/wntwindow.html.
1.2.2 Components ofWnt Pathway
1.2.2.1 Wnt Receptors
There are at least three different receptors that are involved in the reception
of Wnt signals. The first well known Wnt receptors which were first
identified in Drosophila studies are the members of the Frizzled (Fzd) gene
family (Bhanot et al, 1996). The gene encodes an amino-terminal cysteine-
rich domain (CRD), seven-transmembrane spanning domain (Figure 1.3) and
cytoplasmic carboxy-terminus consisting of a S/T-X-V motif which bind to
PDZ domain (Songyang et al., 1997). The CRD is believed to be important for
Wnt binding. There are 10 known members in human and mice, four in
Drosophila and three in C. elegans (Miller, 2002). The interaction between
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receptors and ligand is promiscuous, in that different Wnt proteins can bind
to multiple Fzd's and vice versa (Bhanot et al., 1999).
It is also hypothesized that Fzd receptors may use heterotrimeric G proteins
to transduce Wnt signals; based on the structure of these receptors that
resembles the seven-transmembrane G-protein-coupled receptors. Several
studies have demonstrated that G-protein signalling has able to mediate
calcium release and activate protein kinase C (PKC) in 6-catenin-
independent Wnt signalling pathway (Sheldahl et al., 1999; Liu et al., 1999a;
Kuhl et al., 2000a,b; Slusarski et al., 1997).
Fzd also forms a ternary complex with Wnt and either one or both of two
members of low-density lipoprotein receptor-related protein (LRP) family,
LRP-5 and LRP-6 (Tamai et al., 2000). These are single transmembrane
receptors that act as co-receptor and upon forming the ternary complex
activates Dishveled (Dsh), which then leads to inhibition of fi-catenin
degradation (see section 1.2.3.1). Similar developmental defects as observed
from mutations in certain individual Wnt genes were detected in mice with
mutations in LRP-6 (Pinson et al., 2000). Overexpression of LRP-6 also
resulted in axis duplication and activation of Wnt-responsive gene in
Xenopus, while overexpression of a truncated form of LRP-6 was found to
block Wnt activity in the same assay (Tamai et al., 2000). In Drosophila,
arrow, the orthologue of LRP-5 and LRP-6, is needed for optimal Wg
signalling (Wehrli et al., 2000). These studies therefore demonstrate the
importance of these receptors in transduction of Wnt signals in vertebrate as
well as in invertebrate.
Recently, another Wnt receptor that has a Wnt-interacting WIF domain at its
extracellular region (Flsieh et al., 1999), the tyrosine kinase receptor Derailed
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which belongs to the RYK (in mammals) subfamily has been described.
Derailed is believed to be Dwnt5 receptor and through its unclear signal
transduction appears to regulate axon guidance in the Drosophila CNS
(Yoshikawa et al., 2003). Similar phenotype that displays misrouting of
neuronal projections across the midline was observed both in Dwnt5 mutant
embryos as well as those lacking Derailed. Wnt4 and Wnt5 have been
implicated in axon guidance in vertebrate (Hall et al., 2000; Lyuksyutova et
al., 2003) and therefore it will be interesting to see whether the interaction
between Wnts to Fzd/LRP and RYK receptors occur and function in the same
tissues and cellular processes simultaneously or in parallel pathways (Logan
and Nusse, 2004).
In addition to the Fzd and LRP receptors, cell-surface proteoglycans also
have been suggested to play a role in transduction of Wnt signals. Studies in
Drosophila have shown that Heparan sulphate proteoglycans (HSPGs) are
required as co-receptors during Wg signalling (Lin et al., 1999). Mutations in
genes encoding enzymes necessary for the formation of heparan sulphate
defectWg signalling (Cumberledge and Reichsman,, 1997; Lin et al., 1999). In
vertebrates, HSPGs are also required for Wnt signalling. QSulfl, an avian
protein related to heparan-specific N-acetyl glucosamine sulfatases has been
shown to regulate heparan-dependent Wnt signalling in cultured cells
(C2C12), implying that it can regulate Wnt signals by desulphation of cell-
surface proteoglycans (Dhoot et al., 2001). However, to date, it is unclear
how proteoglycans modulate Wnt signalling (Miller, 2002) although
emerging evidence implies its role in the transport or stabilization of Wnt
(Logan and Nusse, 2004).
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1.2.2.2 Wnt Antagonists
Many extracellular molecules have been found to regulate Wnt activity.
Proteins that act as Wnt antagonists can be categorized into two classes, the
secreted Frizzled related protein (sFRP) class and the Dickkopf (Dkk) class.
Members of sFRP class, which includes Wnt inhibitory factor-1 (Wif-1) and
Cerberus in addition to members of sFRP members, bind directly to Wnts
hence resulting in alteration of their binding specificity to the Wnt receptor
complex. Members of the Dkk class, which consist of certain Dkk family
protein and Wise, inhibit Wnt signalling by binding to the LRP-5/LRP-6
component of Writ receptor complex. Therefore it is suggested that the
members of the sFRP class could inhibit both canonical and non-canonical
pathways whereas those of the Dkk class could only inhibit the canonical
pathway (reviewed in Kawano and Kypta, 2003; Logan and Nusse, 2004).
1.2.2.2.1 sFRPs
Presently there are eight known members of the sFRP family. Each member
protein contains a cysteine-rich domain (Figure 1.3, CRD) that is 30-50%
homologous to Fzd protein and has 10 conserved cysteine residues at the
amino terminus (Melkonyan et al., 1997). However it is unclear whether
sFRP inhibits Wnt signalling by binding to Wnt ligands through the CRD
(Lin et al., 1997) or the carboxyl-terminus that lies outside the CRD (Uren et
al., 2000). Interestingly, the CRD of sFRPl appears to interact with Wnt
ligand and the Fzd receptor suggesting that sFRPs may block Wnt signalling
by forming non-functional interactions with either Wnts or Frizzled receptors
(Bafico et al., 1999). Nevertheless, in addition to acting as Wnt antagonists,
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sFRPs may also promote Wnt signalling depending upon their expression
levels or cellular context (Uren et al., 2000).
Many of the sFRPs have been found to be expressed in the developing
nervous system (Mayr et al., 1997; Floang et al., 1998; Leimeister et al., 1998;
Lescher et al., 1998). In a functional analysis of sFRP2, it was discovered that
the protein may enhance survival and expansion of neural precursor cells
during neural differentiation of ES cells, thus highlighting the importance of
Wnt signalling and Wnt antagonism during the process (Aubert et al., 2002).
The finding may indirectly prove the antagonizing effect on Wnt signalling
by sFRPs in vivo as many of the genes have been discovered to be expressed
in the developing nervous system normally in close proximity to Wnt
responsive tissues (reviewed in Kawano and Kypta, 2003). However more
precise studies need to be carried out in order to understand how sFRPs
could control Wnt activity in healthy tissue. It is interesting to know which
Wnts each sFRP can bind and whether they could be acting as agonists in
addition to as antagonists at a particular time point and in particular tissues
during development.
1.2.2.2.2 Dkks
Dkk proteins are the best characterized secreted Wnt signalling inhibitors
that have not been found in invertebrates (Logan and Nusse, 2004). Four
Dkk genes have been found in vertebrate (Dkkl, -2, -3 and -4) and each gene
contains two cysteine rich domain (Cysl and Cys2, Figure 1.3) separated by a
linker at different length (Glinka et al., 1998; Krupnik et al., 1999). Dkkl and
Dkk4 are inhibitors while, depending on cellular context, Dkk2 can either be
39
an inhibitor or activator of Wnt signalling (Brott and Sokol, 2002; Mao and
Niehrs, 2003). Little is known about the function of Dkk3.
Among the Dkk family, the most studied member is Dkkl. Dkkl does not
bind to either Wnts or Fzd at all, instead it binds to LRP5/6 with high affinity
(Bafico et al., 2001; Mao et al., 2001; Semenov et al., 2001) and to another class
of transmembrane molecules, the Kremens (Mao and Niehrs, 2003; Mao et al.,
2002). Upon forming a complex with LRP5/6 and Kremen (Krm), Dkkl (and
also Dkk2, Mao et al., 2002) promotes the internalization of LRP preventing
LRP5/6 from binding to Wnt, and might also inhibit recruitment of Axin3 to
the plasma membrane resulting in negative regulation of Wnt signalling
(Mao et al., 2001). Dickkopf which means "fat head" has been known for its
head inducing activity through experiments with Dkkl in Xenopus, zebrafish
and mouse embryos. Based on overexpression of Wnts during gastrulation,
which leads to microcephaly in Xenopus (McGrew et al., 1997) and possibly in
mouse (Popperl et al., 1997), it has been suggested that Wnt signalling is
capable of inhibiting the Spemann organizer. Dkkl, which is expressed in the
anterior endomesoderm of the organizer where head inducing activity exists,
is therefore believed to antagonize Wnt activity that inhibits the organizer
during head induction. Overexpression of Dkkl in Xenopus and zebrafish also
results in embryos with enlarged heads (Glinka et al., 1998; Hashimoto et al.,
2000; Shinya et al., 2000). Additionally, coexpression of Dkkl with a
dominant-negative mutant of the BMP2/4 receptor is able to induce complete
duplication of head structures in Xenopus embryos (Glinka et al., 1998).
Observation of early mouse embryos with a Dkkl null mutation reveals a
requirement for the inhibition ofWnt signalling during mouse axis formation
3 Wnt-activated LRP5 recruits Axin (intercellular antagonist) to the plasma membrane and promotes
its degradation, leading to stabilization ofB-catenin (Mao et al., 2001), hence activates canonical Wnt
signalling pathway (section 1.2.3.1).
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in addition to limb morphogenesis (Mukhopadhyay et al., 2001). Specifically,
severe truncation of forebrain and cephalic neural crest-derived head tissues
were observed in these mice. Besides these studies, Krm proteins also have
been shown to inhibit Wnt activity during early anteroposterior patterning of
the Xenopus CNS (Davidson et al., 2002). Taken together, all these findings
suggest that Dkkl acts as a Wnt antagonist and is essential for brain
formation. In general the inhibition of Wnt signalling is necessary for proper
development in vertebrate. In addition, it is interesting to see whether
inhibition of Wnt/|3-catenin signalling pathway by Dkkl is required for
induction of apoptosis. Dkkl is known as a transcriptional target of p53 and
is induced by various agents such as ultraviolet (UV) and chemotherapeutic
agents lead to DNA damage (Shou et al., 2002).
1.2.3 Different Wnt signalling pathways
Wnt signalling diversifies into three main pathways (Figure 1.4); the classical,
canonical Wnt/(3-catenin pathway, the Wnt/Calcium (Ca2+) pathway and the
planar cell polarity (PCP) pathway (Lustig and Behrens, 2003). Based upon
their ability to transform C57MG mammary epithelial cells and to induce
secondary axis formation in early Xenopus embryos, Wnts have been
classified into two functional groups (Wntl and Wnt5a) [reviewed in
Yamaguchi, 2001]. Unlike members of the Wntl group which when
overexpressed are able to transform C57MG and to induce the secondary axis
formation, overexpression of each of Wnt5a group members does not
transform C57MG cells or induce a secondary axis (Wong et al., 1994; Du et
al., 1995). At present, it is still uncertain which Wnt acts through which
pathway. Depending on the receptor, it is possible that Wnt can act through
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more than one pathway. Nevertheless, members of Wntl class (Wntl, -2, -2b,
-3, -3a, -6, -7b, -8a and-8b) are thought to primarily signal through the
canonical Wnt/|3-catenin pathway (Kemp et al, 2005). Members of Wnt5a
(Wnt4, -5a and -11) group may signal through the Wnt/Ca2+ pathway that
involves protein kinase C (PKC). Interestingly, Wnt7a has been shown to
activate both the canonical (Lucas and Salinas, 1997; Caricasole et al., 2003;
Hirabayashi et al., 2004) and PCP (Kengaku et al., 1998; Dabdoub et al., 2003;
Winn et al., 2005) pathways. Other Wnt genes (Wnt5b, -7b, -9a, -9b, -10a, -10b
and -16) are still unclassified. The major function of the canonical Wnt/|3-
catenin pathway is to regulate cell fate determination during development
(Miller, 2002), whereas the (3-catenin-independent pathway primarily
involves in modulation of cell movements and cytoskeletal organization
(reviewed in Kohn and Moon, 2005).
1.2.3.1 Canonical Wnt/p-Catenin Pathway
The Wnt signalling pathway originally identified as (3-catenin-dependent
pathway and which now is known as the canonical Wnt/(3-catenin pathway
has been the most studied. The elevation of cytoplasmic (3-catenin protein
levels is the hallmark of canonical Wnt signalling activation. In the absence
of Wnt, (3-catenin is initially phosphorylated by casein kinase la (CKIa)
(Amit et al., 2002) followed by the serine/threonine kinase glycogen synthase
kinase-3(3 (GSK-3|3) (Yost et al., 1996). GSK-3|3 also phosphorylates Axin and
APC4 (Hart et al., 1998; Kishida et al., 1998) which then act as the scaffolding
proteins facilitating the interaction between these kinases and (3-catenin.
These proteins form a (3-catenin destruction complex which allows
4 Adenomatous Polyposis coli (APC)
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phosphorylated (3-catenin, especially at positions 33, 37 and 41 by GSK-3(3, to
be recognized by the E3 ligase (3-TrCP (Latres et al., 1999), targeted by
ubiquitination (Winston et al., 1999) and degraded by the proteasome (Aberle
et al., 1997; Kitagawa et al., 1999).
In the presence of Wnt, degradation of (3-catenin is inhibited leading to its
nuclear accumulation (Moon and Miller, 1997; Cox et al., 1999; Tolwinski and
Wieschaus, 2004; Logan and Nusse, 2004) and activation of target genes
through binding to transcription factors T-cell factor (TCF)/lymphoid-
enhancing factor (LEF) and co-activators p300 and CBP (cyclic AMP resonse
element-binding protein) [Behrens et al., 1996; Molenaar et al., 1996; van de
Wetering et al., 1997; Seidensticker and Behrens, 2000]. One of the
mechanisms is the phosphorylation of Dshevelled (Dsh), a cytoplasmic
scaffold protein, upon formation of ternary complex between Wnt, Fzd and
LRPs. Dsh through its interaction with Axin then recruits GSK-3|3 binding
protein, Frat-l/GBP5, to inhibit GSK-3(3 activity which could thereby block
phosphorylation of [3-catenin as well as Axin and APC (Li et al., 1999; Farr et
al., 2000; Salic et al., 2000). Alternatively, upon reception of Wnt signal, the
ternary complex could trigger the recruitment of Axin, removing it from the
destruction complex and promotes stabilization of [3-catenin (Cliffe et al.,
2003; Tamai et al., 2004). A mutant form of [3-catenin that lacks the
phosphorylation sites for its degradation is unresponsive to Wnt and can
constitutively activate Wnt target genes (Munemitsu et al., 1996; Yost et al.,
1996).
5 Frat-1 (frequently rearranged in T-cell lymphomas) in the mouse and its homolog GBP
(GSK3 binding protein) inXenopus (Salic et al., 2000).
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In the absence of a Wnt signal, TCF forms a repressor complex with Groucho
(Cavallo et al., 1998), which is mediated by interactions with histone
deacetylases (HDAC) [Chen et al., 1999]. Once in the nucleus, |3-catenin is
believed to convert the repressor complex into transcriptional activator
complex together with CBP which acts as coactivator (Hecht et al., 2000;
Takemaru and Moon, 2000). Similar to its interaction with TCF/LEF, (3-
catenin also has been shown to interact with other binding partners in the
nucleus. One example is its binding to Pitx2 which then leads to conversion
of Pitx2 from a transcriptional repressor into an activator (Kioussi et al.,
2002). The complexity of the regulation of gene expression by nuclear [3-
catenin is added by activity of a number of proteins which are controlling
Wnt signalling events in the nucleus. These include Chibby, a nuclear
antagonist that binds to carboxyl-terminus of (3-catenin (Takemaru et al.,
2003), and ICAT, a (3-catenin-binding protein which blocks the binding of (3-
catenin to TCF (Tago et al., 2000) and destroys the complexes between (3-
catenin, LEF and CP/p300 (Daniels and Weis, 2002; Graham et al., 2001).
The important function of TCF/LEF- [3-catenin binding complex in activating
Wnt signalling target genes is seen in TCF-l/LEF-1 double knock-out mice
which result in an early embryonic phenotype that resembles that of the
Wnt3a knock-out (Galceran et al., 1999). (3-catenin-mediated activation of a
Wnt responsive repoter gene which is driven under the control of a promoter
that contains multiple TCF/LEF consensus binding motifs upstream from a
cFos minimal promoter (TOP, TCF optimal promoter) has been developed.
The first TOP to be used which drives activity of luciferase was built by
inserting the TOP sequence upstream of a luciferase coding region (TOP-
FLASF1) in a promoterless vector (Korinek et al., 1997). Wntl-expressing
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C57MG cells transiently-transfected with TOPFLASH have been shown to
increase luciferase activity indicating the activation of TCF reporter construct
in response to Wnt signal as opposed to the cells transiently transfected with
a mutated version of TOP, FOPLASH, which did not increase the activity of
luciferase (Korinek et al., 1998). However, TOPFLASH only measures the
activity of luciferase from the whole population of cells, but not the specific
cells, that respond to Wnt signals. Consequently, many other TOP
derivatives such as TOP-Galactosidase (TOP-GAL, Das-Gupta and Fuchs,
1999), 6-catenin activated transcription-galactosidase (BAT-GAL, Maretto et
al., 2003), TOP-RED (Megason and McMahon, 2002) and TOP-destabilized
green fluorescent protein (TOP-dGFP, Dorsky and Moon, 2002) which allow
direct visualization of the cells that are responding to Wnt signals were
established. These reporter gene constructs therefore would be useful in
detecting the cells that are responding to Wnt signals in a specific population
of cells at specific time during development.
1.2.3.2 Wnt/Ca2+ Pathway
Calcium was first discovered as a second messenger in Wnt signalling
pathway when injection of Wnt5a (Slusarski et al., 1997) or Wntll (Westfall et
al., 2003) mRNA into 1-cell zebrafish embryo increased the frequency of
calcium transients in the enveloping layer of the blastodisc. Based on studies
with overexpression of Wnt5a and -11 in Xenopus (Shedahl et al., 1999; Kuhl et
al., 2000), elevation of intracellular calcium activates calcium-sensitive
proteins, calcium/calmodulin-dependent kinase II (CamKII) and protein
kinase C (PKC), most probably via frizzled receptor, and Knypek and Ror2
(reviewed in Kohn and Moon, 2005). The pathway, however, is not well-
elaborated, and it is not clear whether this pathway is conserved in
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mammals, even though the pathway can counteract the canonical pathway
(Yamaguchi, 2001; Lustig and Behrens, 2003).
1.2.3.3 Planar Cell polarity Pathway
The last pathway, the planar cell polarity pathway does not directly lead
transcription of target genes but instead involves small GTPases such as
RhoA and Cdc42 and Jun Kinase (JNK) and controls cytoskeletal
rearrangements by regulating cell motility, shape and polarity (Veeman et al.,
2003; reviewed in Kohn and Moon, 2005). Its main role is the temporal and
spatial control of embryonic development, as exemplified in the polar
arrangement of cuticular hairs in Drosophila or the convergent-extension
movements in Xenopus where intercalation of mesenchymal and
neuroectodermal cells along anterior-posterior (A-P) axis results in
elongation and narrowing of embryo and neural plate during gastrulation
(Heisenberg et al., 2000; Wallingford et al., 2000; Lustig and Behrens, 2003). It
is uncertain whether there is a relationship between this pathway and the
Wnt/Ca2+ pathway (Yamaguchi, 2001).
1.3 Brief overview of vertebrate Central Nervous System
(CNS) development
The central nervous system (CNS) develops through a series of rather
complicated steps. The first step is the specification of neuroepithelium from
ectoderm cells through a process known as neural induction, which also
requires an inductive interaction with nascent mesoderm and endoderm.
Ectodermal cells appear during gastrulation stage together with mesodermal
and endodermal cells, forming the three primary germ layers (Figure 1.1). In
the mouse, gastrulation begins at E6.5 with the formation of the primitive
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streak (PS) at the posterior end of the embryo which lengthens towards the
anterior end as the gastrulation proceeds. Before this, around E6.0, distal
visceral endoderm cells migrate anteriorly and form the anterior visceral
endoderm (AVE). Signals secreted by the AVE and newly formed anterior
PS induce anterior structures in the presumptive neural ectoderm (review in
Sasai and De Robertis, 1997; Yamaguchi et al., 2001; Stern, 2005).
Neural ectoderm is a derivative of ectoderm which is formed as a result of
neural induction process and neurulation. Neuralution is a process where
neural plate, which is induced by the underlying notochord, folds along the
craniocaudal axis forming a hollow neural tube (Figure 1.5). Formation of
the neural tube results in ectodermal derivatives; skin ectoderm which gives
rise to epidermis and epidermal derivatives such as hair, glands and nails,
neural crest ectoderm that lead to formation of the peripheral nervous
system (PNS) including various types of nerves, ganglia and receptors, and
finally the neural ectoderm which gives rise to the central nervous system
containing neurons, oligodendrocytes and astrocytes (Figure 1.5). Induction
of neural tissue as opposed to epidermal tissues is believed to be
responsibility of an organiser; the Spemann organiser (dorsal lip of the
amphibian, blastopore in zebrafish) or Hensen's node as in birds and
mammals (Spemann and Mangold, 1924; reviewed in Stern et al., 2001) also
known as the default model. According to this model, secreted factors of the
bone morphogenetic protein (BMP) family functions as neural inhibitors and
epidermal inducers. The organiser thus secrets BMP antagonists to
antagonise BMP activity and signals nearby cells to become nervous system,
while cells further away that do not receive these signals develop into skin








Figure 1.5: Formation of neural tube begins with induction of neural plate
by underlying notocord (A). Then the neural plate begins to fold converting
it to a neural groove (B), which deepens and forms a neural tube (C).
Subsequently two masses of ectoderm at the edges of the neural plate form
neural crest (C,D) which later separate neural ectoderm and skin ectoderm
(E). Skin ectoderm, Neural crest ectoderm and neural ectoderm then gives
rise to epidermis and epidermal derivatives, the PNS and the CNS,
respectively. Diagram and legends are adapted and modified from
Professor A. Cuschieri at http://staff.um.edu.mt/acusl/fourthweek.htm.
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studies with chick embryos and some amphibians suggest that induction by
this organiser only presents the earliest inductive events and that neural
induction may involve rather more complex steps (Stern, 2001).
The second step in development of the CNS involves patterning of neural
tube along the anterior-posterior (A-P) axis. At least three interesting models
have been proposed for neural induction and regulation of neural tube
patterning process. Mangold (1933) proposed the existence of several
distinct organisers for the head, trunk and tail. However these organisers
cannot induce neural fate by itself as demonstrated in experiments with
chicks (Tarn and Steiner, 1999; Foley et al., 2000). Additionally, in the
activation-transformation model, Nieuwkoop et al. (1952) proposed double-
gradient stages for the regulation of neural tube patterning. Initial induction
(activation) stage underlined by BMP antagonists produced nervous system
with rostral (anterior) character followed by activity of posteriorizing
molecules (transforming) that gradually generated more caudal (posterior)
region (reviewed by Ciani and Salinas, 2005). However, various experiments
conducted within the last five decades never really agreed with either of
these two models. Recently, studies by Stern (2001, 2004) proposed a model
that reconciles the classical models on how the neuraxis is patterned. They
believe that an initial event similar to the activation step of Nieuwkoop's is
required for induction of unstable expression of early neural markers such as
Sox3 and Otx2, but required additional signal(s) for stabilisation of anterior
neural development followed by a set of third signals, equivalent to
Nieuwkoop's transformation step for formation of posterior axis.
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As mentioned above, the AVE participates in the formation of the A-P axis
even before gastrulation and later during gastrulation specifies anterior
neural ectoderm. In addition, several families of secreted signalling
molecules have been implicated in the process, in particular members ofWnt
and TGF-fi/BMP families. While inhibition of BMP signalling leads to the
formation of neural tissues, inhibition of both Wnt and BMP signals (Figure
1.6) are required for anterior neural patterning (Niehrs, 1999). Interestingly,
posterior neural patterning depends on three posteriorizing molecules; Wnts
(McGrew et al., 1997; Houart et al., 2002; Wilson and Houart, 2004), FGFs
(Cox and Hemmati-Brivanlou, 1995; Pownall et al., 1998) and RA (Durston et
al., 1989; Blumberg et al., 1997; Kudoh et al., 2002; Martynoga et al., 2005) in
addition to inhibition of BMP (Figure 1.6).
The entire neural tube is divided into four longitudinal divisions; the floor,
basal, alar and roof-plates, which enclose a neural canal (Figure 1.6, Rossant
and Tarn, 2002). Patterning of dorsal-ventral (D-V) axis of neural tube occurs
by signalling molecules initially produced by the adjacent ectoderm and axial
mesoderm (formed from cells at the anterior primitive streak, Beddington,
1994) and later in the roof and floor plates of the neural tube (reviewed in
Campbell, 2003). The patterning of neural tube leads to the formation of three
primary brain vesicles, the prosencephalon, mesencephalon and
rhombencephalon, and the spinal cord in the neural canal along the entire
neural tube (Figure 1.6). The prosencephalon (forebrain) then divides into
the telencephalon which gives rise to cerebrum, hippocampus and olfactory
lobes, and diencephalon that forms thalamic and hypothalamic regions.
Additionally, the mesencephalon (midbrain) gives rise to tectum which
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Posterior part of cerebellum, pons and medulla
Tectum, optic lobes and auditory lobes
I
Telencephalon (cerebrum, hoppocampus and olfactory lobes)
Diencephalon (thalamic and hypothalamic regions)
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BMP Inhibitors Cordin &Noggin,
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FGF, WNT, RA &BMP inhibitors
are posteriorizing signaling
molecules
Figure 1.6: Development of the CNS begins with the formation of neural plate
when gastrulation starts around E6 (A). At this time, anterior-posterior (head-
tail) axis appears with the formation of anterior visceral endoderm (AVE) and
anterior primitive streak secreting signals to induce anterior neural development.
Anterior CNS formation is induced by anti BMPs and Wnt inhibitors (i), while
posterior CNS depends on FGF, Wnt and RA in addition to BMP inhibitors (ii).
Around E7, neural plate undergoes a process celled neurulation forming a
hollow neural tube (B). Along its entire length the neural tube is subdivided into
four longitudinal domains: the floor plate, basal plate, alar plate, and roof plate.
Motor neurons are derived from the basal plate (D). Neuralation (around E8)
subsequently divides the neural tube into prosencephalon, mesencephalon and
rhombencephalon and the spinal cord with each giving rise to regions as
described in C. The diagram is adapted from
http://www.cvm.tamu.edu/labbott/13.
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includes the optic lobes and the auditory lobes, while the rhombencephalon
(hindbrain) develops into posterior part of cerebellum, pons and medulla
(reviewed by Ciani and Salinas, 2005).
Highly proliferative cells in the ventricular and subventricular zones of the
neural tube serve as progenitor cells (neural precursor cells, NPCs) for most
different types of neurons such as interneurons and motor neurons
(Muroyama et al., 2002, 2004) and cortical neurons (Levers et al., 2001). In the
developing mouse brain, NPCs give rise to neurons mostly between E10 and
E17 (Qian et ul., 2000). A variety of signalling molecules are believed to
regulate maintenance and proliferation/differentiation of NPCs (Edlund and
Jessell, 1999). Among these, BMPs have been shown to promote neuronal
differentiation of cortical ventricular zone precursors (Li et al., 1998b). Notch
signalling, FGF2 and epidermal growth factor (EGF) can also maintain neural
stem cells in an undifferentiated state (Reynolds and Weiss, 1992; Ohtsuka et
al., 2001; Hitoshi et al., 2002). Besides that Wnt signalling also has been
shown to promote differentiation of the posterior forebrain and also involved
in the formation of dorsal spinal neurons (Lee and Pfaff, 2001; Dickinson et
al., 1994). The signalling molecule Sonic Hedgehog (Shh) secreted from the
notochord and floor plates has been shown to function as a gradient signal
for generation of motor neuron and ventral spinal neurons (Roelink et al.,
1995; Tanabe et al., 1995; Ericson et al., 1996; Tanabe and Jessell, 1996; Jessell,
2000). The roof plate, in addition, has been indicated as a major source of
inductive signals controlling the generation of dorsal interneurons (Lee and
Jessell, 1999). Moreover, expression of secretory proteins of the BMP, FGF
and Wnt families has also been detected from cells at the dorsal end of the
53
neural tube at around the time when the dorsal interneurons are generated
(Lee and Jessell, 1999).
The regulation of these signalling molecules is regulated through the
expression of various transcription factors which control a number of unique
genes to perform different functions during development. These include,
Emx2 and Pax6, which help to regulate early regionalisation of neocortex
(Muzio et al., 2002), Gli3 expression, which is essential for telencephalon
maintenance (Rallu et al., 2002), Foxgl, which is required for the correct
projection of thalamocortical tract (Pratt et al., 2002) and a major regulator for
telecephalic neurogenesis (Martynoga et al., 2005), and the proneural basic-
helix-loop-helix (bHLH) neurogenin (Ngnl and 2) proteins are needed for
neurogenesis of neocortex (Schuurmans et al., 2004). It is therefore important
to note that the development of the CNS requires activities and interaction
between different sets of player genes ranging from different types of
signalling molecule families to different functions of transcription factors.
Understanding the mechanisms of each individual player during the
development process is essential in order to understand the process itself.
The information gained hence would be useful, among many others, in
recapitulating the process in ES cells especially for future use of ES cells as a
potential source for transplantation replacement therapies. One of the
players worth examining is Wnt signalling.
1.4 Wnts and neurogenesis
1.4.1 Developmental Patterning ofWnt Expression in the CNS
A number of RNA expression studies by in situ hybridization, quantitative
reverse transcription polymerase chain reaction (qRT-PCR) and microarrays
have revealed the expression of Wnt genes since the very early stages of
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embryogenesis which later demonstrates the central nervous system as the
primary region for expression of mouse Wnt genes (Gavin et al., 1990;
McMahon et al., 1992a; Parr et al., 1993; Lloyd et al., 2003; Hamatani et al.,
2004; Mohamed et al., 2004; Wang et al., 2004; Kemp et al., 2005). Specifically,
these studies demonstrate the expression of Wntl, -2b, -3, -3a, -4, -5a, -5b, -6, -
7a, -7b, 10b and -11 at preimplantation stages with highest expression of
Wnt3a, -6, -7a, -9a and -10b in the blastocyst (Kemp et al., 2005). In accordance
with this, Wang and co-workers (2004) discovered nuclear localization of 13-
catenin in the ICM at this stage, which indicates the probable function of the
canonical Wnt/ 13-catenin signalling pathway in the region; most of the Wnt
genes expressed in the blastocyst/ICM have been shown to activate the
canonical pathway (reviewed in Wodarz and Nusse, 1998). Just before
gastrulation, around E6.25, Wnt3 is expressed in the prospective anterior and
posterior proximal embryonic ectoderm, after the establishment of AVE (Liu
et al., 1999b). Mouse embryos lacking Wnt3 lack primitive streak and display
gastrulation defects with no appearance of A-P axis formation and inhibition
of neural differentiation (Liu et al., 1999; Yamaguchi et al., 1999). These two
studies clearly demonstrate the requirement of a specific Wnt in particular
developmental event (Logan and Nusse, 2004). Additionally, TOP-GAL
activity was also observed at E6.5-7.0 along the forming primitive streak
(Merrill et al., 2004) indicating the presence of canonical Wnt signals. A
number ofWnt antagonists such as sFRPs, Dkks and Cerebrus also have been
shown to be expressed prior to and during early gastrulation (Belo et al.,
1997; Kemp et al., 2005) consistent with the suggestion that subsequent
induction of forebrain requires inhibition of Wnt signalling (Huelsken et al.,
2000; Mukhopadhyay et al., 2001; Yamaguchi, 2001; Ishikawa et al., 2003). In
agreement to this, Ishikawa and colleagues (2003) show that Ape mutant
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mouse embryos formed truncated forebrain. Besides that, Wnt signalling also
has been shown to inhibit the formation of neuroectoderm and anterior PS as
it is observed that LRP5+/~LRP6-'- mouse embryos generate more
neuroectoderm and display an expanded anterior PS during gastrulation
(Kelly et al., 2004).
During late gastrulation stage, around the time of neural tube closure (E8-
8.5), Wnt7b and -3a RNA are detected in the presumptive diencephalon,
anterior to the midbrain-forebrain junction. By E9.5, various expression
palterns of Wnt genes are found to encircle the entire neural tube (Parr et al.,
1993). At this time, Wntl and Wnt3a are detected in dorsal midbrain, Wnt4
and Wnt7b at dorsal forebrain and Wnt5 and Wnt7a at ventral forebrain.
Studies by Grove et al. (1998) and Lee et al. (2000b) also have identified a
potential source of patterning signals regulated by multiple Wnt genes
(Wnt2b, -3a, -5a, -7a, -7b and -8b) expressed in the embryonic medial
telencephalon (cortical hem). Their expression in the cortical hem may imply
that at least one of the proteins is involved in hippocampal development.
Indeed, a loss of the hippocampal region was observed in Wnt3a and LEF1
mutant mice (Lee et al., 2000b; Galceran et al., 1999). Mouse with deletion of
6-catenin in the dorsal telecephalon also formed hippocampal region similar
to those observed in Wnt3a'h and LEFmutants. In an earlier study, Wnt5a
transcripts were also demonstrated to be present in the developing CNS,
specifically in the ventral portion of the entire midbrain (Gavin et al., 1990).
In addition, Wnt expression is also detected at midbrain-hindbrain boundary
(MHB, Parr et al., 1993; Panhuysen et al., 2004)). Wntl, the first Wnt
identified, is expressed in the dorsal midline of diencephalon to spinal cord
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including the MHB (McMahon et al., 1992b). Loss of Wntl activity has been
shown to result in deletion of midbrain and dorsal metencephalic structures
(McMahon and Bradley, 1990; Thomas and Capecchi, 1990; McMahon et al.,
1992). However, no phenotypic abnormalities were observed in the
diencephalon, caudal hindbrain and spinal cord of the Wntl mutant mice
even though its normal expression has been detected in these regions.
Together with Wntl, Wnt3a and -7b are also expressed in the MHB (Parr et al.,
1993; Panhuysen et al., 2004). Interestingly, a wider region of the CNS is
affected in Wntl/Wnt3a double knockout compared to when only Wntl or
Wnt3a is deleted (Ikeya et al., 1997). This case represents several cases where
full mutant phenotypes are revealed only when multiple Wnt genes are
eliminated (Logan and Nusse, 2004). A similar scenario was observed when
downstream Wnt pathway components were deleted. Defects similar to
Wnt3a mutants were observed in LEF1 and TCF1 mutants but only when
both LEF1 and TCF1 were eliminated (Galceran et al., 1999). Besides Wntl
and Wnt3a, Wnt5a, -7a and -7b are also expressed in hindbrain region with
each expression restricted to its specific subregions (Parr et al., 1993).
Expression ofWnt genes in the spinal cord is a continuation of the expression
profiles in the hindbrain which results in emergence of three expression
patterns. First, expression of Wntl, -3 and -3a which are detected in dorsal
roof plate region, except for expression of Wnt3 which does not extend into
the most posterior region of the spinal cord (Parr et al., 1993). A second
pattern of expression was demonstrated by Wnt5a, -7a and -7b which are
expressed in more ventral portions of the spinal cord (Gavin et al., 1990).
However, none of these are expressed in the floor plate while expression of
Wnt5a is restricted to the most anterior part of the spinal cord (Parr et al.,
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1993). Finally, Wnt4 is expressed at dorsal domain and the only Wnt gene
that is expressed in the floor plate of the spinal cord at this stage, E9.5. The
expression patterns of these Wnt genes are observed at the same time that the
first spinal cord neurons are born (around E9.5, Nornes and Carry, 1978)
which may imply the function of these genes in the specification of neuron
types or formation of neuronal connections. Indeed, Muroyama and co¬
workers (2002) discovered that Wntl and Wnt3a proteins are required for
proper generation of interneuron subclasses in the spinal cord. Additionally,
Wnt3 expressed in motorneurons regulates terminal arborisation of muscle
sensory afferents in the spinal cord demonstrating the role of Wnt protein in
the formation of the sensory-motor connections in the mouse spinal cord
(Krylova et al., 2002). Wnt7a has also been shown to regulate axonal
remodelling and presynaptic differentiation of pontine mossy fibers (Hall et
al., 2000). Moreover, Wnt7a mutant mice also show morphology of delayed
maturation of synapses in the cerebellum (Hall et al., 2000). Wnt4 that is
specifically expressed in a rostrocaudal gradient in the floorplate is believed
to be involved in axon guidance in commissural axons (Lyuksyutova et al.,
2003).
Expression profiles of Wnt genes during the development of CNS clearly
suggest the important role of Wnt activity in the process as well as the
complexity of Wnt signal transduction mechanisms. Its knockout
phenotypes which closely correlate with the expression patterns, very
importantly, indicate the requirement of that particular Wnt gene in the
specific event during the development (Logan and Nusse, 2004). In addition,
the complexity of Wnt signalling is also added by the redundant function of
Wnt signalling components (LEF1+ and TCF1-'- double mutants, Galceran et
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al., 1999) as well as by the activity of different Wnt genes (Wntl_/~ and Wnt3a'''
double mutants, Ikeya et al., 1997; McMahon et al., 1992b). Promiscuous
Wnt/Fzd interactions as well as activation of at least three different pathways
also add up to the complexity of Wnt signalling. Wnt also forms gradients
which through direct or indirect interaction with other secreted signalling
molecules and transcription factors regulate the expression of target genes in
a concentration-dependent manner (Wodarz and Nusse, 1998). Nevertheless,
Wnt signalling has been seen to be involved in controlling the initial
formation of neural plate and many subsequent patterning decisions in the
embryonic nervous system, dorsal-ventral (Megason and McMahon, 2002;
Saint-Jeannet et al., 1997) and anterior-posterior (McMahon and Bradley,
1990) patterning of the CNS as well as axon guidance and synapse formation
(reviewed in Ille and Sommer, 2005). Specifically, it is reasonable to believe
that one of the main functions of Wnt signalling in the development of CNS
is to regulate cell fate decision; between promoting cell proliferation or
differentiation.
1.4.2 Multiple roles ofWnt signalling during CNS Development
A balance between proliferation and differentiation rate of
progenitors/neural stem cells is essential for proper development of the CNS.
Unfortunately, due to overlapping and redundant functions of individual
Wnt genes besides being difficult to be isolated in active form proteins,
understanding the roles of Wnt signalling in mouse neural development in
vivo mostly comes from transgenic mice overexpressing downstream Wnt
signalling pathway components, specifically fi-catenin or APC (Chenn and
Walsh, 2002; Kielman et al., 2002; Zechner et al., 2003; Israsena et al., 2004;
Backman et al., 2005). As it is believed that the components of the Wnt
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pathway may be involved in promoting proliferation of primitive cells in the
human skin (Zhu and Watt, 1999) and the mouse gut (Korinek et al., 1998),
the components also have been indicated through regulation of Wnt
signalling to be involved in proliferation of progenitors/neural stem cells in
the mouse brain (Chenn and Walsh, 2002).
In vitro and in vivo studies of neural stem cells, specifically, have implicated
the role of Wnt signalling in regulating proliferation or differentiation of
these cells (reviewed by Patapoutian and Reichardt, 2000; Kleber and
Soinmer, 2004). Transgenic mice overexpressing a stabilized form of 13-
catenin in neural progenitors (under the control of nestin enhancer) increased
the number of progenitor cells and decreased neuronal differentiation, which
resulted in massive enlargement of the cerebral cortex (Chenn and Walsh,
2002, 2003; Zechner et al., 2003). On the contrary, retroviruses overexpressing
13-catenin in NPCs isolated from mouse E14 cortex produced increased
number of neurons upon withdrawal of FGF2 even though in the presence of
this mitogenic stimulus the NPCs produced high number of neurospheres
(Israsena et al., 2004). Even though there was a concern raised against the use
of FGF2 that led to the different roles of 13-catenin between these two studies;
in promoting proliferation and also differentiation of cortical cells.
However, it is believed that the difference is most likely due to the timing at
which the stabilized form of 13-catenin is expressed (Hirabayashi et al., 2004).
Similar to the study by Israsena and colleagues, a study by Hirabayashi et al.
(2004) also revealed that a stabilized form of fi-catenin promoted neuronal
differentiation of cortical NPCs harvested from El1.5 neocortex. The
difference between these studies compared to that of Chenn and Walsh
(2002) is that the ectopic expression of the stabilized form of 13-catenin in the
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earliest study was activated at around E8.5 as activation of nestin enhancer is
known to be at around E8.5. Therefore these studies strongly suggest that
the response of NPCs to Wnt signalling, in particular the canonical Wnt/ 13-
catenin pathway is stage dependent; exposure of NPCs to Wnt signalling at
early stage increases proliferation of NPCs but also promotes the formation
of neurons upon exposure to Wnt activity at the late stage during
development.
Many other studies also exhibit the same phenomena. In an ex vivo study,
Viti and co-workers (2003) also show that cell proliferation of neural
progenitors from E10.5-13.5 mouse forebrain (dorsolateral cortex) transfected
with a retrovirus expressing HA-tagged Wnt3a, -7a or -7b increased while
delaying the differentiation of these cells into neurons. When the viruses
expressing Wnt7a-HA were injected into the lateral ventricles of E10.5 mice,
more progenitors were diverted to subventricular zone (SVZ) instead of
differentiating into neurons as normal. Interestingly, they also discovered
that Wnt7a did not enhance proliferation when the progenitors were infected
at later stage, E16. Their studies clearly demonstrate that Wnt is able to
promote proliferation of early cortical progenitor cells in vivo and in vitro.
Additionally, Hirabayashi and colleagues (2004) also demonstrated that
inhibition of Wnt signalling results in reducing number of neurons when
NPCs were infected with a retrovirus expressing Axin and that retrovirus-
mediated expression ofWnt7a in dorsal cerebral cortex at late stage promotes
the formation of neurons. In another study, treatment of Wnt3a conditioned
medium (CM) onto neural stem cells isolated from El 1.5 mouse embryos
inhibits the formation of neurospheres but promoted and enhanced neuronal
differentiation of these forebrain neurospheres when treated with Wnt3a CM
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at late stages (Muroyama et al., 2002, 2004) and also increased self-renewal
activity of neurospheres from ganglionic eminence (Israsena et al., 2004). The
absence of hippocampus region in Wnt3a mutant mice also implies the
involvement of Wnt3a-mediated proliferation in the specification of
hippocampal cell fate (Lee et al., 2002). In further analysing the Wnt3a
mutant mouse, the authors discovered that Wnt3a regulates the proliferative
expansion of caudomedial cortical progenitor cells at E10.5. These studies
therefore obviously imply the importance role of Wnt signalling in
maintenance, proliferation and differentiation of forebrain progenitor cells in
vivo and in vitro.
The effect of Wnt signalling on the proliferation and differentiation of
progenitors is also observed in the midbrain. Studies by Castelo-Branco et al.
(2003), demonstrate that treatment of Wntl-HA or Wnt3a-HA CM increases
the proliferation of dopaminergic precursor cells obtained from ventral
midbrain (VM) precursors, while treatment with Wnt5a-HA CM increases
differentiation of these precursors into dopaminergic neurons (DA). The
authors also discovered that treatment with Wntl-HA CM on the VM cells
increased the number of both DA and non-DA VM neurons. Similar result
was also obtained in a recent study when rat VM E14.5 precursor cultures
were treated with purified Wnt5a-HA (Schulte et al., 2005); Wnt5a promotes
differentiation of dopaminergic precursors into DA neurons at midbrain
region. Wnt signalling also has been shown to strictly regulate cell
proliferation of progenitor cells in the mid/hindbrain boundary (MHB)
region in a spatiotemporal manner which is essential in maintaining the
MHB region (McMahon and Bradley, 1990; Thomas and Capecchi, 1990;
Panhuysen et al., 2004). Overexpression of Wnt'l in mouse embryos under
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control of the engrailed (Enl) promoter from E8.5 of embryonic development
strongly increases the proliferation of neural progenitors in the dorsal region
but not in the ventral region of MHB (Panhuysen et al., 2004). Ectopic
expression of Wntl under a control of the Hoxb-4 region A enhancer also
increased the proliferation of spinal cord precursor cells when analysed at
E10.5 and E12.5 (Dickinson et al., 1994).
These studies undeniably suggest the important roles of Wnt signalling in
cell fate specification for forebrain, midbrain, hindbrain and spinal cord
regions for proper development of the CNS. The different roles played by
this complex signalling pathway highly depend on the cellular contexts and
very stage specific. Based on these studies, it is reasonable to suggest that
early exposure to Wnt signals promotes the proliferation rate of neural
precursor cells while the formation of neurons seems to be enhanced upon
exposure to Wnt signals at late stages during development. Nevertheless, it
is worth noting that constitutive overexpression of genes leading to
continuous activation of Wnt signalling pathway seem to inhibit the
formation of neural lineages.
1.5 Wnts and neural Differentiation of ES cells in vitro
To date, not many studies have been carried out to unravel the roles of Wnt
signalling during neural differentiation of mouse ES cells in culture. In an
effort to identify genes that could play a role in the commitment or
specification of neural lineage in ES cells, Aubert and colleagues (2002), by
using microarray technique, identified the Wnt antagonist sFRP2 as a major
unregulated gene during neural differentiation. When functionally
evaluated, using an episomal expression technology, they discovered that
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overexpression of sFRP2 enhances neural development of ES cells in culture,
implying the inhibitory effect of Wnt activity to neural differentiation
process. To further examine the effect of Wnt signalling during the process,
they used Wnfl-overexpressing ES cells and also lithium chloride treatment,
which partially mimics Wnt signalling by inhibiting the activity of GSK-3fi.
Results from both experiments showed that Wnt activity suppressed neural
differentiation.
A study by Kielman et al. (2002) also showed that ES cells lacking APC were
unable to differentiate into neural lineages. In addition, inhibition of neural
differentiation was also observed from APC-deficient and stably transfected
dominant active fi-catenin ES cells (Heagele et al., 2003). In the study, both of
these ES cell lines activated Wnt signalling target genes suggesting
modulation of Wnt signals in the differentiation of ES cells. Interestingly, a
recent study by Watanabe et al. (2005) demonstrated that treatment with
Wnt3a at late culture stages in neural differentiation process increased the
number of neural cells, while exposure to Wnt3a at the early culture stages
strongly suppressed neural conversion. Another study by Schmidt and
colleagues (2001) also suggested a specific influence of lithium chloride on
neuronal differentiation. The study discovered that upon treatment with
LiCl, mRNA expression of Mash and Enl were decreased while mRNA
levels of neuron-specific genes such as synaptophysin and neurofilament,
NFM, were increased, implying that Wnt signalling inhibits the formation of
NPCs but also promotes differentiation into neurons. These studies are also
supported by a recent study by Otero et al. (2004) which demonstrates that an
increase in fi-catenin signalling by treatment with Wnt3a CM or
overexpression of fi-catenin induces neuronal lineage commitment.
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Therefore, these studies indicate that Wnt signalling also affect neuronal
differentiation of ES cells in vitro.
Taken together, these studies seem to suggest thatWnt signalling inhibits the
formation of neural precursor cells, and also stimulates the differentiation of
these cells into neurons. Thus, Wnt activity appears to be stage-dependent,
which depends on the cell-intrinsic properties at a particular point during
neural differentiation process. Therefore, it would be interesting to monitor
the effect of stimulating or inhibiting the activity of Wnt signal at different
stages during neural differentiation of mouse ES cells in vitro.
1.6 Conditional Gene Expression System
One major drawback toward understanding the mechanisms underlying the
control of self-renewal and differentiation of ES cells is the lack of an
inducible expression system that would allow overexpression of certain gene
of interest to be turned on in undifferentiated as well as their differentiated
derivatives both in vivo and in vitro (Vallier et al., 2000). The system not only
provides an invaluable tool that overcomes the lethality problem with
constitutive expression of knockouts but also gives us the ability to tightly
control gene expression in a temporal-, spatial- and tissue-specific manner.
In other words, it would be useful to have a system that could control the
timing of transgene expression, avoid the problem with transgene extinction,
for example, during differentiation and also any toxicity problem upon
constitutive overexpression of a transgene. This type of control can be
accomplished using binary transgenic systems, which fall into two
categories. One of the categories uses an effector that transactivates
transcription of the transgene and is normally used to activate transgene in
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gain-of-function experiments. The second uses an effector which is a site-
specific DNA recombinase that rearranges the transgene and is normally
used to activate or silent target gene (reviewed in Lewandoski, 2001; Van der
Weyden et al., 2002). For the purpose of this study, only the site-specific
DNA recombination category will be described.
1.6.1 Site-specific DNA Recombination
The conditional gene expression by site-specific recombination system is
composed of a recombinase enzyme and its target sequence, which,
depending on the orientation and location of the target sequence, allows for
the deletion, insertion, inversion or translocation of specific regions of DNA.
Presently, two members of the A-integrase family, Cre, (cause recombination)
from bacteriophage PI (Sauer and Henderson, 1989) and Flp, from
Saccharomyces cerevisiae (O'Gorman et al., 1991), have been used in this
system. Cre and Flp recombinases catalyse a DNA recombination event
between two 34-bp recognition sites known as loxP and FRT, respectively.
Cre appears to be more effective in recombining a transgene array in vitro
and in vivo than Flp (Ringrose et al., 1998), and Cre/loxP has been the most
widely used site-specific DNA recombinase system in both ES cells and mice
(Van der Weyden et al., 2002). The system is known for its simplicity, no loss
of gain of nucleotides after recombination, small 34-bp target site (loxP)
which does not affect adjacent genes in the chromosome, long distance
function and function in a wide range of cell types. However, Cre
recombinase can also cause chromosomal rearrangements or aberrations
(Loonstra et al., 2001).
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Chemically inducible forms of Cre have been used in order to create
spatiotemporally controlled transgene expression. Tamoxifen-dependent
Cre-mediated recombination which uses the ligand-binding domain of
mutated human estrogen receptor, ERT and ERT2, fused to Cre (Cre-ERT and
Cre-ERT2) is often used. Cre is activated upon exposure to tamoxifen or
synthetic estrogen, 4-hydroxytamoxifen (4-OHT, Feil et al., 1996, 1997; Indra
et al., 1999). Cre-ERT2 recombinase is more sensitive to 4'-OHT than the
original Cre-ERT (Feil et al., 1996; Indra et al., 1999).
1.6.2 Inducible expression of Wnts
Dramatic phenotypes ranging from embryonic lethality and CNS
abnormalities to kidney and limb defects were observed in vertebrates with
loss of a single Wnt gene (review in Logan and Nusse, 2004). An inducible
expression system, therefore, would be useful in order to circumvent the
problem with lethality from constitutive deactivation or even constitutive
overexpression of a particular Wnt gene. However, few studies, looking for
the function of Wnts in neural development have used the system. As far as
this study is concerned, to date, very few studies have ever described the use
of conditional transgenic mice embryos overexpressing Wnt gene to study a
specific Wnt function at a particular time during development of the CNS.
Only tissue-specific and no temporally controlled of transgenic expression
has been described. A recent study by a group of researchers in Germany
has managed to generate transgenic mouse embryos ectopically expressing
Wntl under the control of Enl promoter using a conditional knock-in
approach (Enl+/Wntl, Panhuysen et al., 2004). Dickinson and co-workers (1994)
used transgenic mouse embryos overexpressing Wntl under the control of
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the Hoxb-46 Region A enhancer. Conditional expression of a stabilized form
of fi-catenin under a control of nestin promoter also has been described by
Backman et al., 2005.
Similarly, when looking for the roles of Wnt signalling during neural
differentiation of ES cells, most of the studies have either used constitutive
overexpression or deactivation of a specific gene of interest (Aubert et al.,
2002; Kielman et al., 2002; Haegele et al., 2003; Otero et al., 2004). A system
that gives us the ability to tighly control transgene expression in temporally-
controlled manner during neural differentiation of ES cells in culture
condition, therefore, would be useful in avoiding the problem with Wnt
toxicity besides circumventing the effect of conditioned medium
underscoring the function of Wnt protein if Wnt conditioned medium were
to be used. Unfortunately, few of the existing inducible systems designed
test for inducible expression restricted to both undifferentiated and
differentiated derivative of ES cells in vitro. An interferon-based conditional
expression of the chloramphenicol aceyltransferase (CAT) gene has been
successfully regulated in undifferentiated ES cells. However, the interferon-
mediated CAT expression in the differentiated-derivatives of ES cells in vitro
was not tested (Whyatt et al., 1993). In another study, tamoxifen-dependent
Cre-mediated recombination has also been shown to activate a stably
integrated lacZ reporter gene in ES cells. Again, only undifferentiated ES
cells were tested for tamoxifen-mediated expression of lacZ (Zhang et al.,
1996). In addition, high dose of tamoxifen, which far exceeded the threshold
above which tamoxifen becomes detrimental to cell growth (Danielian et al.,
1998), was required to induce the expression in the study in addition to
6 The gene is expressed in proliferating NPCs (ventricular zone) of the hindbrain and spinal cord
(Dickinson et al., 1994)
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strong background expression. One study reported tightly controlled
expression of the Oct3/4 transgene driven under a tetracycline-regulated
transactivator, tTA, which in responding to low dosed of tetracycline
induced the expression of the transgene in undifferentiated ES cells (Niwa et
al., 2000). The study also, since only interested in analysing the effect of
Oct3/4 in pluripotent cells, reported no induction of the transgene in
differentiated ES cells.
A study by Vallier et al. (2001) has successfully managed to develop a
conditional gene expression system that allows an expression of human-
alkaline phosphatase (hAP) to be tighly controlled both in undifferentiated as
well as differentiated ES cells in vitro and also in vivo. Transgene expression
in the study was tightly controlled in response to a nondetrimental dose of
tamoxifen. The study thus provides an invaluable approach in inducing
ectopic expression of gene during differentiation of ES cells directed to
various lineages. Hence allowing for a variety of gene functional analyses to
be carried out in efforts to understand the mechanisms behind differentiation
process of ES cells.
1.7 AIMS
Previous in vivo and in vitro studies have strongly suggested the important
roles of Wnt signalling during neural development. A few studies using ES
cells also seem to imply that Wnt inhibits the differentiation of ES cells into
NPCs, and, at later stage, promotes the differentiation of these precursors
into neurons. Using an invaluable system that allows the analysis of gene
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function to be carried out in a more simplified environment, ES cells, this
study therefore was conducted in order to unravel the roles ofWnt signalling
during neural development in vitro with a focus to the hypothesis that Wnt
signalling may inhibit differentiation of ES cells into NPCs, and may also
stimulate the differentiation of NPCs into neurons. The general aims of this
thesis are as follows:
1) To examine the expression profiles of all 19 mouse Wnt genes and
two Wnt antagonists during neural differentiation of ES cells.
2) To generate and characterise inducible and reporter gene expression
systems in ES cells
3) To analyse the effect of overexpressing Wnt and Wnt antagonist at
particular time points during neural differentiation of ES cells
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Chapter 2: Materials and Methods
2.1 Materials
2.1.1 Suppliers and equipment
All chemicals used were of analytical, molecular biology or tissue culture
grade, where appropriate, and were supplied by Sigma, Merck or Fisher
Scientific unless otherwise stated. Electrophoresis grade agarose was from
Flowgen (Seakem LE agarose). Restriction and modifying enzymes were
from Roche Molecular Biochemicals or New England Biolabs. All primers
were synthesized by MWG Biotech AG.
All centrifugations using 1.5 ml and 0.2 ml tubes were carried out using
bench-top centrifuge Biofuge Pico (Heraeus) at room temperature (RT) or
Biofuge Fresco at 4°C. Centrifugations using 20 ml universal bottle for tissue










2.67 mM KC1, 1.47 mM KH2PO4, 137.93 mM
NaCl, 8.06 mM NaaHPO^HzO
0.1 M Tris Borate, 0.02 M EDTA
100 mM Tris base, pH 7.5,150 mM NaCl




1.6% Tryptone, 1% yeast extract, 0.5% NaCl;
autoclaved at 121°C for 20 minutes
50 mM NaOH, 4% paraformaldehyde in IX





100 mg/ml in double distilled water, sterile
filter (0.22 pm, Nalgene)
ESM without LIF
IX GMEM (BHK-21, Gibco), 10% (v/v) Foetal
calf serum (Gibco), 1% MEM non-essential
amino acids (Gibco), 1 mM sodium pyruvate
(Gibco), 0.1 mM 2-mercaptoethanol (Gibco), 2
mM L-glutamine (Gibco), LIF lOOU/ml
Human recombinant Leukaemia inhibitory
factor (LIF) was made in house by Mrs
Rowena Smith by transfection of COS-7 cells
with an expression plasmid harbouring the
human LIF construct.
HEK-M RPMI 1640 medium (Gibco), 10% (v/v) foetal
calf serum (FCS, Gibco), 20 mM L-Glutamine
(Gibco), 20 U/ml Penicillin (Gibco), 20 mg/ml
streptomycin (Gibco)
0.3% BSA, 1% appropriate serum, 0.1%
Immuno-blocking solution Tween-20 in IX PBS, sterile filter (0.22 pm,
Nalgene)
LB/2xYTagar 1.5% agar (w/v) in appropriate broth;
autoclaved at 121°C for 20 minutes
Luria-Bertani (LB) broth 1% (w/v)Tryptone, 0.5% (w/v)yeast extract,
0.5% (w/v) NaCl; autoclaved at 121°C for 20
minutes
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Mowiol 2.4g Mowiol (Calbiochem Cat no 475904), 4.76
ml Glycerol (Fisher Scientific) and 12 ml
ddhhO-mixed overnight at RT. 12ml of 0.2M
Tris (ph8.5) was added and heated at 50°C for
1-2 hours. The solution was spun at 2000 rpm
for 15 minutes. Finally, 2.5 % of antifade [1,4-
diazobicyclooctane (DABCO) Sigma] was
added. Store in aliquots at -20°C.
Protein-lysis buffer TENT buffer with 1.0 pg/ml Aprotinin, 1.0 pM
Leupeptin, 2.0 pM Pepstatin, 1 pg/ml Pefabloc
(Calbiochem)
Orange loading dye 50% glycerol, 2 mM EDTA, few grains of
orange G dye in double distilled water
PBSG 5% goat serum in IX PBS
Permeabilisation solution 1% Triton-XlOO in IX PBS
TE
TENT buffer
10 Mm Tris-HCl, 1 mM EDTA, pH 7.4
20 mM Tris pH 8, 2 mM EDTA, 150 mM NaCl,
1% Triton-XlOO
Western-transfer buffer
20% methanol, 0.1 M glycine, 0.01M Tris-base
in double distilled water or 20% methanol in
IX transfer buffer (NP0006, Invitrogen)
Western blot-blocking
buffer
10% (w/v) skimmed milk (Marvel) in
IX TBS-T
2.2 Cell culture techniques
2.2.1 ES Cell lines
All ES cell lines used were obtained from Institute for Stem Cell Research,
University of Edinburgh. Background information on the cell lines is
described in later chapters of this thesis. Among the cell lines used were 46C
73
ES cell line, a Soxl-GFP knock-in reporter ES cell line (Aubert et al., 2003),
and R26CT2S cell line, a Cre-expressing cell line (Grotewold, unpublished).
46C was used in screening for the Wnt expression profiles during neural
differentiation process, and was also used for transfection with TOP-Red2
construct for determination of specific cells that were responding to the Wnt
signalling during the process (more details are described in Chapter 3 and 4
of this thesis).
2.2.2 Other mammalian cell line
The only other cell line used was human embryonic kidney (HEK 293) cells
obtained from European Cell Culture Collection. This cell line was used to
test the functionality of a plasmid construct that was built, TOP-Red2 prior to
transfecting the construct into an appropriate ES cell line.
2.2.3 Routine work
Sterile conditions according to Class II procedures were applied during
maintainance of all cell lines. Culture wastes and glassware were soaked and
washed in 5% Virkon after use. The wastes were then autoclaved at 121°C
for 20 minutes prior to disposal.
2.2.3.1 Pre-coating plate
2.2.3.1.1 Gelatin
Plates or flasks for growing embryonic stem (ES) cells were pre-coated with
pre-warmed 0.1% gelatin (Sigma) in IX PBS for at least 10 minutes at room
temperature. The excess gelatin was pipetted out prior to plating the cells.
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2.2.3.1.2 PDL/laminin
Plates and glass chamber slides used to grow dissociated embryoid bodies
(EBs) for the formation of neural precursor and neuron-like cells were pre-
coated with 10 pg/ml of poly-D-lysine (PDL, Sigma) or 2 pg/ml of laminin
(Sigma), in IX PBS. They were coated with PDL for at least 20 minutes at
room temperature, washed with IX PBS twice prior to coating with laminin
for at least 20 minutes at room temperature. The excess laminin was pipetted
out before plating the cells.
Alternatively, PDL-coated plate could be left dry at 4°C up to several weeks.
The plates could also be kept at 4°C overnight in laminin.
2.2.3.2 Thawing cells
Frozen cells from liquid nitrogen tank were quickly thawed in 37°C water-
bath (Grant) for about 1 minute with shaking after being transported into ES
tissue culture room in dry ice. The thawed cells were then gently transferred
into 9 ml of pre-warmed complete ES medium (ESM, refer to section 2.1.2)
and spun down for 5 minutes at 1000 rpm. Depending on the size of the
pellet, which approximately indicates the amount of cells present, an
appropriate volume of ESM was used to resuspend the pellet. Normally, 7
ml, 5 or 1 ml of pre-warmed ESM was used to resuspend the pellet before
plating the cells into gelatin-coated (refer to section 2.1.3) T25 flask, 6- or 24-
well plate (Nulge-Nunc or Greiner), respectively. The cells were then grown
in 37°C incubator in an atmosphere of 5% CO2 (Sanyo).
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2.2.3.3 Splitting cells
The cells were ready to be split once they were 90-100% confluent for HEK
293 or 70-90% confluent for ES cells. The cells were rinsed with IX PBS twice
after the medium had been aspirated off, followed by an incubation in an
appropriate volume (Table 2.1) of IX trypsin-EDTA (Gibco-Invitrogen) in
37°C incubator for 1-3 minutes until the cells detached from the flask. The
trypsin was then deactivated in an appropriate volume of ESM or HEK-M
(Table 2.1) before the cell suspension was triturated 6-12 times to dislodge
the cells. Subsequently, the cells were collected by spinning the suspension
at 1000 rpm at RT for 5 minutes, and resuspended in an appropriate volume
before being counted using haemocytometer. The cells were then seeded
into a desired flask (pre-coated with 0.1% gelatin for ES cells see section 2.1.3)
at appropriate density (Table 2.1), and incubated in 37°C incubator in an
atmosphere of 5% CO2 (Sanyo) until confluent.
Table 2.1: Splitting cells
IX Trypsin (ml)
ESM or HEK-M for
deactivation of
trypsin (ml)
Cell density for plating
cells
96-well plate 0.04 0.10 -
24-well plate 0.10 0.25 3-5 X 103
48-well plate 0.25 0.25 3-5 X 104
6-well plate 0.5 0.5 2-4 X 105
T25 flask 1.0 4.0 1-2 X 106
T75 flask 2.0 8.0 1.5-2.5 X 106
T180 flask 4.0 16.0 4-5.5 X 106
60 mm dish 0.5 1.0 2-4 X 105
100 mm dish 2.0 8.0 1.5-2.5 X 106
2.2.3.4 Freezing cells
In general, 70-80% confluent monolayer grown cells were trypsinised as
described in section 2.4.3.2. Following the deactivation of trypsin in an
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appropriate volume of ESM (Table 2.1), the cell suspension was spun after
the addition of an equal volume of freezing medium (10% DMSO, 10% FCS
in ESM) at 1000 rpm for 5 minutes at RT. The cell pellet was then
resuspended in an appropriate volume of freezing medium (2.0 ml for T25
flask or 4.0 ml for T75 flask) prior to freezing at -80°C for a few days until
permanently stored in liquid nitrogen, in 1.0 ml aliquot per cryovial
(Nalgene).
2.3 Molecular Biology Techniques
2.3.1 RNA extraction
RNA was extracted with all standard precautions in handling RNA taken.
Gloves and sterile filter tips and tubes were used throughout the whole
procedure. The extracted RNA was kept at -20°C for a short storage, and at -
70°C for longer storage.
2.3.1.1 Whole embryo
RNA was extracted from whole mouse embryo E10.5, 11.5 and 12.5, where
E0.5 is taken as midday on the day hat plug was detected. The mouse was
killed by cervical dislocation and the whole embryos were taken out and
washed in sterile IX PBS. The embryos were kept on ice in the PBS until
processed.
RNA extraction was carried out using TRIZOL (GibcoBRL), a phenol-
chloroform based protocol, following the manufacturer's protocol. The
embryo was weighed on a cleaned weighing boat prior to chunking them
using a sterile blade. The tissue was lysed in the appropriate amount of
TRIZOL following the manufacturer's recommendation. The RNA pellet
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was properly dried before being reconstituted in nuclease-free water
(Qiagen).
2.3.1.2 Cell lines
RNA extraction from cell lines was carried out using RNAeasy mini kit
(Qiagen), a spin column based protocol, following the protocol described by
the manufacturer with slight modifications, where appropriate. In general,
most extractions were carried out from cell lines trypsinized from 6-well
plate. After trypsinization, the cells were washed twice with IX PBS and the
cells were collected by spinning the cells at 10,000 rpm in 1.5 ml centrifuge
tube at room temperature. The cell pellet could then be stored at -70°C or
immediately processed for RNA extraction.
The number of single cells harvested from a well of 6-well plate would
normally be lysed in 400 pi of guanidine-isothiocyanate contained lysis
buffer [1 ml RLT buffer (Qiagen) + 10 pi 2-mercaptoethanol (Sigma)]. The
cell lysate was pipetted and vortexed to completely lyse and homogenize the
lysate. It is very important to ensure that the cells are completely lysed in
order to have a good yield and quality RNA. In order to promote a selective
binding of total RNA to the silica-gel-membrane, an equal volume of 70% of
ethanol in nuclease-free water was added into the lysate prior to applying
the sample into a spin column. The spin column was spun at 13,000 rpm for
15 seconds and the flow-through was discarded. Following the
manufacturer's suggestion, RNase-free DNAse (Qiagen) treatment was
conducted to efficiently remove any DNA contamination. The column was
washed several times as suggested by the manufacturer, prior to eluting the
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RNA in appropriate volume (normally 25-30 pi) of RNase-free water into a
spun-dried column membrane.
2.3.1.3 Embryoid bodies (EBs)
RNA extraction from EBs was also carried out using RNAeasy mini kit
(Qiagen) following the protocol described by the manufacturer. The EBs
were transferred into a 20 ml universal tube using a pastette. By letting the
EBs settle down for 5 minutes, the medium was pipetted off using 20 ml
disposable plastic pipette as it has a wider tip. Using the same method, the
EBs were then washed with IX PBS twice before being transferred into a 1.5
ml tube, where they were finally collected by spinning at 10,000 rpm at RT.
The EBs pellet was either stored at -70°C or immediately processed for RNA
extraction, as described in section 2.2.1.2, except that the EBs were passed
through sterile 21 gauge needle for several times for complete cell lysis.
Generally, EBs from 60 mm dish would be lysed in 600 pi lysis buffer
(Qiagen) after passing them through the gauge needle fitted on an RNAse-
free syringe.
2.3.2 DNA/plasmid extraction
Plasmid DNA was extracted from overnight grown bacterial culture using
Qiagen mini-, midi-or maxi-preps kits depending on the volumes of the
cultures as recommended by the manufacturer. Bacterial cultures were
either grown at 37°C (Sanyo) or 30°C (SI-600R, Lab Companion) with
shaking at 225 rpm. A 2 ml-starter culture for maxi- and midi-preps kits was
incubated at the appropriate temperature with the indicated speed of
shaking for 6 hours prior to growing the culture in a larger volume of
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cultures in 1 in 500 dilutions overnight (16-18 hours) with an appropriate
antibiotic.
2.3.3 DNA precipitation
Precipitation of DNA was conducted when certain concentration of DNA
was required for specific molecular applications; DNA sequencing or
introducing DNA construct into bacterial cells via electroporation.
The required volume of DNA was pre-determined before the DNA could be
precipitated, or directly precipitated from ligation mixture. 0.4 volume (0.4Y
pi) of 5M ammonium acetate (NH4 OAc, pH 5.5) and 2.5 volumes (2.5Y pi) of
absolute ethanol were added to the required volume of DNA (Y pi). The
mixture was vortexed to mix and the DNA was precipitated by
centrifugation at 13,000 rpm for 30 minutes at 4°C. The DNA pellet was then
washed with 500 pi of 75% absolute ethanol twice by centrifugation, as
above, for 15 minutes. The pellet was then dried at 37°C for 5-10 minutes
before being sent for sequencing or reconstituted in the required volume of 2
pi prior to electroporation.
2.3.4 DNA sequencing
Plasmid DNA was sequenced using the MWG Biotech Sequencing Facility
(http://www.mwg-biotech.com). In general, the DNA was precipitated (refer
section 2.2.4) to the required amount by the company, and posted off for
sequencing. Normally, 1 pg of plasmid DNA was required for one
sequencing reaction. Sequencing primers were either supplied or
synthesized upon given primer sequence on-site, by the company, or sent
together (10 pmol/pl) with the plasmid.
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2.3.5 Agarose electrophoresis
DNA and RNA were visualized on agarose gel. The gel was prepared by
heat-dissolving the agarose powder in IX TBE (0.1 M Tris Borate, 0.02 M
EDTA) buffer using a microwave oven (Panasonic). Then the agarose
solution was cooled to 50°C before the addition of 0.5 pg/ml ethidium
bromide solution. The solution was poured onto a gel tray where a flat-tooth
comb was used to make up wells. The solution took 15 to 20 minutes to
solidify before the samples could be loaded into the wells. Depending on the
concentration of the agarose gel, samples were run in IX TBE buffer at
appropriate constant voltage, or electrophoresed at 45 mA/cm for
appropriate duration of time. The bands were then viewed under ultra¬
violet (UV) light.
2.3.6 RNA quantification
RNA was quantified using an UV spectrophotometer (Jenway) by measuring
the absorbance at A=260 nm. RNA was also run on a gel to confirm the
integrity of the RNA.
2.3.7 DNA quantification
Plasmid DNA was quantified using agarose gel electrophoresis. The plasmid
was linearised by restriction enzyme digestion prior to running it on the gel
alongside with known quantity of DNA ladder (100 base pair and 1 kilobase
pair ladders, New England Biolabs). The combination of ethidium bromide
and UV transilluminator with the use of imaging software were used in this
procedure, where the intensity of linearised band was compared to the
intensity of a same size band on a known concentration DNA ladder.
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Normally, the average concentration from different dilutions of linearised
plasmid ran on the gel was used as the final concentration.
2.3.8 Protein extraction
Protein was extracted from either monolayer grown cell line or three
dimensional cell aggregates, embryoid bodies (EBs).
2.3.8.1 Cell lines
Protein extraction was normally carried out from confluent monolayer cell
lines grown in T25 or T75 flasks after being washed with IX PBS twice. The
cells were then scraped using a tissue culture grade cell scraper (Nalgene) in
1 ml IX PBS. The detached cells were transferred into 1.5 ml tube and spun
at 10,000 rpm at RT for 5 minutes. The cells were then lysed in 80 pi or 200 pi
of ice-cold protein-lysis buffer (see section 2.1.2) depending on the flasks they
originated from; T25 or T75, respectively, on ice for 20 minutes. The cell
lysate was spun at 13,000 rpm for 20 minutes at 4°C to harvest the protein.
Alternatively, the lysate was kept at -20°C before being spun as described
above. The supernatant was transferred into a new 1.5 ml centrifuge tube
and kept at -70°C.
2.3.8.2 Embryoid bodies
Protein was also extracted from EBs growing in 100 mm bacterial grade
plates. The EBs were collected into a universal bottle and washed with ice-
cold IX PBS twice. After the last wash, 1 ml of EBs in PBS was transferred
into a 1.5 ml tube and spun at 10,000 rpm for 5 minutes at 4°C. The EBs were




Quantification of total protein was conducted using the BCA Protein Assay
Reagent Kit (Pierce), following the manufacturer's instructions. It is a
colourimetric based detection technique which detects the colour produced
by the reaction between a unique reagent containing bicinchoninic acid
(BCA) with cuprous ions present in the protein. Protein concentrations were
determined with reference to series of dilutions of known concentrations of
bovine serum albumin (BSA) as the standard protein. The protein samples
were assayed alongside with the standards in duplicates where the
absorbance was then measured at 562 nm in 9b-well plate using a
spectrophotometer plate reader (Dynex) or in disposable plastic cuvettes
using a spectrophotometer (Jenway). The protein concentration was finally
calculated from a linear regression of a standard curve of known range of




Western blotting was conducted in order to detect expression of certain
protein of interest using commercial antibodies (Appendix A for the list of
antibodies used). Samples were run as denatured and reduced protein in
TENT buffer alongside a pre-stained protein marker (SeeBlue Plus 2,
Invitrogen) for western blotting. The marker was used for band sizing and
confirmation of complete protein transfer.
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2.4.1.1 SDS-PAGE
A total volume of 20 pi containing 10-20 pg of total protein, IX sample buffer
(NP0007, Invitrogen), and IX reducing agent (NP0004, Invitrogen) in TENT
buffer was loaded into 12% Tris/glycine polyacrylamide Novex pre-cast gel
(EC60058, Invitrogen) setup in the Xcell SureLock Mini-Cell (Invitrogen) .
The solution was vortexed to mix and boiled at 95°C for 5 minutes prior to
loading into a lane of the gel filled with IX NuPage MOPS SDS running
buffer (NP0001, Invitrogen). The protein samples together with the protein
marker were run for 1 hour and 30 minutes at constant voltage of 150 V.
Upon completion, the gel was equilibrated in transfer buffer (NP0006,
Invitrogen) for a few minutes before being setup for protein transfer.
2.4.1.2 Protein transfer
Mini Trans-Blot Electrophoretic Transfer Cell Unit (Bio-Rad Laboratories,
USA) was used to electrophoretically transfer the protein bands from the gel
onto a membrane. During the electrophoresis of the SDS-PAGE gel, a pre-cut
PVDF membrane (Bio-Rad), Whatman 3 MM papers (Whatmann, USA) and
fibre pads (provided in the transfer set) were pre-soaked in transfer buffer
(NP0006, Invitrogen) for at least 10 minutes at RT. Following exactly the
instructions in the manual provided by the manufacturer, the unit was
assembled and operated accordingly. Transfer was conducted in transfer
buffer at a constant current of 400mA (150 V) for an hour or 50mA for 16
hours in the cold room (4°C). Upon completion, the membrane was stained
with Ponceau S (Sigma) for few seconds and rinsed with ddFhO to visualise
transferred proteins. The image was then scanned (GS-710 Calibrated
Imaging Densitometer, BioRad) and recorded (Quantity One 4.0.3, BioRad),
and the membrane was ready for immunodetection.
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2.4.1.3 Protein detection
Immunoblotting began with blocking the membrane in Western-blocking
buffer (section 2.1.2) overnight at 4°C or 2 hours at RT. Then, the membrane
was incubated with shaking in appropriate dilution of primary antibody
(Appendix A for the list of antibodies used) in blocking buffer for 2 hours at
RT or at 4°C overnight. The antibody was drained off prior to washing the
membrane with TBS-T (section 2.1.2) for 10 minutes at RT three times. The
procedure proceeded with incubation with an appropriate dilution of
peroxidase-conjugated secondary antibody in Western-blocking buffer for an
hour at RT with slow shaking prior to washing the membrane as described
above. Immunodetection was then carried out using ECL Plus Western
Blotting Detection Reagents (Amersham Biosciences) following the protocol
suggested by the manufacturer and exposed to X-ray film, which
subsequently developed and processed in an automatic X-ray processor.
2.4.2 Immunocytochemistry
Immunocytochemistry was generally conducted in 4-well plate (Delta,Nunc)
or 8-well glass slide chamber (Fisher Scientific). The attached cells were
gently rinsed with IX PBS prior to being fixed in 4% paraformaldehyde
(PFA) (section 2.1.2) for 30 minutes at RT before being permeabilised in 1%
Triton-XlOO in IX PBS (permeabilization solution, section 2.1.2) for 15
minutes at RT. Cells were then blocked for 30 minutes at RT in Immuno-
blocking buffer (section 2.1.2) prior to incubating the cells in an appropriate
dilution of primary antibody (Appendix A for the list of antibodies used) in
the blocking buffer for 2 hours at RT or overnight at 4°C. After rinsing with
IX PBS twice, the cells were then incubated with diluted secondary antibody
(Appendix A for the list of antibodies used) for 1-2 hours at RT in the dark.
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The cells were then counterstained with T0-PR03 (Molecular Probes) or
propidium iodide (Sigma), where appropriate, for 10-15 minutes at RT after
being rinsed with IX PBS twice. The cells were either left in PBS or mounted
in mowiol (section 2.1.2), and kept in the dark until viewing under
fluorescent microscope (Axiovert 132, Ziess).
2.4.2.1 Cell counting
Cell counting was carried out from at least 3 different fields from at least 2
duplicate wells of 4-well plate (Delta Nunc). The percentage of positive cells
stained for certain antibody was taken over the total cells stained with nuclei
staining such as ToPR03 or propidium iodide. Counting for cells stained
with specific antibody was done manually using Image Tool while counting
for cells stained with nuclei staining was performed using IMARIS software
programme.
2.4.3 Flowcytometry
Analysis by fluorescent activated cells sorting (FACS) was carried out using
FACS calibur (Becton Dickinson) on live and fixed cells.
2.4.3.1 Detection of GFP
Expression of enhanced green fluorescent protein (eGFP) from 46C EBs was
detected and analysed by FACS using live cells. Day 4, 6, 8, 12 and 14 EBs
from 46C ES cells were trypsinized in 4X trypsin (section 2.7). Instead of
using EBM to deactivate the trypsin, FACS wash buffer (10% foetal calf
serum in IX PBS) was used and the single cells were immediately analysed
by FACS. EBs from non-expressing eGFP cell line (R26CT2S) was used as the
negative control and also for gate setting.
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2.4.3.2 Antibody staining
FACS was also used to detect percentage of positive cells by antibody
staining. Antibody staining was carried out on trysinised neural precursor
and neuron-like cells grown on PDL/laminin coated 60 mm dish (Greiner).
After neutralization of trypsin, the cells were washed in IX PBS twice by
spinning the cells at 6500 rpm in 1.5 ml tube for 3 minutes at RT prior to
fixing them in 200 pi of 70% ethanol for 15 minutes at RT. Then, the ethanol
was diluted in 1 ml of IX PBS before being kept at -20°C.
On the day of the analysis by FACS was to be carried out, the samples were
thawed at RT and 300 pi of PBSG (5% goat serum in IX PBS) was added into
the tube prior to spinning the tube at 6500 rpm for 3 minutes at RT.
Subsequently, 150 pi of diluted primary antibody (Table 2.2) was gently
mixed into the cells and incubated at RT for an hour. Once completed, 1 ml
of PBSG was added into the tube, inverted to mix and incubated for 2
minutes to wash the cells before spinning the cells as described above.
Incubation with 150 pi of secondary antibody [R-Phycoreithrin (PE)
conjugated antibody (1:100 dilutions)] was carried out in the dark for 30
minutes at RT. The cells were then washed as described above prior to
finally be resuspended the cell pellet in 350 pi of PBSG for the analysis by
FACS.
For analysis purposes, fixed cells, fixed cells stained with primary antibody
only and fixed cells stained with secondary antibody alone were run together
with the samples for checking the sensitivity and specificity of the antibodies
used, and for gate setting.
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Table 2.2 : List of antibodies for FACS
Primary Antibody Secondary antibody
Nestin (1:50)
(Mouse IgGl, DSHB)
















Goat Anti Rabbit IgG-PE (1:100)
(P2771, Molecular Probes)
2.5 Construction of Transgenic ES cells
Chapter 4 will describe the details of the construction of transgenic ES cell
lines. The construction began with building the plasmid construct in E. coli
followed by introducing the plasmid into ES cells by Genejuice (Novagen).
The same procedure was applied when constructing transient or stable
transfected HEK 293 cells.
2.5.1 Bacterial work
All bacterial work used E. coli strain JM109 (Promega) or its derivative, Stbl2
or Stbl4 (Invitrogen).
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2.5.1.1 Cloning and subcloning
All cloning and subcloning strategies in constructing the appropriate DNA
constructs are described in Appendix B.
2.5.1.1.1 Restriction endonucleases
In preparing the appropriate digested vector or digested DNA fragment for
cloning or subcloning purposes, at least 4 pg of DNA was digested with 40
units of enzyme in a total volume where the volume of the enzyme did not
exceed 10% of the total volume. The digestion was carried out using
manufacturer's suggested buffer and BSA (Roche) at 37°C for 5 hours, prior
to running the digested DNA on a 0.8% agarose gel to check for the complete
digestion. Upon the completion of the digestion, the digested DNA was
either directly purified or run on agarose gel for excision of the desired band
using QIA-quick gel extraction kit (Qiagen).
Clones were screened using an enzyme that cut both the insert and the vector
to verify the orientation of the insert inside the vector. For screening
purposes, 0.5 pg of plasmid/DNA was digested in 5 units of enzyme in a
total volume of 20 pi for 90 minutes at 37°C, together with IX buffer with or
without IX BSA as recommended by the manufacturer (Roche). The reaction
was scaled up for a digestion that resulted in 200 bp or lower digested band
size.
2.5.1.1.2 Dephosphorylation and ligation
Dephosphorylation was performed whenever there were possibilities of self
religation from digested vectors. The procedure was carried out using
shrimp alkaline phosphatase (SAP, Roche) following the manufacturer's
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recommendation as the phosphatase could be completely deactivated by
heating the mixture at 65°C for 15 minutes. The DNA was then either
purified (QIA-quick gel extraction kit, Qiagen) or directly quantitated (by
running on agarose gel, section 2.2.7) prior to ligation.
The purified DNA fragment was directly ligated into appropriate purified
digested-cloning vector. Generally, 50 or 100 ng of purified vector was used
to ligate appropriate amount of the purified DNA fragment (the insert) based
on the formula described in Table 2.3 as the guideline. The ligation was
carried out using 1.5 Weiss units of T4 DNA ligase (Roche, UK) in IX ligation
buffer (Roche, UK) where a total volume of 12 pi was incubated at 16°C for
16 hours or for 5 hours at RT. A ligation mixture with the insert and the
vector alone were also included as the negative controls, and for checking the
ligation efficiency. Subsequently, 5.5 pi of the ligation mixture was used for
transformation.
Table 2.3: Ligation formula
ng of insert= ng of vector X size of insert (kb) X molar ratio of insert
size of vector (kb) vector
ng = nano gram, kb = kilobase
2.5.1.2 Transformation
In most cases, transformation was carried out using JM109 competent cells.
However, for cloning involving unstable inserts such as direct repeats, MAX
Efficiency Stbl2 or Stbl4 competent cells were used. Stbl2 was transformed
by heat-shocking while Stbl4 via electroporation.
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2.5.1.2.1 Antibiotics
Depending on the plasmid, 100 pg/ml of ampicillin or 50 pg/ml of
kanamycin were used for selection.
2.5.1.2.2 Heat-shock
Transformation was carried out by incubating the mixture of the ligated
vector or plasmid DNA with competent cells in ice-cold sterile 17 X 100 mm
polypropylene tube (Falcon) on ice for at least 10 minutes. Depending on the
type of vector involved, the competent cells used were either JM109
(Promega), for stable vector, or Stbl2 (Invitrogen) for unstable vector.
Normally 50-200 pi of competent cells were mixed with 5-10 pi of ligation
mixture or 1-50 ng of purified plasmid DNA by gently flicking the tube.
After 10 minutes on ice, the mixture was heat-shocked for 60 seconds at 42°C
in a water bath without shaking (Grant). The transformants were then
propagated in one ml pre-warmed (37°C) Luria-Bertani (LB) broth for JM109
cells, or SOC medium (provided with Stbl2, Invitrogen) for Stbl2 cells for 90
minutes at 37°C or 30 °C, respectively, with shaking. Following this, the
bacterial cell cultures were transferred into 1.5 ml tube and spun at 6000 rpm
at RT for 30 seconds. The supernatant was poured off, leaving
approximately 200 pi of the supernatant in the tube to fully resuspend the
pellet. For each transformation reaction, 100 ul of the undiluted cells or 1:100
dilutions were plated on LB or 2xYT agar containing appropriate antibiotic at
either 37°C or 30 °C overnight.
2.5.1.2.3 Electroporation
Transformation via electroporation was carried out for certain ligation
mixtures involving unstable vector using Stbl4 competent cells (Invitrogen).
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The ligation mixtures were purified by ethanol precipitation (see section
2.2.3), and reconstituted in 2 pi TE buffer (lOmM Tris-HCl, 1 mM EDTA, pH
7.4) prior to adding into 20 pi of Stbl4 competent cells in 1.5 ml tube. The
cell suspension was properly mixed by gently flicking the tube before being
electroporated at 1.2 kV, 0.25 pF and 200 Q in disposable electroporation
cuvettes (BioRad) using GenePulser (BioRad). Immediately, using a long
pipette tip the cell suspension was transferred into 1.0 ml SOC medium in 14
ml round bottom Falcon tube and incubated for 90 minutes at 30°C with
shaking at 225 rpm. The cells were plated on LB agar plate with 50 pg/ml
ampicillin as described above (section 2.5.1.2.1).
2.5.2 Introduction of construct plasmids into ES cells
2.5.2.1 Genejuice
Among the transfection reagents tested, Genejuice (Novagen) was found to
give high transfection efficiency based on the number of colonies formed
after about one week in selective medium. The procedure was conducted
following the manufacturer's recommendation with slight modifications, as
described in Table 2.4 below. The ES cells were seeded one day before
transfection was to be carried out, so that the cells would be about 20-60%
confluent on the day of transfection. The transfection began with mixing pre-
warmed serum-free BHK21 medium (Gibco: 21710-025) with Genejuice by
tapping the tube prior to incubating the mixture for 5 minutes at RT.
Following the incubation, the plasmid DNA was then added into the
mixture, tapped to mix and incubated at RT for another 15-60 minutes to
build DNA-GeneJuice complex. Once the incubation was completed, the
DNA/GeneJuice complex was added to the cells that had been grown in
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serum-free medium, and incubated for 2-8 hours in 37°C incubator (Sanyo).
The medium with DNA/GeneJuice was discarded and the cells were grown
in complete medium (ESM) in the incubator until the cells were confluent.
The cells were then either analysed for transient transfection, or selected in
selective medium for stable transfection.
Table 2.4: Transfection using Genejuice (Novagen)
100 mm dish 60mm dish/ 6
well-plate
4-well plate 8-well slide
chambers
Number of ES cells 1X106 2-4 X 105 1-2 X 104 0.5-1 X 104
Serum-free BHK21 medium 150 pi 100 pi 30 pi 20 pi
Genejuice 3 pi 3 pi lpl 0.75 pi
DNA/Plasmid 1-2 pg 0.5-1 pg 0.2-0.5 pg 0.2 pg
Serum-free into plate/ES
cells
2 ml 1 ml 150 pi 100 pi
Growth medium (ESM) 10 ml 5 ml 1 ml 500 pi
2.5.2.2 Selection medium
All of the constructs built carried a neomycin resistance gene which confers
resistance to geneticin (G418). Thus, screening for the positive clones was
carried out using G418 selective medium. With exception of constructs
carrying pCAG-floxed neomycin pA IRES puromycin cassette, the neomycin
resistant clones were then subjected to screening for puromycin resistant
clones upon excision of the neomycin floxed cassette with tamoxifen (more
details are discussed in Chapter 4 of this thesis).
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2.5.2.3.1 Geneticin (G418)
Neomycin resistant clones were selected by growing the cells in 400 pg/ml
geneticin (G418) in ESM as soon as the cells reached confluency. The
selective medium was changed every other day until the cells n the non-
transfected control plate died off. The transfected plates were incubated
until the clones appeared which normally took about 7-10 days after the
initiation of selection. The clones were then picked using a yellow tip
(Greiner) attached to P200 pipette (Gilson) and transferred into gelatin-
coated 96-well plate after being washed in IX PBS twice, and grown in the
selective medium in 37°C incubator. Once confluent, the cells were
trypsinized and grown in gelatin-coated 24-well plate in the selective
medium. The procedure was repeated and the cells were split in 6-well
plate. The selection was stopped once the cells were grown in a T25 flask.
The positive clones were frozen and kept in liquid nitrogen.
2.5.2.3.2 Puromycin
Cells carrying a complete pCAG-floxed neomycin pA IRES puromycin
cassette were further screened using 1 pg/ml puromycin. The positive clones
for neomycin resistant genes were seeded into 24-well plate and grown in
ESM containing 0.2, 0.5 and lpM tamoxifen (4'-Hydrotamoxifen, 4-OHT,
Sigma) for the excision of the neomycin-pA cassette which would then allow
for the expression of puromycin resistant gene protein. The cells were
selected in puromycin selective medium 2 days after being exposed to
tamoxifen, at which time the cells were about 80-90% confluent. The clones
that survived puromycin were selected as the positive clones for carrying the
complete cassette, and were subjected to the manipulation of the
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overexpression of the gene of interest during neural differentiation of ES cells
(more details in Chapter 5 of this thesis).
2.6 Inducible ES cells system: Activation of Cre by tamoxifen
Chapter 4 will discuss in detail the inducible ES cell system. The expression
of the gene of interest was induced by activation of Cre-recombinase upon
exposure of the cells harbouring the complete pCAG-floxed-neomycin-pA-
IRES-puromycin (Figure 4.1) to tamoxifen. Optimal conditions for the
induction of Cre-recombinase were determined by exposing the
undifferentiated and differentiated (EBs DO of neural differentiation protocol,
section 2.7) clone cells to 0.2, 0.5, 0.8 and 1.0 pM tamoxifen for 24 or 48 hours
before being harvested for total RNA and protein. The undifferentiated ES
cells were seeded into 6-well plate at a density of 2-4 X 105 cells per well
(Table 2.1), while the EBs were formed in 60 mm dish (Greiner).
2.7 Neural differentiation of Mouse ES cells
The differentiation of ES cells into neurons was carried out through the
formation of embryoid bodies (EBs) using all-trans retinoic acid (ATRA)
following the 4-/+4 protocol (Bain et al., 1995). Around 5xl05/ml of lightly
trypsinised 46C cells were allowed to aggregate in suspension culture (EBs
day 0, DO) in the absence of LIF in non-tissue culture-treated petri dishes
(Greiner) for four days before the addition of 10 6M of ATRA for another 4
days. On D8, some of the embryoid bodies (aggregates) were trypsinised in
high concentration of trypsin (4X Trypsin-EDTA, 4% chicken serum in IX
PBS) at 37°C water bath for 5 minutes. The trypsinized cells were then
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stained with trypan blue (Sigma) and counted using heamacytometer prior
to plating on PDL and laminin coated plate (Li et al., 1998) at 2xl06 cells in 6-
well plate (l-2xl05/cm2) for terminal differentation in DMEM/F12
suplemented with N2 (Gibco) and neurobasal medium supplemented with
B27 (Gibco). Trypan blue was used to exclude apoptotic cells during cell
counting. The rest of the EBs were transferred into smaller petri dishes as to
get higher density of EBs population (details are described in Chapter 3 of
this thesis).
Detail description on neural differentiation assay for manipulation of Wnt
signalling during neural differentiation process of mouse ES cells is
discussed in chapter 5 of this thesis.
2.8 Polymerase Chain Reaction (PCR)
PCR has been widely used throughout the whole project. Chapter 3 of this
thesis specifically applied this important technique in determining the
expression profile of all 19 Wnt genes, besides other genes, during neural
differentiation of mouse ES cells.
2.8.1 Primer design
Primers were designed using Primer 3 programme at
http://frodo.wi.mit.edu/cgi-bin/primer3/primer3www.cgi and Web Primer:
DNA and Purpose Entry at http://seq.yeastgenome.org/cgi-bin/web-primer.
The DNA sequences were taken from Nucleotide sequence (Genebank) at
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide or Ensembl
Mouse Genome website at
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http://www.ensembl.org/Mus musculus/index.html. The designed primer
sequences were synthesized by MWG Biotech AG (http: //www.mwg-
biotech.com). Primers for light cycler were designed based on guidelines
provided in the Quantitect SYBR Green PCR handbook (Qiagen).
2.8.2 Optimization of PCR parameters
Positive samples were used in optimizing the conditions for PCR parameters.
Thus, cDNA synthesized from total RNA extracted from mouse embryo day
8.5, 10.5 and 12.5 were used in optimizing the PCR conditions for each Wnt
gene. All 19 Wnt genes are expressed during development of mouse
embryo. Opimization conditions for each gene began with amplification of
the gene transcript using 1.5 mM MgCk with annealing temperature taken
from the melting point of its corresponding forward and reverse primers,
following [2 (A + T) + 4 ( G + C)] formula as the guideline. Different
concentration of MgCk and annealing temperature were applied until the
best conditions were discovered.
2.8.3 cDNA synthesis
The cDNA was synthesized by adding 1.0 pg of extracted RNA to 100 ng of
random hexanucleotide primers (PROMEGA) in nuclease-free water in a
total volume of 15 pi at 70°C for 10 minutes followed by a quick chill on ice
(about 2 minutes). The synthesis was continued in a total volume of 25 pi
containing the RNA/random primers mix, together with IX RT-buffer
(Promega), 1.0 mM of the four deoxyribonucleoside 5'-triphosphates (dNTPs,
Promega), 1 unit of RNase inhibitor (Promega) and 200 units of MMLV
reverse transcription enzyme (Promega) at 42°C for an hour. All components
were properly mixed by vortexing prior to a quick spin before being loaded
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into a PCR machine (MJ Research) for the incubation. The reverse
transcriptase was deactivated and the RNA-cDNA hybrid was denatured by
incubating the mixture at 95°C for five minutes. Finally, the samples were
either kept on ice for immediate amplification of cDNA or stored at -20°C
until used.
2.8.4 Reverse-transcription (RT)-PCR
RT-PCR was carried out in a total volume 20 pi consisting of 1 pi of
synthesized cDNA, 1.5 mM MgCk, 0.2 mM of dNTPs, 7.0 pmol of both
forward and reverse primers and 1 unit of Taq polymerase enzyme
(Promega). PCR parameters for the amplification of each gene are
specifically described below in Appendix C.
2.8.5 Quantitative RT-PCR (qRT-PCR)
Quantitaive RT-PCR was performed using Quantitect SYBR Green PCR
master mix (Qiagen) in DNA Engine Opticon (MJ Research) following the
suggestions described in Quantitect SYBR Green PCR handbook (Qiagen). A
total reaction of 25 pi containing IX SYBR Green PCR master mix, 10 pmols
of each forward and reverse primers, and lpl of synthesized cDNA in
nuclease-free water was properly mixed in 8-well strip (BioRad) prior to
loading into the machine. Normally, 5-8 dilution series of purified plasmid
carrying the transcript sequence of interest or a sample known to express the
gene of interest were used as the standards and were run together with the
samples. Arbitrary units for amplification of each transcript were generated
from these standards. The cycle began with the initial activation step at 95°C
to activate DNA polymerase for 15 minutes, followed by 35 cycles of
denaturation step at 94°C for 15 seconds, annealing step at 50-60°C (refer to
98
Appendix C) for 30 seconds and extension step at 72°C for 30 seconds. In
order to verify the specificity and identity of the PCR product, melting curve
analysis was performed for every reaction between 65°C and 95°C following
the instructions provided by the manufacturer.
Amplification of the target transcript sequence was quantified using relative
quantification where the ratio between the value of target and a suitable
housekeeping gene transcript was determined. 6-Actin was used as the
housekeeping gene as its expression during neural differentiation process
was found to be the most stable as compared to other housekeeping gene
tested. In addition the gene has been frequently used in previous studies
involving the differentiation of mouse ES cells (Lako et al., 2001; Conti et al.,
2005). The differential gene expression in different samples was compared as
relative expression to fi-Actin or relative expression to non-treated sample
following the formulae described in Table 2.5.
Table 2.5 : Quantitative differential gene expression by light cycler
Relative Expression to 8-Actin
= unit expression of gene of interest(samP|e)
unit expression of fi-Actin (samPle)
Relative Expression to non-treated sample
= unit expression of gene of interest<samP|e)
unit expression of fi-Actin (samP|e>
unit expression of gene of interest(non-,reated samP|e)
Unit expression Of 8-Actin (non-treated sample)
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Chapter 3: Expression profiles of Wnt genes during
neural differentiation of mouse ES Cells
3.1 Introduction
As discussed in chapter 1, Wnts have been implicated to play important roles
in regulating development of the nervous system. Therefore, they are strong
candidates for regulating aspects of the in vitro differentiation process of ES
cells into neurons. However, knowledge of their function during this process
is limited. Preliminary findings have suggested that they may influence
neural development of ES cells in culture. It is believed that Wnts may
inhibit the differentiation of ES cells into neural precursor cells (NPCs) but
may also promote the differentiation of NPCs into neurons.
One study found that Wnt antagonist sFRP2 is upregulated during neural
differentiation of ES cells in vitro (Aubert et al, 2002). The gene function
analysis from the study demonstrated an increase of neural precursor cell
differentiation from sFRP2-overexpressing ES cells implying an inhibitory
effect of Wnt activity on neural differentiation. Inhibition of neural
differentiation was also observed from ES cells treated with lithium chloride,
which partially mimics Wnt signalling, as well as from forced expression of
Wntl. This study has been supported, among other studies, by a recent
study which demonstrated that treatment with Wnt3a at late culture stages in
neural differentiation increased the number of neural cells, while exposure to
Wnt3fl at early culture stages strongly suppressed neural conversion
(Watanabe et al., 2005). Taken together, these studies suggest a role for Wnts
in inhibiting the differentiation of ES cells to NPCs, but also promoting the
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differentiation of NPCs to neurons. Therefore, looking at the expression
profiles of all members of the family gene during the process would be a first
step to determining whether or not Wnts may be involved in neural
differentiation of ES cells in vitro.
In this chapter, the expression profiles of all 19 Wnt genes and two Wnt
antagonists, Dkkl and sFRP2, during neural differentiation of mouse ES cells
in vitro were examined. Neural differentiation was induced through the
formation of embryoid bodies (EBs) in the absence of LIF followed by the
addition of retinoic acid (RA) for four days [Bain et al., 1995; Li et al, 1998a].
The expression of all 19 Wnt genes was screened in five different stages
during the process; undifferentiated ES cells (day 0, DO), early formed EBs
(D2 and D4), RA-treated EBs (D6 and D8), attached EBs (D10, D12 and D14)
and neuron-like cells (D14 or six days after re-plating). Figure 3.1 shows a
schematic flowchart for the steps involved.
Neural differentiation was carried out using an ES-cell line engineered to
monitor the formation of neural precursor cells (NPCs), 46C ES cell line. This
line carries a Soxl reporter allele constructed by insertion of the coding
sequence of enhanced green fluorescent protein (eGFP) into the Soxl open
reading frame (ORF, Aubert et al., 2003). As the endogenous Soxl, the
expression of eGFP was silent in undifferentiated ES cells but activated upon
neural induction. Soxl is the earliest specific marker for neural precursor
cells (NPCs) and is only expressed in proliferating progenitors in the lens
and throughout the CNS in the mouse embryo (Wood and Episkopou, 1999;
Aubert et al., 2003). It is not expressed in undifferentiated ES cells but is








(100mm non-adherent bacterial culture dish)
+RA (EBM)
D4-D8
(100mm non-adherent bacterial culture dish)
-RA (EBM) N2/B27 medium
D8-D14 NLC (D14)
(60mm non-adherent bacterial culture dish) (60mm PDL/laminin coated dish)
Figure 3.1: Schematic diagram of neural differentiation assay for 46C cells using the
4-/4+ protocol. RA was added for four days (D4-8) after the aggregates (EBs) were
grown for four days (D0-4) without LIF. On D8, the EBs were either transfer into
smaller dishes to promote attachment and neurite outgrowth or dissociated and
plated on PDL/laminin-coated plates.
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cells (Pevny et al., 1998; Ying et al., 2003b). 46C ES cells were used to facilitate
the identification of NPCs, thus allowing us to monitor the success of the
neural differentiation protocol. In addition, the presence of NPCs that are
expressing GFP upon neural induction, after the addition of RA, therefore
can be quantitated by FACS analysis.
In the next part of this study, the specific Wnts expressed during the neural
differentiation process were identified by RT-PCR from total RNA harvested
from each stage as described earlier (Figure 3.2 describes in detail the time
points for RNA extraction for each stage). The expression of selected Wnt
genes that showed particularly interesting expression profiles was further
quantitated using light cycler (SYBR Green), quantitative RT-PCR (qRT-
PCR). Hence, the expression of Wnts at the specific time points along the
process was determined.
3.2 Results
3.2.1 Neural Differentiation of Mouse ES cells (46C) In vitro
In this study, we applied the most common approach, 4-/4+ protocol, for the
induction of neuronal differentiation of ES cells (Bain et al., 1995). As
described in Figure 3.1 and 3.2, the EBs were treated with 1.0 pM all-trans
retinoic acid (ATRA) for four days after being grown for four days in the
absence of LIF. The formation of multicellular aggregates, EBs, was observed
the next day (Dl) after the withdrawal of LIF. As previously observed, the
EBs appeared small with irregular boundaries after two days in culture
without LIF. On D4, the EBs looked mature, in which they became larger
and mostly were spherical with more prominent smooth boundaries (Figure




















Figure 3.2: Detailed schematic diagram of neural differentiation assay for 46C cells in
vitro showing the specific time point where the cells were harvested for RNA extraction.
Stage 1 is the undifferentiated ES cells (DO). Stage 2 and 3 are the EBs before and after
the addition of all-trans Retinoic acid (ATRA), respectively. Stage 4 contains mostly the
attached EBs. Stage 5 is the neuron-like cells (NLC) grown on a PDL/laminin coated
plate.
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addition of ATRA (D6), cells expressing GFP were visible under fluorescence
microscope (Figure 3.3E) indicating the presence of dividing neural precursor
cells, as Soxl is the earliest specific marker of neural precursors in the mouse
embryo (Wood and Episkopou, 1999). After 4 days in ATRA (on D8), the EBs
were either transferred onto smaller petri dishes to encourage the attachment
of EBs to the plate since low density of EBs resulted in slower attachment of
EBs to the dish, or dissociated and plated on PDL/laminin-coated plates.
On D10, many EBs in the smaller dish were attached and started to form
outgrowth of neurites (Figure 3.4A). The EBs were monitored until D14 to
observe the growth of the neurites. On D14, almost all the attached EBs were
hardly seen as a ball-shaped clumps as they seemed to have dispersed,
forming more dense growth of neurites (Figure 3.4D). In addition, the
expression of GFP was still observed indicating that neural precursor cells
were still present (Figure 3.4E). Alternatively, the GFP expression might be
due to its half-life (maximum half-life for GFP is 54 hours, Sacchetti et al.,
2001). The GFP expression was also analysed and confirmed by
fluorescence-activated cell sorting (FACS) analysis (Figure 3.5). FACS
analysis demonstrated that the highest number of cells expressing GFP
(about 70%) was seen at D8.
Two days after plating the dissociated EBs on PDL/laminin-coated plates
(D10) in the medium supplemented with N2/B27, the dissociated cells started
to form clumps and gave rise to a network of neuron-like cells with apparent
death of other cell types. Six days after the re-plating, more distinct neuron¬
like networking (Figures 3.4) and more positively stained cells for class III (3-






Figure 3.3: Expression of Sox1-GFP during neural differentiation of 46C ES cells in vitro. (A)
Morphology of undifferentiated 46C ES cells. (B, D and F) phase contrast pictures of embryoid
bodies (EBs) at D4, D6 and D8. (C, E and G) fluorescent images of the EBs shown in B, D and
F demonstrating clear expression of Sox1-GFP at D6 and D8. Double arrows show the smooth
boundaries of mature-looking EBs. Scale bar is 100 pm.
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Figure 3.4: Formation of neurites and neuron-like cells (NLC) from neural
differentiation of 46C cells. (A, B and C) phase contrast pictures of EBs at D10, D12
and D14 showing the formation of neurites outgrowth in cultures with higher density of
EBs. (D) the fluorescent image of C showing a faint expression of GFP at D14
indicating reduced number of dividing npc. (E and F) phase contrast picture and
expression of neuronal marker, class III S-tubulin, respectively, of NLC 6 days after
plating on PDL-laminin-coated plate indicating the formation of neurons.
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1998a). The protocol also gives rise to a small percentage of GFAP, and RC2
positive cells for astrocytes, and radial glial cells, respectively (Figure 3.6).
At this stage, no expression of GFP was observed demonstrating the absence
of neural precursor cells. These results show that RA is able to induce
extensive differentiation of neurons when plated on a permissive substrate,
and that the protocol activates a pathway that leads to expression of neuron
associated genes as previously described (Bain et al., 1995).
3.2.2 Efficiency of Neural Differentiation of 46C cells in vitro
To further analyze the efficiency, reproducibility and success of the
differentiation protocol of 46C ES cells into neurons, gene expression profiles
for specific cell population markers was carried by RT-PCR for Oct4, Soxl
and Wntl. RT-PCR analysis was conducted on total RNA extracted from EBs
DO-14 and NLC from three independent 46C ES cell neural assays; 46C ES
cells passage 17, 19 and 23 for batch A, B and C, respectively (Figure 3.7).
The expression pattern of Oct-4, a marker for undifferentiated ES cells in vivo
as well as in vitro (Scholer et al., 1989, 1990; Pesce et al., 1999; Pesce and
Scholer, 2000, 2001) demonstrates that the differentiation protocol was
successful (Figure 3.7). Oct-4 is expressed in undifferentiated ES cells and
downregulated as differentiation occurs (Niwa et al., 2000). As expected,
expression of Soxl, a marker for neural precursor cells, was observed upon
induction of neural cells, on D6, indicating the presence of NPCs in
agreement with the FACS analysis (Figure 3.5). However, D6 EBs seem to
have the highest RNA expression of Soxl, a disagreement with the protein
expression level by FACS analysis, which demonstrates D8 EBs as to have
the highest Soxl-GFP expression (Figure 3.5 and 3.7). This might be due to
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Figure 3.5: FACS analysis of Sox 1-GFP expression during neural differentiation of 46C
cells. (A) FACS profile of D6 EBs of control cells, non-GFP expressing cells (R26CT2S),
which were used to set the M1 gate. (B and C) FACS profiles for D2 and D4 EBs of 46C
cells, respectively, showing almost no expression of Sox1-GFP before the addition of ATFtA.
(D, E, F and G) FACS profiles for D6, D8, D10 and D12 EBs after the addition of ATF?A,
respectively, clearly showing high expression of Sox1-GFP at D6 and D8 of the process.
The percentage of cells expressing GFP is shown in parentheses. (H) Graph showing the
percentage of cells expressing Sox1-GFP from D2, D4, D6, D8, D10 and D12 EBs during
the process. Error bars show the mean ± the range between the highest and the lowest
values from two independent experiments.
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Figure 3.7: Efficiency of neural differentiation of mouse ES (46C) cells in
vitro. RT-PCR from total RNA extracted from cells at 2 day intervals. The
expression patterns of Oct4 (marker for undifferentiated ES cells), Sox1
(marker for dividing neural precursor cells), Wnt1 (known to be RA-induced)
and IS-actin from 3 different batches of neural assay demonstrates the
reproducibility and efficiency of the protocol in directing differentiation
towards neural lineage. (A, B and C) show the genes expression patterns
from 46C cells passage 17, 19 and 23 respectively. The PCR was carried
out for 30 cycles for Oct4 and Sox1, and 35 cycles for Wnt1 and li-actin.
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before being able to be detected and analysed. The expression profile of
these genes shows that the differentiation has successfully been directed
towards the neural lineage.
In addition, the study also confirmed the success of the differentiation
protocol by the expression pattern of Wntl, which is known to be RA-
induced (St-Arnaud et al., 1989). As expected, expression of Wntl was
detected on D6 onwards (after the addition of RA) with low expression in the
neuron-like cells, NLC, in one of the batches (Figure 3.7). Quantitative RT-
PCR, however, has confirmed the reproducibility of Wntl RNA expression
profile from these three batches (Figure 3.12).
3.2.3 Expression Profiles of Wnt genes by RT-PCR during neural
differentiation in vitro
The expression ofWnt genes was monitored from D0-D14 to ascertain which
Wnt genes were differentially expressed during the differentiation process.
At this time, the target was to identify the expression ofWnt gene(s) from the
whole population of five different stages during the differentiation process;
undifferentiated ES cells (stage 1, DO), early formed EBs (stage 2, D2 and D4),
RA-treated EBs (stage 3, D6 and D8), attached EBs (stage 4, D10, D12 and
D14) and neuron-like cells (stage 5, D14 or six days after re-plating) [Figures
3.1 and 3.2]. Suitable primer pairs for all 19 mouse Wnt genes primers were
optimized using total RNA extracted from whole mouse embryos day 10.5,
11.5 and 12.5, as the embryos at these stages express allWnt genes (Parr et al.,
1993; Parr and McMahon, 1994; Kemp et al., 2005). Most of the primers were
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designed to span an intronic region as a way to check for any contamination
with genomic DNA. All gene primers were run at least twice.
The expression patterns of all 19 Wnt genes are shown in Figure 3.8. Out of
19 Wnt genes that were screened, two genes (Wnt8b and WntlOa) were
detected at a very low level of expression. WntlOa was consistently detected
at a very low level on D12 going up to a slightly higher expression level on
D14 with no expression detected in neuron-like cells. No expression of this
gene was ever detected at stage 1-3 and on D10. Expression of Wnt8b was
detected inconsistently at a very low level between stages 2-3. The other
gene with low expression level is Wnt2a, which is first expressed on D4. The
expression was down-regulated on D8 onwards with no expression detected
in neuron-like cells. Expression of Wnt3, -9b(15) and -16 were detected in
undifferentiated ES cells (DO EBs) at different level of expression. High
expression of Wnt3 was also detected at later stages of the process (D10, D12
and D14) with very low expression detected on D6, D8 and NLC. For Wnt9b,
high expression was detected on D4, D8 and D10 with no expression
detected in NLC. Low level of Wnt9b expression was seen on D2, D6, D12
and D14. Wnt5b and -7b were detected at high level at all stages with low
expression level in NLC.
At least six Wnts (Wntl, -2b, -3a, -4, -5a, -10b and -11) have been shown to
have dynamic expression patterns during the differentiation process.
Among these, only Wnt3a is highly expressed in neuron-like cells, while
Wnt4 was not expressed in these cells at all. While Wnt5a was expressed at
low level in neuron-like cells, a very low level expression of Wnt10b and -11
were also detected in these cells. High expression of Wnt2b started on D10
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Figure 3.8: Expression profile of Wnt genes during neural differentiation of mouse
ES cells (46C) in vitro by RT-PCR. RNA extracted on DO-14 EBs and neuron-like
cells (NLC) was subjected to RT-PCR with all 19 mouse Wnt genes, as indicated.
The EBs were exposed to ATRA for four days after being grown in the absence of
LIF for four days. NLC were harvested 7 days after plating the dissociated D8 EBs
on PDL/laminin plates. The results were from a single experiment from the same
synthesized cDNA. The PCR cycles were 35 for all genes except for Wnt3,
Wnt8b, Wnt9b, WntlOa and Wnt16 which were 30 cycles.
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while for Wnt4 and -11, their high expression began at D8. The expression
for Wnt3a and -10b started on D4 with the highest expression detected on D6.
Wntl gave the expected expression pattern as being induced on D6, after the
addition of RA and low expression level in neuron-like cells.
The other interesting expression patterns are the expression of Wnt6, -7a and
-9a. High expression of Wnt6 was detected on DO and D8-14 with no
expression on D2 and NLC, and low level of expression on D4-6. For Wnt7a,
its expression seemed to be downregulated on D2-D6, but it is highly
expressed in undifferentiated ES cells (DO). However, the expression went
up again on D8 onwards except in neuron-like cells, which showed low
expression level. The same scenario was observed with Wnt9a. The gene
was also expressed in undifferentiated ES cells (DO) and downregulated on
D2-6. The expression was then continued on D8 onwards including the
neuron-like cells. On the contrary, high expression of Wnt8a has been
observed to occur in undifferentiated ES cells (DO) as well as in non RA-
treated treated EBs (D2-4), with low expression detected on D6-8 and in
neuron-like cells. No expression of Wnt8a was detected on D10-14.
These RT-PCR results, therefore, show that many Wnt genes are expressed
during neural differentiation of mouse ES cells in vitro. Among all, Wnt5b, -6,
-7a, -7b, -8a, -9a and -16 were expressed at high level in undifferentiated ES
cells (stage 1). In early formed EBs (D2 and D4, stage 2), high level of Wn3, -
3a, -5a, -5b, -7b, -8a, -9b and -10b were detected. In stage 3 EBs after the
addition of ATRA (D6 and D8), Wntl, -3a, -5a, -5b, -6, -7a, -7b, -9a, -9b, -10b,
and -11 were detected at high level of expression. In stage 4 which mainly
contained attached EBs (D10, D12 and D14), Wntl, -2b, -3, -3a, -4, -5a, -5b, -6, -
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7a, -7b, -9a, -10b and -11 were detected. A high level expression of only one
gene (Wnt3a) was detected in neuron-like cells (stage 5), while Wnt5a, 5b, 7a
and 9a were detected at low level in these cells. However, these results were
based on RT-PCR results which are not quantitative and may be influenced
by the number of PCR cycles. Thus, the Wnt genes with interesting
expression patterns were subsequently subjected to quantitative RT-PCR.
3.2.4 Evaluation of qRT-PCR analysis
In this analysis, the expression level of each gene at specific time points
during the differentiation process was normalized to the expression of fi-
Actin, as the reference gene. The expression level for each gene was then
expressed as relative to fi-Actin and relative to the expression of
undifferentiated ES cells (fold increase to DO, refer to Chapter 2 for their
specific formulae). fi-Actin was used as the reference gene since the gene
was found to be expressed at constant level throughout the differentiation
process (Appendix D). Besides that, it has also been widely used in previous
studies (Aubert et al, 2003; Otero et al, 2004; Israsena et al.r 2004; Kemp et al,
2005. Therefore, the amount of RNA present in the population cells was not
absolutely quantified. Instead, the ratio between the amount of target (Wnt
genes, Dkkl or sFRP2) and a reference transcript (fi-Actin) within the same
sample was calculated. Thus, differential gene expression in different
samples (DO-14 EBs and NLC) can then be compared using the normalized
value.
In this study, the standards used were a series of diluted synthesized cDNAs
from EBs that have the highest expression level of the gene of interest as
shown by RT-PCR. The same cDNA was also used in setting up the
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standards iov jl-Actin. Subsequently, a set of the same arbitrary units for the
standards were setup for the amplification of both transcripts. It does not
matter what units were used as the results were given in ratio. A value of 1
would indicate the expression level of the gene of interest is the same as the
reference gene, and the value of more or less than 1 would indicate a relative
higher or lower expression of the gene of interest accordingly. The value of
relative expression to fi-actin can therefore be used in comparing the
differential gene expression between the expression levels of different genes
in the same set of samples (since fi-actin is consistently expressed through
out the process) in addition to the comparison of the differential gene
expression in the same set of sample using the same gene. Relative
expression of the normalized gene expression (to fi-actin) to the gene
expression on DO or undifferentiated ES cells (stage 1) was also determined.
This gives the information on fold induction between the expression in
undifferentiated and differentiated cells throughout the whole differentiation
process.
The other important factor is the level of background fluorescence from
primer dimers, since the amplification is detected by SYBR Green which
fluoresces when bound to double-stranded DNA (dsDNA). Therefore the
fluorescence from artifact dsDNA of primer dimer could impede proper
quantification. Fortunately, melting curve analysis and gel electrorophoresis
of the DNA amplified never indicated such problem in our work. This
problem was avoided by designing appropriate primers, optimum
concentrations for all components and optimized SYBR Green-PCR
conditions (as described in Chapter 2).
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Based on this study, we find that qRT-PCR is a good technique for analysis of
differential gene expression, provided that all the factors influencing the
analysis are carefully taken into account. Besides that the analysis between
different samples should be done in parallel with proper choice of standards.
Finally, the qRT-PCR analysis should be qualitatively confirmed by other
method, such as in situ hybridization or northern blotting, or may be
quantitatively extended using TaqMan real time PCR, which was not done in
this study. This is because the main objectives for this part of study are to
confirm the expression profiles as demonstrated by RT-PCR and quantified
the expression level of each gene at different stages during the differentiation
process by qRT-PCR.
3.2.5 Expression Profiles of Wnt antagonists by qRT-PCR: Dkkl
and sFRP2
Expression profiles of two Wnt antagonists were examined during the
differentiation process (Figure 3.9, Table 3.1 section 3.2.6). Dkkl, which
antagonizes Wnt signalling by direct interaction with Wnt receptor, LRP5/6,
and sFRP2, which antagonizes Wnt signalling by directly bind to Wnts (as
described in Chapter 1), were included. In addition, sFRP2 was also
included since its expression has been shown to be upregulated during
neural induction (4-/4+) of ES cells and downregulated in differentiated
neurons and glial in mouse brain (Aubert et al., 2002).
Interestingly, Dkkl was found to be highly expressed at stage 2 during the
differentiation process, which mainly consists of Soxl negative EBs (Figure
3.9). The highest expression was detected on D4 with a 30 fold increase
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Table 3.1: Grouping ofWnt genes based on relative expression to fi-actin by
qRT-PCR
Group Stage 1 Stage 2 Stage 3 Stage 4 Stage 5
DO D2 D4 D6 D8 D10 D12 D14 NLC
A Wnt8a 1 + +
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Dkkl + ++ + + + ++ + + + + + + + + + + + + + +
sFRP2 + 1++ + + + + ++ + + + ++ + + + + + + ++ + ++
(Based on relative to 6-actin value (x); - = x < 0.01; + = 0.01 < x <0.25; ++ = 0.25 < x < 0.5; +++ =
0.5 < x < 1; ii i i = x > 1)
Canonical pathway, Non-canonical pathway, both pathways,
Upregulation of expression
compared to its expression on DO. The expression was, however,
downregulated on D6 onwards, where the formation of NPCs was detected,
consistent with downregulation of Dkkl expression upon neural induction.
sFRP2 was found to be expressed at all stages of the process with D8 having
the highest expression level. The highest expression was increased five fold
compared to expression on DO. Lower levels of sFRP2 expression were then
observed at stages 4 and 5. In agreement with the published results by
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Figure 3.9 : Expression profile of Wnt Antagonists by qRT-PCR. Expression
profiles of Dkk1 and sFRP-2 during neural differentiation of mouse ES cells in vitro.
(A and C) Expression of Dkk1 and sFRP-2 normalized to ti-Actin, respectively. (B
and D) are expression of the respective genes (normalized to 8-actin) relative to DO
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Figure 3.10 Group A - Wnt Expression profile by qRT-PCR. Group A consists of
only Wnt8a, which is up-regulated during early stages of neural differentiation
process (D2 and 4) and seems to be down-regulated upon induction of neural
fate. (A) Expression of Wnt8a normalized to /2-Actin. (B) Its normalized
expression relative to DO or undifferentiated ES cells. Standard error bars show
mean ± SEM from three independent experiments.
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NPCs (stage 3) followed by lower expression level of the gene in
differentiated neuronal cells (stage 4 and -5). The expression profile of sFRP2
in our assay therefore may imply an inhibitory effect on Wnt signalling by
sFRP2 activity during the differentiation process, as demonstrated by the
study. Flowever, in overall expression, the expression of Dkkl was higher
than that of sFRP2 in this neural differentiation assay. The highest
expression level of Dkkl was discovered to be 3-fold higher than that of
sFRP2 relative to fi-actin.
3.2.6 Expression profile ofWnt genes by quantitative PCR (qRT-
PCR) during neural differentiation in vitro
12 of the Wnt genes with an interesting expression pattern demonstrated by
RT-PCR results were quantitatively analysed using SYBR green real time
PCR (qRT-PCR). Besides Wnt genes, two of the Wnt antagonists, Dkkl and
sFRP2, were also analysed by qRT-PCR. Total RNA from three independent
experiments were analysed for the expression of the 12 Wnt genes and the
twoWnt antagonists.
Based on qRT-PCR results, the expression of Wnt genes during the
differentiation process have been classified into four groups (Table 3.1);
group A genes which are expressed at stage 1 and 2 (D2 and D4 EBs), group
B genes which are highly expressed at stage 1 (DO/undifferentiated ES cells),
3 (D6 and D8 EBs) and 4 (D10, D12 and D14 EBs), group C genes which were
up-regulated at stage 3 and finally group D genes which were highly
expressed at stage 4.
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3.2.6.1 Expression ofGroup A gene: Wnt 8a
Wnt8a was observed to have a dynamic expression pattern starting from high
expression at stage 1 (DO) going to a higher expression level at stage 2 (D2
and D4, Figure 3.10, Table 3.1). Its highest expression level on D4 increased
8-fold compared to its expression on DO. It was found to be down-regulated
upon the induction of neural cells. Interestingly the expression was down-
regulated in the EBs of stages 3 and 4 after the addition of ATRA with almost
no expression detected in NLC. The expression profile agrees with the
expression described by RT-PCR (Figure 3.6).
3.2.6.2 Expression ofGroup B genes: Wnt 6, -7a and-7b
Interestingly, Wnt genes in this group showed biphasic expression (Figure
3.11, Table 3.1). Wnt6, -7a and -7b were expressed in undifferentiated ES
cells but were down-regulated at stage 2 (D2 and D4), that mainly contains
young EBs before the addition of ATRA. The genes seemed to be expressed
at high levels of expression starting from D6-D14 for Wnt6 (1-1.2 fold
increase from its expression on DO) and D8-D14 for Wnt7a and Wnt7b (1.5-2
and 5-6 fold increase from their expression on DO, respectively). However,
the expression of Wnt6 was detected at low level in NLC while Wnt7a and
Wnt7b were detected at high level in these cells indicating both genes were
expressed in neuronal cells.
3.2.6.3 Expression ofgroup C genes: Wntl, -3a and -10b
The expression of Wnt genes in this group were upregulated at stage 3
(Figure 3.12, Table 3.1). Wntl, Wnt3a and WntlOb exhibit the highest
expression level on D6-10, two days after the addition of ATRA. Very low
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Figure 3.11 : Group B - Wnt Expression profile by qRT-PCR. Group A consists
of Wnt genes that were expressed in undifferentiated ES cells (DO) followed by
down-regulation of the expression in early stages of neural differentiation
process. The expression was then up-regulated either on D6 or D8. (A, C and
E) Expression of Wnt6, Wnt7a and Wnt7b normalized to li-Actin, respectively.
(B,D and F) Expression of the respective genes (normalized to H-actin) relative
to DO or undifferentiated ES cells. Standard error bar is the mean ± SEM from
three independent experiments.
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Figure 3.12. : Group C - Wnt Expression profile by qRT-PCR. Quantitative reverse-
transcription polymerase reaction (qRT-PCR) was carried out from total RNA
extracted from EBs DO-14 and neuron-like cells (NLC). Group C consists of Wnt
genes that seem to be RA-induced or up-regulated after the addition of RA. (A, C
and E) The expression of Wnt1, Wnt3a and WntlOb normalized to 6-Actin,
respectively. (B, D and F) B-Actin normalized expression of Wnt1, Wnt3a and
WntlOb relative to DO or undifferentiated ES cells, respectively. Standard error bar is
the mean ± SEM from three independent experiments.
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expression of these genes was detected in undifferentiated ES cells (DO).
Their expression was downregulated in stage 4 EBs (D12-14), which mainly
consist of attached EBs with the formation of neurites outgrowth, and stage
5, neuron-like cells (stage 5). The highest expression of Wntl was
determined to be on D10 as shown by relative expression to fi-Actin, which is
an increase of 500 fold from undifferentiated ES cells (DO). Wnt3a was
expressed at the highest level on D6 which is an increase of 93 fold as
compared to DO. With an increase of almost 80 fold from undifferentiated ES
cells, WntlOb reached its maximum expression level on D10. Comparatively,
it was also noted that Wntl was highly expressed followed by Wnt3a with
WntlOb being the lowest expressed gene of this group in this neural
differentiation assay. These results demonstrate dynamic gene expression
profiles for Wntl, 3a and 10b with their highest level of expression seen in the
highest percentage of cells expressing Soxl-GFP (Figure 3.5 and 3.6).
3.2.6.4 Expression ofGroup D genes: Wntlb, -4, -5a, -14 and -11
All genes in this group showed high level of expression at stage 4 (Figure
3.13, Table 3.1). Low level expression of these genes was seen in
undifferentiated ES cells (DO) and EBs before the addition of ATRA, on D2
and D4. Their expression was then up-regulated on or after D8. For Wntlb, -
4 and -11, high expression was detected at stage 4 (D10, D12 and D14) which
mainly consists of attached EBs (Figure 3.2 and 3.3). However these three
genes were expressed at a low level at stage 5 which mainly consists of
neuronal cells (Figure 3.4). This most likely indicates that the expression of
these genes occurred in non-neural cells since the attached EBs (stage 4)
consist of heterogeneous populations as compared to more homogeneous
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Figure 3.13. : Group D - Wnt Expression profile by qRT-PCR. Group D
consists Wnt genes that were up-regulated either on or after D8 EBs. (A, C, E,
G and I) Expression of Wnt2b, Wnt4, Wnt5a, Wnt9a(14) and Wnt11 normalized
to ti-Actin, respectively. (B, D, F, H and J) Expression of the respective genes
(normalized to tl-actin) relative to DO or undifferentiated ES cells. Standard
error bar is the mean ± SEM from three independent experiments.
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the highest increase of expression as compared to DO (on D14). Its
expression was increased 60 fold while Wnt2b has an increase of 33 fold from
their expression on DO. The highest Wnt4 expression (on D12) was only 4.5
fold increased compared to its expression on DO.
The other gene in this group, Wnt5a, was up-regulated at the very late stage
of the differentiation process (D12 and D14 EBs) and also in neuron-like cells
population. Its highest expression was detected on D14 with an increase of
40 fold compared to the expression on DO. The gene was also expressed in
NLC with an increase of more than 10 fold (Figure 3.13) compared to its
expression on DO which highly suggests that Wnt5a is expressed in neuronal
cells. Lastly, group D also includes Wnt9a which was upregulated at stage 3
with high expression level detected on D8 onwards including NLC.
3.3 Discussion
3.3.1 Neural differentiation of ES cells
In this study a favoured protocol for differentiating ES cells into the neural
lineages that involves the treatment of three dimensional multicellular
aggregates, embryoid bodies (EBs), with all-trans retinoic acid (ATRA) was
applied (Strubing et at, 1995; Fraichard et al.r 1995; Bain et al, 1995; Li et al,
1998a). The protocol involves growing the EBs to maturity in the absence of
LIF, in the presence of serum, for four days prior to RA treatment for another
four days (4-/4+ protocol, Bain et al., 1995). In this protocol, the events
occurring during the first 4 days, prior to ATRA treatment, in culture are
thought to parallel those occurring between embryonic days 4-6 (E4-6)
[Doetschman et al., 1985; Shen and Leder, 1992; Coucouvanis and Martin,
1995; Bielinska et al., 1999; Duncan et al., 1997]. One of the major events
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occurring at this stage is the expression of a transcription factor for
pluripotent embryonic cells, Oct-4 (Scholer et al., 1990; Rosnier et al., 1990;
Shen and Leder, 1992; Ovitt and Scholer, 1998). In an embryo its expression
is downregulated between E5 and E8 (Ovitt and Scholer, 1998). In this study,
its expression was also observed in undifferentiated ES cells, which are
pluripotent cells, and downregulated as the EBs mature, as previously
demonstrated (Shen and Leder, 1992; Niwa et al., 2000).
Upon neural induction, after the addition of ATRA, gene expression studies
also have indicated that the stages of differentiation in EBs recapitulate that
of the embryo (Gottlieb and Huettner, 1999). One of the genes that are
expressed during early neural development within approximately one day of
the neural plate formation (E8) is Wntl (Wilkinson et al., 1987; McMahon and
Bradley, 1990; Thomas and Capecchi, 1990). In our study as well as in Bain
et al., 1996, Wntl expression was detected two days after the addition of
ATRA.
In addition, the protocol also generated cells expressing Soxl-GFF positive
cells as previously described (Aubert et al., 2002; Stavridis and Smith, 2003).
More than 60% of cells expressing Soxl-GFP were detected on D6 and D8 in
this study (Figure 3.6). RT-PCR results also showed high expression of Soxl
being detected on D6 and D8, thus indicating formation of dividing neural
precursor cells. A week after plating the dissociated D8 EBs onto an
adhesive substratum, positively stained cells for class III fi-tubulin (Figure
3.4) were observed as previously demonstrated (Bain et al., 1995; Li et al.,
1998a). The same phenomena were also observed in differentiation of a
human teratocarcinoma (NT2) (Pleasure et al., 1992) and D3 ES cell line (Bain
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et al., 1995) into neurons using retinoic acid, RA. Besides the expression
patterns of Oct4, Wntl and Soxl, we also observed an upregulation of Pax6
expression (a homeodomain protein present in neural tube, Novitch et al.,
2003), in EBs after ATRA treatment (data not shown) as previously
demonstrated (Gajovic et al., 1997; Li et al., 1998a; Bibel et al., 20004). Taken
together, the expression patterns of these genes in this study demonstrate
that the protocol was successfully carried out in directing the differentiation
of mouse ES cells to neural lineage and that the differentiation process may,
in part, recapitulate that of the early stage of embryogenesis in vivo.
3.3.2 Expression ofWnts andWnt antagonists
Due to the unavailability of good antibodies against Wnt proteins, analysis
for Wnt gene RNA expression profile became the method of choice. Wnt
gene RNA expression was identified at a particular time points during the
differentiation of mouse ES cells into neurons. The expression level of all 19
mouse Wnt genes were first analysed by RT-PCR. Gene expression level for
Wnt genes with interesting expression profiles were then further quantified
by qRT-PCR. In this study, expression levels of Wntl, -2b, -3a, -4 ,-5a, -6, -7a, -
7b, -8a, -9a, -10b and -11 from five different stages during neural
differentiation of 46C ES cells in vitro were quantitatively analysed. Together
with these Wnt genes, two Wnt antagonists which have been shown to be
involved in the neural differentiation process (Aubert et al., 2002; Diep et al.,
2004; Watanabe et al., 2005), Dkkl and sFRP2, were also subjected to qRT-PCR
analysis.
Expression profile for each of the 19 Wnt genes was monitored at five
different stages. As the formation of EBs contains all three primary germ
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layers (Weiss and Orkin, 1996; Rathjen and Rathjen, 2002), it is very
important to note that they give rise to highly heterogeneous cell populations
for each stage. Stage 1 (DO) consists of cells which mainly are Oct4 positive
and Soxl negative, indicating that the majority of the cells are
undifferentiated ES cells. Stage 2 (D2 and D4) consists of the cells of
immature EBs before the addition of ATRA that are Soxl negative with
downregulation of Oct4 expression. Being exposed to ATRA, at stage 3 (D6
and D8) most cells expressed high level of Soxl and very minute expression
of Oct4 indicating the majority of cells might be neural precursor cells
(NPCs). After the withdrawal of RA and grown in high density of EBs, most
EBs at stage 4 (D10, D12 and D14) were attached to the dish with the
formation of neurite growth. The majority of the cells in this population are
both Oct4 and Soxl negative indicating the absence of pluripotent cells and
NPCs. Finally, containing many fi-tubulin positive cells, stage 5 is highly
occupied by neuronal cells. It seems that stage 5 and 4 contain a proportion
of neuronal cells, even though cells at stage 4 are more heterogenous with
more types of non-neuronal cells.
3.3.2.1 Expression ofWnts and Wnt antagonists at Stage 1
The first stage of neural differentiation process in this study involves the
propagation of undifferentiated ES cells. These cells, that are pluripotent, are
originally harvested from preimplantation state, specifically the ICM of the
blastocyst in the mouse embryo day 3.5-4.5. A good proliferative state of
these uncommitted ES cells, which are maintained in the presence of LIF, is
essential in directing the differentiation process into enriched neural lineage
(Bibel et al., 2004). However, even in the present of LIF, spontaneous
differentiation of the cells might also occur (Stavridis and Smith, 2003).
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Comparison ofWnt gene expression in the ES cells in vitro to that of the ICM
in the mouse embryo may therefore provide some information regarding the
probable function of a particular Wnt gene in maintaining the
pluripontentiality of ES cells in vitro. Activation of Wnt signalling has been
shown to be sufficient in maintaining the pluripotency of mouse ES cells
(Sato et al., 2004). Besides that localization of fi-catenin in the nucleus of the
ICM has also been demonstrated (Wang et al., 2004) which indicates the
activation of canonicalWnt pathway in these cells.
In the present study, a high level expression of Wnt5b, -6, -7a -7b, -8a and -16
was detected by RT-PCR at this stage. A low level expression of Wnt3, -4, -
5a, -9a, -9b, -10 and -11 was also detected by RT-PCR as well as by qRT-PCR,
except for Wnt3 which was not analysed by this method. Interestingly,
expression of most of these genes, in particular Wnt3, -3a, -4, -5a, -5b, -6, -7a, -
7b, -10a and -11, has also been detected at RNA level in the mouse blastocyst
by other studies (Llyod et al., 2003; Mohamed et al., 2004; Hamatani et al., et
al., 2004; Wang et al., 2004; Kemp et al., 2005). Among the studies, the most
striking one is the recent study by Kemp et al., 2005 that showed Wnt7b,
among other genes, to be highly expressed in the whole blastocyst (E3.5
embryo) including the ICM as showed by qRT-PCR and whole-mount in situ
hybridisation. Interestingly, Wnt7b was also highly expressed in our
undifferentiated ES cells as indicated by RT-PCR and qRT-PCR (Figure 3.8
and 3.11). The expression of Wnt7b hence may indicate its probable function
in maintaining the pluripotentiality of ES cells. Besides that, they also
detected high expression of Wntl, -3a, -6, -10b and -9a in the blastocyst. In
our study, however, Wnt6, -7a, -7b and -8a were found to be expressed at
high level in undifferentiated ES cells. The high level expression in different
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type of Wnt genes detected in both populations may indicate the different
role of specificWnt genes in vitro compared to their role in vivo. On the other
hand this might also indicate that these Wnt genes were expressed in the
differentiated cells as a result of spontaneous differentiation that occurred in
the cultures.
Multiple gene expression detected in undifferentiated ES cells in this study
may also indicate redundant roles or different roles that may be acting
through different Wnt pathways. Our qRT-PCR results also reveal the
expression of Wnt genes that are known to activate the canonical (Wnt6,
Wnt7a Wnt7b and Wnt8a) and non-canonical (Wnt7a) pathway. Interestingly,
a study by Kemler et al., 2004 also has suggested a possible role of Wnt
pathways in the development of pre-implantion embryos by acting through
fi-catenin independent pathway. The study showed mouse embryo
constitutively expressing a stabilized form of fi-catenin did not exhibit
localization of the mutated protein in the nuclei of preimplanttaion embryos
suggesting the expression of multiple Wnt genes at this stage may indicate
the possible functions of certain gene through non-canonical pathway. The
expression of multiple Wnts in our study may also suggest the function of
certain genes acting through differentWnt pathways.
3.3.2.2 Expression ofWnts and Wnt antagonists at stage 2
Based on gene expression studies, the outer layer of EBs at this stage strongly
resembles the visceral endoderm (VE), which is the first layer to form in the
postimplantation embryo E.5.5 prior to the start of gastrulation at E6.5
(Bielinska et al. 1999; Duncan et al., 1997; Gottlieb and Huettner, 1999).
During early gastrulation, the pluripotent epiblast (the ICM) cells are
132
allocated into the three primary germ layers (ectoderm, mesoderm and
definitive endoderm) of the embryo (Loebel et al., 2003), where expression of
Wnt2br -3, and -8a are highly expressed (Takada et al., 1994; Bouillet et al.,
1996; Zakin et al., 1998; Kemp et al., 2005). Migration of the visceral
endoderm cells from the distal tip of pre-gastrula embryo to the presumptive
anterior side forming the anterior VE was defected in 6-catenin mutant
mouse (Huelsken et al., 2000). This may highly suggest the role of canonical
Wnt signalling in the process which might explains the expression of these
genes at this period. Interestingly enough, these genes were also detected at
high level in our study (Figure 3.8) which may signify their role in the
process in vitro.
In addition, lack of mesoderm has also been demonstrated in Wnt3- and jl-
catenin mutant embryos indicating the role of Wnt signalling in axis
formation. Therefore, expression of Wnt3 and Wnt8a are most likely to
indicate the presence of mesodermal layer in the EBs at this stage of neural
differentiation process. In agreement to this, Brachyury, a gene marker for
early mesodermal that is transiently expressed during gastrulation, is also
highly expressed around D4 in EBs (Rohwedel et al., 1994,1998a,b, 1999). The
very strong Wnt antagonists, Dkkl and sFRP2 were also observed in this
study. Interestingly, expression of Dkkl has also been found in the anterior
VE (Pearce et al., 1999; Zakin et al., 2000), which highly explains the high
expression level of the gene in our study. Even though analysis of Dkkl
mutant phenotypes did not reveal its requirement for the formation of the
head at the early gastrulation stage in mouse embryo (Mukhopadhyay et al.,
2001), study in zebrafish has demonstrated a crucial function for Dkkl for
specification of the anterior nervous system and axial mesendedorm
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(Hashimoto et al., 2000). In another study, a member of sFRP family, tic, has
also showed the requirement of this gene for the initial formation of the
anterior brain in zebrafish (Houart et al., 1998, 2002). In frog, another Wnt
antagonist, Cerberus, has been found to antagonize Wnt signalling and
expressed in the endoderm region that is equivalent to the mouse anterior
VE (reviewed in Shibata et al., 2000). These studies therefore demonstrate the
important of inhibitory of Wnt signalling in the initial patterning of the
anterior brain, which might explain the probable function of Dkkl and sFRP2
in our cultures.
On the other hand, overexpression of Dkkl has also been shown to promote
anterior neuroectoderm in zebrafish indicating Wnt inhibitory effect on the
formation of neuroectoderm. Overexpression of sFRP also has been shown
to promote the formation of neural progenitors in ES cells (Aubet et al., 2002).
The high expression of these two genes therefore may highly indicate the
inhibitory effect on Wnt signalling at this stage of neural differentiation
process in this study. In addition, expression of neurectodermal markers,
Pax6 and Mashl, have also been shown to be expressed during early stages of
EBs development as early as day one (Rohwedel et al., 2001) indicating the
formation of neuroectodermal cells at this stage. With the possible inhibitory
effect showed by the expression ofWnt antagonists, Dkkl and sFRP2, at this
stage, it is therefore reasonable to suggest that this might explain the smaller
number of Wnt genes that were highly expressed at this stage. Hence this
might suggest the possible role of Wnt signalling in inhibiting the
differentiation of ES cells to NPCs in vitro. Out of 12 genes that were screened
by qRT-PCR, only four genes were highly expressed at this stage.
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3.3.2.3 Expression ofWnts and Wnt antagonists upon neural
induction
Stages 3, 4 and 5 in the differentiation process involved the enhancement of
neural lineage by ATRA treatment. Previous study has shown that
differentiation rate for neuronal cells increased 100% after the induction by
ATRA compared to only 15-30% of spontaneous neuronal differentiation
frequency in cultured EBs (Strubing et al., 1995). In addition, the application
of ATRA at high concentrations (10~6 to 107 M) not only significantly
increased neuronal differentiation but also repressed mesodermal
differentiation (Bain et al., 1995, 1996; Fraichard et al., 1995; Strubing et al.,
1995). In a study where RA-treated EBs were transplanted into a chick
neural tube, the authors found that RA appears to restrict the ES-cell derived
progenitors to the CNS fate (Plactha et al., 2004). RA-treated EBs also have
been shown to generate a variety of neural cells including excitatory and
inhibitory neurons and glial (Fraichard et al., 1995; Strubing et al., 1995; Finley
et al., 1996). However, RA is believed to have posteriorizing effect during
neural development (Blumberg et al., 1997). It has been used to induce
posteriorization of ES-cell-derived NPCs (Barberi et al., 2003) and
differentiation into motorneurons (Wichterle et al., 2002) and interneurons
(Renoncourt et al., 1998). On the other hand, with suitable concentration of
ATRA and a good proliferative state of the starting uncommitted ES cells,
Bibel et al., 2004 have manage to induce cortical pyramidal neurons. These
results therefore imply that RA-treated EBs are able to induce the formation
of different type of neurons present in the CNS in vitro.
Previous studies have demonstrated the CNS as the primary regions for the
expression of numerous Wnt genes (Wilkinson et al., 1987; Roelink and
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Nusse, 1991; McMahon et al., 1992a,b; Salinas and Nusse, 1992; Parr et al.,
1993) which suggest that Wnt signalling plays significant roles in the early
development of the CNS in vivo. Numerous dynamic expressions of Wnt
genes also were detected upon neural induction in this study which highly
suggests the importance of Wnt signalling in neural development of ES cells
in vitro.
A study by Chenn and Walsh, 2002 has suggested the regulation of fi-catenin
on the proliferation of neural stem cells. In their study, progenitor cells that
were constitutively expressing a stabilized form of 6-catenin produced high
number of NPCs suggesting a role of canonical Wnt pathway in proliferation
of neural progenitors in the mouse embryo brain. Interestingly, we
discovered that expression of Wntl, -3a, -7a, -7b, and -10b, which are known to
activate canonical Wnt pathway, was upregulated at stage 3 (D6 and D8 EBs)
which consists mainly of NPCs. The expression of these genes therefore may
highly signify their role in maintaining or stimulating the proliferation of
NPCs in vitro. In agreement to this, expression of these genes were also
detected at the early stage of neural tube development in vivo (Parr et al.,
1993) which highly to suggest that the neural differentiation in EBs
recapitulates that of the embryo. Wntl and Wnt3a also have been shown to
promote cell proliferation in the neural tube (Dickinson et al., 1994; Ikeya et
al., 1997). A recent study involving overexpression of Wnt7a in neural
progenitor cells also showed an early defect in neurulation during E8.5 and
E10.5 embryos (Shariatmadari et al., 2005). They observed a striking
disruption of adherens junctions which resulted in incomplete cranial and
spinal neurulation, and interestingly the defect was found to be activated
through non-canonical Wnt signalling. These studies hence might highly
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suggest the important function of these Wnt genes in ensuring the proper
formation of neural tube hence on the proper development of the CNS
through the activation of both non- and canonical pathways.
In contrast to the study by Chenn and Walsh, 2002, a study by Muroyama
and colleagues (2004) on the role of Wnt3a on the expansion of the number of
neurosphere-forming neural stem cells derived from the telencephalon of
El 1.5 mouse embryos in vitro suggested the opposite. In the study, the
authors discovered that treatment with Wnt3a conditioned medium on the
dissociated telencephalic cells decreased the number of newly-formed
neurospheres in culture condition. High expression of Wnt3a in NPCs in our
culture therefore may suggest a function of the gene that agrees with Chen
and Walsh. The agreement might indicate that the proliferation process of
NPCs in our culture recapitulates the proliferation process in vivo. Further
examination on effect of overexpressing Wnt3a during neural differentiation
process of ES cells in culture would lead us to some explanation regarding
this matter.
As development proceeds, more Wnt genes were highly expressed at stage 4
especially at the beginning of the stage (D10 and D12) compared to the late
period of stage 4 (D14) and stage 5. We found Wnt2b, -4, -5a, -9a and -11 in
addition to Wntl, -3a, -7a and -7b to be highly expressed at stage 4, while
Wntl, -5a, -7a, -7b and -9a were highly expressed in the cells at stage 5. It is
believed that these genes were highly expressed in neuronal cells since the
formation of neurites growth was observed at these stages. Various studies
have implicated the roles ofWnt genes in promoting differentiation of neural
stem cells/progenitor cells in vivo. In a study by Israsena et al., 2004, the
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authors discovered that overexpression of fi-catenin or of a constitutively
active form of fi-catenin from E14 neural progenitors from lateral and medial
ganglionic eminence significantly increased the number of fi-tubulin neurons
and significantly decreased the number of nestin cells. In agreement to the
study, another study also showed that overexpression of a stabilized form of
fi-catenin together with overexpression of Wnt7a in NPCs prepared from the
dorsal cerebral cortex of mouse embryos at El 1.5 also induced neuronal
differentiation (Hirabayashi et al., 2004). These studies therefore suggested a
significant role of canonical Wnt signalling in promoting neuronal
differentiation of NPCs. The study is supported by work by Muroyama and
colleagues which demonstrated the function of Wnt3a in promoting neuronal
differentiation of neural stem cells harvested from El 1.5 telencephalic cells in
culture (Muroyama et al., 2004). Besides that the group also showed the
important role ofWnt signalling in neuronal specification of the dorsal spinal
cord (Muroyama et al., 2002). Taken together, these studies clearly suggest
the important role ofWnt signalling, particularly the canonical Wnt pathway
in promoting differentiation of NPCs into neurons. Hence, this may
significantly implies the function of those highly expressed Wnt genes in our
culture, especially Wnt3a and Wnt7a, in promoting the differentiation of
NPCs into neurons. Functional analysis such as overexpression of these
genes at this point might reveal their role regarding this matter.
3.4 Conclusion
This study has revealed the expression of numerous Wnt genes with
interesting dynamic patterns during neural differentiation process of ES cell
in culture. We have also shown that the expression pattern of most genes
temporally agrees with the expression pattern of Wnt genes during early
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development of the CNS in the embryo. We also have categorized the
expression pattern of the 12 Wnt genes screened by qRT-PCR into 4 groups
(Table 3.1) and identified the pathways that are known to be activated by the
genes. We also discovered thatWnt antagonist, Dkkl and sFRP2 were highly
expressed at all stages upon development of EBs. However, there are
limitations from what can be learned from the analysis in this study.
The analysis was only done based on the RNA harvested from a complex
structure of EBs, which contain highly heterogeneous cells. The expression
of all genes was displayed relative to B-actin which is highly expressed in
most cells in the EBs. Therefore, the relative expression may not all be
presenting the actual RNA expression of particular functional gene especially
if the particular gene is only expressed in a few localized cells in the EBs.
The RNA expression from this gene would be misidentified since its relative
expression would be very small. Therefore the analysis could not tell us
where exactly the cells are expressed.
Wnts are secreted proteins which act extracellularly. Our analysis which
only based on RNA expression therefore does not give the information on
the functional properties of each expressed gene at particular stage during
the differentiation process. The gene expression also does not lead us the
information of which Wnt pathway is actually active even though the
analysis does give us the idea that different pathways might be involved
during the process.
In summary, the analysis, however, does give us the information on which of
the Wnt genes that are highly expressed during the process. Upon neural
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induction, the study has highly suggested the probable function of Wntl, -3a,
-6, 7a and 7b in maintaining or promoting the proliferation of NPCs (stage 3)
while Wnt5a and Wnt9a in addition to Wntl, -3a, 6, 7a and 7b may have
certain function in neuronal differentiation of NPCs or ES cells in vitro.
Manipulation ofWnt signalling through both pathways by overexpression of
these particular genes or inhibition of the pathway by overexpression of Wnt
anatagonist at specific time point during the process might lead us some
answers.
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Chapter 4: Characterization of Inducible and Reporter
Gene Expression Systems in ES cells
4.1 Introduction
4.1.1 ES cells inducible expression system
As described in chapter 3, many Wnt genes show dynamic RNA expression
profiles during neural differentiation in vitro, suggesting the possibility that
Wnts may have regulatory roles in this process. Specifically, the activity of
Wnt signals may be stage-dependent. Unfortunately, due to the nature of
Wnt proteins, the use of their soluble proteins is almost impossible. To date,
only purification of soluble Wnt3a protein has ever been used which is in a
study to determine the effect of Wnt signalling on self-renewal of
haematopoietic stem cells (Willert et al., 2003). Therefore, a system that is able
to activate or inactivate the genes in a temporally or spatially controlled
manner would be useful in testing their functional properties. Here an
inducible expression system would be a valuable tool.
Not many ES cells conditional expression vectors used in previous studies
have reported the ability of the system to induce the expression of the
transgene in undifferentiated ES cells as well as their differentiated
derivatives in vitro (Whyatt et al., 1993; Zhang et al., 1996; Niwa et al., 2000).
In this chapter, we report the generation of an inducible expression system in
ES cells that allows for further analysis on the functional properties of Wnts
at specific time points during differentiation of ES cells. A conditional gene
expression system involving Cre/loxP site-specific recombination was used.
The system has proven to be very useful not only in activating or
deactivating specific genes of interest in a spatiotemporally controlled
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manner but also useful for elucidating a complete picture of gene function,
especially the genes with multiple roles at different times and in different
population of cells. Therefore the system offers great advantages for us in
conducting further analysis on the functional properties of specific Wnt
genes and Wnt antagonist during neural differentiation assay in vitro.
We have constructed five plasmids carrying Wntl-HA, Wnt3a, Wnt5a, Wnt7a
and Dkkl and stably-transfected Cre-expressing ES cells with each of them.
In this chapter, characterization of these stable integrants will be presented,
particularly, the ability of the system to tightly control the expression of these
genes in undifferentiated ES cells and in their differentiated derivatives in
vitro.
4.1.2 Wnt reporter system
Analysis of RNA expression does not tell us which cells are expressing
Wnts, and perhaps more importantly which cells are actually responding to
Wnt signal. Therefore, it would be useful to have a system that allows for a
direct visualization of specific cells that are responding to Wnt signals at a
particular time point and in specific cell population. Existing tools for Wnt
reporter gene expression such as TOP-FLASH (Korinek et al., 1997), TOP-
GAL (DasGupta and Fuchs, 1999) and BAT-GAL (Maretto et al., 2003), which
rely on fi-catenin-mediated activation of a reporter gene, have limitations in
providing a direct detection of Wnt signals. Detection of LacZ/B-
galactosidase in TOP-GAL and BAT-GAL requires the use of chemical
substrate for histological staining such as X-gal that requires the cells to be
fixed. Similarly, TOP-FLASH also requires a subsequent analysis in
detecting the activity of luciferase which actually relies on the activity of a
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control substance such as Renilla. On the other hand, TOP-dGFP (Dorsky et
al., 2002) even though is allowing for direct visualization of the signal, it does
not permit the visualization of Wnt signal in GFP-expressing cells, which is
commonly used in fluorescent protein knock-in cells.
In this study, red fluorescent protein (RFP) was used as a reporter gene,
which was activated in response to canonical Wnt signals. The system not
only allows for direct visualization of cells that are responding to canonical
Wnt signals is but also useful in distinguishing the expression of RFP and
GFP (or other GFP spectral variant expressing cells such as ECFP and EYFP)
due to its different wavelength spectrum and genetic origin from GFP (Long
et al., 2005). The system allows us to examine the cells that are responding to
only canonical Wnt signals during neural differentiation assay and at the
same time permits us to monitor Wnt response in neural precursor cells
(NPC) by using Sox2-GFP knock-in ES cells (46C, Chapter 3). In this chapter,
the reliability of reporter gene expression in HEK-293 and ES cells will be
evaluated. Finally, the system was used to monitor the specific cells that
were responding to Wnt signals during neural differentiation of 46C ES cells
in culture.
4.2 Results
4.2.1 Tamoxifen-controlled Inducible Expression in ES cells
Our aim for this part of study was to generate an inducible expression
system that would be active not only in ES cells but also upon differentiation.
We had identified the best available candidate system (Srinivas et al., 2001)
and attempted to adopt it for our purposes (Appendix E). This was,
however, unsuccessful for technical reasons. The plasmid contains multiple
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direct repeats and despite extensive efforts, recombination always made
plasmid construction impossible. We therefore adopted an alternative
system. A binary system that applied the Cre/ZoxP-based strategy for an
inducible gene expression system was then generated (Figure 4.1). The first
part of the system is a ubiquitous Cre-ERT2 expressing ES cell line, R26CT2S
(Grotewold, unpublished). The ere is fused to a mutated ligand-binding
domain (LBD) of a human oestrogen receptor (ERT2) and targeted into the
ROSA26 locus, which is constitutively active both in un- and differentiated
ES cells. As a result of specific point mutations in the LBD, treatment with
tamoxifen or synthetic 4'-hydroxytamoxifen (4'-OHT) highly activates Cre
expression but not by endogenous oestrogen normally present in the serum
used in culture medium (Feil et al., 1997; Indra et al., 1999). The inducibility
of cre-recombinase was tested in driving the expression of GFP in a stably-
transfected CAG-floxed-Nanog-IRES-pacpASTOP-cassette upstream of
enhanced GFP (eGFP) coding region in R26CT2S cells (Figure 4.2A, the
experiment was carried out by Lars Grotewold). The expression of GFP was
observed upon excision of the floxed cassette upon treatment with 4'-OITT
(Figure 4.2B). The ability of this cell line, R26CT2S, to drive 4'-OHT-
dependent expression of any genes was applied in this study.
The second part of the system involves an inducible expression vector,
pCAG-floxed-neopA, which is transfected into R26CT2S cells to generate
stable clones (Figure 4.1). The vector pCAG-floxed-neopA contains CAG (a
chicken-beta actin promoter associated with cytomegalovirus immediate-
early enhancer)-floxed-neo-stop sequence upstream of a cloning site followed
by an internal ribosome entry site (IRES) to puromycin N-acetyltransferase
(.Pac) [Figure 4.1A], Exposure to 4'-OFIT results in Cre-mediated deletion of
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Figure 4.1: Schematic representation of tamoxifen-controlled inducible expression
in ES cells. pCAG-floxed-neopA vector carrying a gene of interest (A) is stably
transfected into R26CT2S cells (B) by GeneJuice (Novagen) which then makes
them resistant to neomycin (G418). Upon treatment with tamoxifen (4'-OHT), Cre-
ERT2 is activated which then excises the floxed-neo-stop cassette (C). The CAG
promoter subsequently drives the expression of downstream genes, the gene of
interest and the pac gene. As a result, the cells become resistant to puromycin.
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R26CT2S cells: Test for CreER72 inducibility
A) Stable transfection with :
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Figure 4.2: Inducibility test for Cre-ERT2 was done on stably-transfected R26CT2S
cells with pCAG-floxed plasmid (A). B) After selection in puromycin, the clone was
treated with different doses of 4'-OHT for 30 hours. The analysis for recombination
was then done by FACS. The percentage of cells expressing GFP after treatment
with 0 (B-i), 25 (B-ii), 100 (B-iii), 200 (B-iv) and 400 nM of 4'-OHT (B-v) were
presented, indicating the efficiency of cre-mediated recombination by 4'-OHT.
Diagram and data are from Lars Grotewold, unpublished.
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the neo-stop cassette and activation of downstream genes (Figure 4.1C). As a
consequence, the cells become neomycin (G418) sensitive but are resistant to
puromycin. Hence, stable transfection of this plasmid vector into the
ubiquitous Cre-ERT2 expressing ES cell line, R26CT2S, allows us to tightly
control the expression of selected Wnt genes and Wnt antagonists in
undifferentiated and differentiated ES cells at any desired time point during
neural differentiation process.
4.2.1.1 Generation of stably-transfected pCAG-floxed-neopA
ES ell lines
Based on the RNA expression profiles demonstrated in chapter 3, four Wnt
genes and one Wnt antagonist, Dkkl, were chosen to generate transgenic ES
cell lines. For canonical or 6-catenin/Wnt signalling pathway, Wnt 1 and
Wnt3a were chosen. Wnt5a was chosen as a representative of the Ca2+
pathway. Finally, Wnt7a which can activate both pathways was also
included in the list. To antagonize the endogenous Wnt gene activities, we
decided to use Dkkl.
In generating pCAG-floxed-neopA vector plasmid carrying these genes, a
variety of different transitional vectors were used in order to find the
appropriate restriction endonuclease sites (Xhol and Sail) as the vector only
has one cloning site, Xhol (for details in construction of these plamids, refer
to Appendix B). Sail was used as it generates compatible 5'-overhangs with
Xhol. Fortunately, in contrast to pBigT and p9.8 Pac/Asc vectors (Appendix
E), pCAG-floxed-neopA vector was much easier to handle and the cloning
activities were more straightforward.
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4.2.1.1.1 pCAG-floxed-neopA-Wntl-HA ES cell line
Due to the unavailability of a good antibody for Wntl, we decided to use a
haemagglutinin (HA) antigen epitope tagged-Wnfl. No negative effect of an
HA epitope tag on Wntl has ever been reported. In order to generate the
pCAG-floxed-neopA carrying Wntl-HA, a 1.3 kb Wntl-HA fragment was
excised from Wnfl-HA/pBSIIKS" plasmid (Shimizu et al., 1997) by digestion
with Asp 718 and Xbal prior to cloning into Asp7l8-Xbal digested
pGEM3zf(+) vector. As a result, a plasmid carrying two Sail sites flanking
the Wnfl-HA sequence was created. The Wntl-HA fragment used encodes a
portion of Wntl 5'UTR upstream of the gene's open reading frame (ORF)
immediately followed by the HA sequence. Subsequently, the Wnfl-HA
fragment was excised by Sail digestion and cloned into the Xhol site of a 7.8
kb pCAG-floxed-neopA vector, generating a 9.2 kb pCAG-floxed-neopA-
Wnfl-HA plasmid (Figure 4.3). Screening for all correct plasmids at each
step was done by restriction enzyme digestion (as described in chapter 2 and
appendix B). The nucleotide sequence at both of the junctions between the
insert and the vector of the correct clone carrying pCAG-floxed-neopA-Wntl-
HA was also sequenced.
R26CT2S ES cells were then stably-transfected with the plasmid as described
in chapter 2. However, upon induction with 4'-OHT, not all of the clones
expressed Wntl when screened by qRT-PCR. Consequently, we decided to
test the stability and integrity of the construct by selecting a few of the G418
resistant clones in 1 pg/ml of puromycin (as described in chapter 2) after the
clones were treated with 0.5 pM of 4'-OHT. Only clones carrying a stably
integrated construct would survive puromycin selection upon excision of the
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puromycin selection which were then referred to as pCAG-Wn£2-HA-Tp or
constitutively overexpressing Wntl-HA clones. 4'-OHT-untreated cell lines,
which were neomycin (G418) resistant, were called CAG-floxed-neopA-WnU-
HA ES cell lines.
4.2.1.1.2 pCAG-floxed-neopA-Dkkl ES cell line
In generating pCAG-floxed-neopA carrying Dkkl, Dkkl cDNA (0.9 kb) was
released from Dkkl/pGEM-T Easy plasmid (a gift from Sarah Millar,
University of Pennsylvania) upon digestion with BamHl and cloned into
BamHl site of pBlueScript II KS(+) plasmid. The generated plasmid was then
degested with Asp718 and Xbal prior to subclone into Asp718 and Xbal sites
of pGEM3zf(+) vector. Subsequently, a 0.9 kb Dkkl cDNA was excised from
this plasmid upon digested with Sail and cloned into Xhol site of pCAG-
floxed-neopA vector (Figure 4.4), resulting in the final 8.7 kb pCAG-floxed-
neopA-Dkkl plasmid. The correct plasmids for each of the cloning step were
screened by restriction enzyme digestions (appendix B). The nucleotide
sequence at both of the junctions between the insert and the vector of the
correct clones carrying pCAG-iloxed-neopA-Dkkl was also sequenced.
Screening for stably-transfected R26CT2S cells with pCAG-floxed-neopA-
Dkkl was conducted as described above. Out of 6 clones that survived G418,
only two were resistant to puromycin upon exposure to 4'-OHT. We named
these clones pCAG-D/cAT-Tp for constitutively expressing Dkkl, and their 4'-
OHT-untreated cell lines, which were neomycin (G418) resistant, were called
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4.2.1.1.3 pCAG-floxed-neopA-Wnt3a ES cell line
Due to a recent report on the negative effect of HA epitope tag on expression
of Wnt7a (Hirabayashi et al., 2004), we decided to use untagged-Wnt3a for
the construction of transgenic Wnt3a ES cell lines despite the unavailability of
a good mouse Wnt3a antibody. Unlike for Wntl-HA and Dkkl, a different
transitional vector was used. We began with excision of 1.5 kb Wnt3a
transcript from pCDNA5FRT plasmid by EcoRl digestion prior to cloning the
transcript into an EcoRl site of a transitional vector, pDsRed2-l. A plasmid
carrying Xhol and Sail sites flanking the Wnt3a transcript was thereby
generated. Subsequently, the 1.5 kb insert containing the Wnt3a fragment
was excised by Sall-Xhol digestion and cloned into the Xhol site of the 7.8 kb
pCAG-floxed-neopA vector, generating a 9.3 kb pCAG-floxed-neopA-Wnt3a
plasmid (Figure 4.5). Screening for all correct plasmids at every step was
done by restriction enzyme digestion (as described in chapter 2 and
appendix B).
Screening for stably-transfected R26CT2S with pGAG-floxed-neopA-Wnt3a
began with selection in G418 (chapter 2). The clones were subsequently
screened by selection in puromycin after being treated with various
concentrations of 4'-OHT, as described in chapter 2. Out of 11 clones, only 4
survived puromycin selection. These were named CAG-Wnt3a-Tp ES cell
lines. Their 4'-OHT-untreated cell lines, which were neomycin (G418)
resistant, were named CAG-lloxed-neopA-Wnt3a ES cell lines
4.2.1.1.4 pCAG-floxed-neopA-Wnt5a ES cell line
A more direct strategy was applied in constructing pCAG-floxed-neopA-
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Figure4.5:Constr ctionofpCAG-floxed-neopA-tV f3alasmid.Xho1 digestedWnt3afragment(B)wasclonin oXho1sipCAG-fl xed- neopAv ctor(A)tg nerateh9.3kbpC G-floxed-neopA-l/W?f3a plasmid.
excised from pCMV.SPORT6 (Mammalian Gene Collection 3493095) by
digestion with Sail and Xhol prior to directly cloning the insert into pCAG-
floxed-neopA at the unique Xhol site. As a result, a 10.2 kb pCAG-floxed-
neopA-Wnt5a was produced. The 2.5 kb insert contained a part of Wnt5a
5'UTR, a complete Wnt5a ORF and a portion of Wnt5a 3'UTR (Figure 4.6).
Clones carrying the correct plasmid were screened by restriction enzyme
digestion (Appendix B).
Screening for stably-transfected R26CT2S with pCAG-floxed-neopA-Wnt5a
began with selection in G418 (chapter 2) followed by procedures as described
above. Out of eight clones that survived G418 (8 out of 18), only one clone
survived puromycin upon deletion of neo-stop cassette by 4'-OHT. This
puromycin resistant clone was referred to as CAG-Wnt5a-Tp ES cell line. Its
4'-OITT-untreated cell line, which was neomycin (G418) resistant, was named
CAG-(\oxed-neopA-Wnt5a ES cell line.
4.2.1.1.5 pCAG-floxed-neopA-Wnt7a ES cell line
In generating the pCAG-floxed-neopA-Wnt7a, we began with digestion of
pYx-Asc/Wnt7a (Mammalian Gene Collection 6415801) with EcoRl to release
a 1.7 kb fragment encompassing Wnt7a cDNA. The 1.7 kb EcoRl fragment
was subsequently cloned into pDsRed2-l at the EcoRl site to generate a
plasmid carrying Xhol and Sail sites flanking the Wnt7a cDNA. The resulting
plasmid was then digested with Xhol and Sail, and the 1.7 kb Xhol-Sall
fragment containing the Wnt7a coding region was cloned into the Xhol site in
pCAG-floxed-neopA (Figure 4.7). As a result, a 9.5 kb pCAG-floxed-neopA-
Wnt7a was generated. Screening for all plasmids at each cloning step was
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Screening for the integrity of stably-transfected R26CT2S with pCAG-floxed-
neopA-Wnt7a was done as described above. After 4'-OHT treatment, five
out of 15 clones that survived G418 were resistant to puromycin. These
puromycin resistant clones were referred to as CAG-Wnf7a-Tp ES cell lines,
while their 4'-OHT-untreated cell lines, which were neomycin (G418)
resistant, were named CAG-t\oxed-neopA-Wnt7a ES cell lines.
4.2.1.2 Characterization of transgenic ES cell lines
4.2.1.2.1 Functionality of transgenes
To examine the functionality of pCAG-floxed-neopA-Wnfi-HA construct and
the ability of the R26CT2S ES cell line in regulating the expression of Wntl-
HA in response to 4'-OHT, we performed immunocytochemistry (ICC) on
CAG-Wnfl-HA-Tp ES cells using an anti-HA antibody. Approximately 80%
of the cells expressed Wntl-HA both in the presence and the absence of LIF
(Figure 4.8B,C). Expression of Wntl-HA was not detected in 4'-OHT-
untreated CAG-i\oxed-neopA-Wntl-HA ES cells (Figure 4.8A). Western blot
analysis also showed the appropriate band size (-48 kDa) of HA-tagged
Wntl protein (Figure 4.10F).
We also looked at protein expression of Wnt7a and Dkkl in GAG-Wnt7a-Tp
and CAG-Dkkl-Tp cells by ICC. The results clearly show the respective
protein expression both in the presence and the absence of LIF (Figure 4.8D-
I). These results demonstrate the functionality and stability of the tamoxifen-
dependent Cre-mediated activation of transgenes in all of stably-transfected
clones forWntl-HA, Wnt7a and Dkkl.
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Uninduced Puromycin resistant (Tp)
Figure 4.8: Functionality of inducible expression vectors. Expression of Wnt1-HA
(B,C), Wnt7a (E,F) and Dkk1 (H,l) from constitutively expressing Wnt1-bA, Wnt7a
and Dkk1 transfectants, respectively, in the presence (B,E,FI) and the absence
(C,F,I) of LIF. No expression of these proteins were detected in the respective
uninduced cells (A,D,G). Scale bar is 50 pm.
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4.2.1.2.2 Inducibility in ES cells
We wanted to see whether 4'-OHT would have any effect in inducing Wntl
and Dkkl expression in the parental line, R26CT2S ES, cells stably-
transfected with pCAG-floxed-neopA vector. RNA expression for both genes
was determined by qRT-PCR on day 2 of culture after treatment with 400 nM
of 4'-OHT for 16, 24 and 48 hours (Figure 4.9A). No significant increase of
either Wntl or Dkkl was observed in all treatment conditions for CAG-
floxed-neopA ES cell lines. These results indicate that treatment with 4'-OHT
does not have any effect in inducing the expression of either Wntl or Dkkl in
this cell line.
Time- and dose-dependent experiment was then carried out with two of
CAG-floxed-neopA-Wnfl-HA and CAG-i\oxed-neopA-Dkkl ES cell clones
that were shown to be resistant to puromycin in order to find the optimal
conditions for induction of transgene expression. For the Wntl-HA
transgenic ES cell line, we treated the clones with 200, 400, 500 and 1000 nM
of 4'-OHT for 24 and 48 hours (Figure 4.9B). In this assay, the ES cells were
cultured at 2-4 x 105 cells in a well of 6-well plate in the presence of LIF and
treated as described above. After two days in culture, the cells were
harvested, total RNA was extracted and the expression of Wntl was
quantitatively determined by qRT-PCR. Expression of Wntl was also
determined by qRT-PCR from CAG-Wnfl-PIA-Tp ES cells for comparison
(Figure 4.9B). Each clone has a different response towards 4'-OHT, even
though 48 hour-treatment with every dose of 4'-OFiT produced a higher
level of Wntl expression than the 24-hour-treament. After 2 days of culture,,
a strong activation of Wntl expression (200 fold) for clone 1 was observed
after treatment with 400 nM of 4'-OHT for 48 hours, while the highest level
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B) CAG-floxed neo pA-Wnt1 -HA ES cell clones (+LIF)
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Figure 4.9: Quantitative analysis of Wnt1 and Dkk1 overexpression by qRT-PCR.
A) 4'-OHT treatment does not affect the induction of either Wnt1 or Dkk1 expression
in R26CT2S stably-transfected with pCAG-floxed-neopA vector. (B) Quantitative
expression of Wnt1 (B) and Dkk1 (C) from their respective undifferentiated CAG-
floxed-neopA-Wnff-HA and CAG-floxed-neopA-DWcf clones after two days grown in
the presence of LIF treated with various time and concentrations of 4'-OHT.
Overexpression of Wnt1 (B, Tp-secondary axis) and Dkk1 (C, Tp-secondary axis)
from CAG-H/nff-HA-Tp and CAG-DWc/-Tp ES cells, respectively, was also
quantitavely determined. The error bars show mean ± standard deviations from 3
independent experiments.
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of Wntl expression for clone 2 (70-fold) was achieved after treatment with
500 nM for 48 hours. In every experiment the overexpression of Wntl was
never observed in untreated CAG-floxed-neopA-Wnfl-HA ES cells indicating
a complete repression of Wntl-HA transcription downstream the floxed neo-
stop cassette in the absence of 4'-OHT. Hence, in this study, the highest level
of Wntl expression for undifferentiated ES cells was achieved at 48 hours
after 48-hour-treatment with 400 nM of 4'-OHT for clone 1 and after 48-hour-
treatment with 500 nM of 4'-OHT for clone 2.
However, the level of induced Wntl expression achieved was far less than
the expression level of Wntl produced by the CAG-WnH-HA-Tp ES cell
clone 1, which was constitutively expressing Wnfl-HA (Figure 4.9B). About
10-fold increase was observed from these constitutively expressing Wntl-HA
cells (about 2000-fold) when compared to the highest level of the induced
Wntl expression (of clone 1, 200-fold). The selection by puromycin after 4'-
OHT treatment therefore has efficiently eliminated those cells that have
incorporated truncated plasmid in CAG-floxed-neopA-WnH-HA ES cells.
Induction of Wntl-HA protein expression in undifferentiated CAG-floxed-
neopA-Wntl-HA ES cells after treatment with 400 nM 4'-OHT was detected
at low level by ICC using an anti-HA antibody (Figure 4.10). A very low
level of expression of Wntl-HA was also detected by western blot analysis
when the cells were treated with 500 nM of 4'-OHT for 48 hours (Figure 4.10).
These results, albeit producing low level of transgene expression, show that
the conditional gene expression system managed to activate the expression of
transgene protein in undifferentiated ES cells.
161
Figure 4.10: Inducibility of pCAG-floxed-neopA-l/l/nff-HA in undifferentiated ES
cells. Protein expression ofWnt1-HA induced by 400 nM 4'OHT for 48 hours on
clone 1 (C, D) and clone 2 (E, F) by immunocytochemistry against HA. (A, B)
Untreated cells. (A, C, E) anti-HA, (B, D, F) nuclei staining with propidium iodide
(PI). G) A very low level expression of Wnt1-HA (an arrow) from clone 1 after
treatment with 500 nm 4'-OHT for 48 hours compared to high level expression of
the protein from constitutively expressed Wnt1-HA (Tp) cells. Scale bar is 100
pm.
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For Dkkl transgenic ES cell line clones, it was observed that the highest
expression of Dkkl after 2 days in culture was achieved after treatment with
400 nM of 4'-OHT for 48 hours for both treated clones (Figure 4.9C). A
different activation level of Dkkl was observed from each clone. As high as
20-fold increase of Dkkl expression was seen from clone 1 whereas less that
10-fold induction was observed from clone 2 after treatment with 400 nM of
4'-OHT for 48 hours.
Similar to Wnfl-HA transgene, the induced expression of Dkkl from both
clones was less than the expression level of Dkkl from constitutively
expressing Dkkl cells, CAG-Dkkl-Tp ES cells. A difference of 2.5- to 6-fold
was determined between the induced and constitutively expressed cells from
clone 1 and 2, respectively. No activation of Dkkl expression was observed
in untreated clones when compared to expression from in line cells as well as
stably-transfected ES cells with pCAG-floxed-neopA. Taken together, these
results clearly show that treatment with 4'-OHT results in inducible
expression of the transgenes.
Due to technical problems with western blotting and the unavailability of a
good Dkkl antibody, we were unable to detect any protein expression in
either induced or constitutively expressing Dkkl cells. However, the RNA
expression of Dkkl in induced and constitutively expressed cells
demonstrated the ability of the system to activate the transcriptional activity
of the transgene in undifferentiated ES cells.
In summary, it is observed that our constructs for Wntl-HA and Dkkl
transgenes are working and, after two days in culture, giving the highest
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inducible expression of the transgenes after treatment with 400 nM 4'-OHT
for 48 hours in undifferentiated ES cells.
4.2.1.2.3 Inducibility in EBs
In order to activate the expression of each transgenes during neural
differentiation, for future application, we also conducted a time- and dose-
response assay in differentiated transgenic ES cell lines. The cells were
grown for two days (D2) in the absence of LIF to promote the formation of
EBs before treatment with 200, 500, 800 and 1000 nM of 4'-OHT for 48 hours
(Figure 4.11). On D4, the EBs were harvested for RNA extraction and the
expression ofWntl was quantitatively determined by qRT-PCR.
From two independent experiments, a strong activation of Wntl expression
(about 25-fold) on day 4 EBs (D4 EBs) was observed after treatment with 800
nM of 4'-OHT (Figure 4.11). Higher concentration of 4'-OHT (to 1000 nM)
decreased the expression level of Wntl to 20-fold when compared to the
untreated cells. The overall induction of Wntl expression in these
differentiated ES cells (D4 EBs) was lower than that of the induction in
undifferentiated ES cells. However, Wntl expression in the CAG-Wnfl-HA-
Tp EBs was still higher (about 4-fold) than the highest induced expression
level from the CAG-floxed-neopA-WnH-HA EBs.
To our surprise, the maximum induction level of Dkkl expression from D4
EBs was quite similar to the maximum induction level in undifferentiated ES
cells (Figure 4.11). From two independent experiments, a strong activation of
Dkkl expression (15-fold), by qRT-PCR, from D4 EBs was observed after




























El Inducible Wnt1 expression
■ Inducible Wnt3a expression
g Tp=constitutive Dkk1 expression
B Inducible Dkk1 expression
ED Tp=constitutive Wnt1 expression
■ Tp=constitutive Wnt3a expression
Figure 4.11: Dose- and time-dependent activation of Wnt1, Dkk1 and Wnt3a
expression in their respective transgenic ES cell lines. RNA expression was
quantitatively analysed by qRT-PCR from RNA harvested on D4 EBs, grown in
the absence of LIF, after treatment with 200, 500, 800 and 1000 nM 4'-OHT for 48
hours. Overexpression of each transgene in D4 EBs from each constitutively
expressing transgenic lines was also quantitatively determined (Tp-secondary
axis). The error bars are mean ± the range from 2 independent experiments.
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OHT (1000 nM 4'-OHT) decreased the level of Dkkl expression down to less
than 10-fold. Only a slight reduction in the expression of Dkkl of D4 EBs
from CAG-Dkkl-Tp cells was seen as compared to the induced expression of
Dkkl from CAG-f\oxed-neopA-Dkkl cells after treatment with all the doses of
4'-OHT.
Due to limitation of time, we only conducted time- and dose-dependent
assay for differentiated CAG-floxed-neopA-Wnt3a ES cells. The assay was
carried out as described for Wntl-HA and Dkkl transgenic ES cell lines. An
activation of 5-fold was observed from D4 EBs of CAG-f\oxed-neopA-Wnt3a
cells after treatment with 800 nM of 4'-OHT for 48 hours (Figure 4.11).
Similar to previously mentioned transgenic ES cell lines, higher expression of
Wnt3a (20-fold) was seen from constitutively expressed Wnt3a cells when
compared to the induced Wnt3a expression. These results show the ability of
the system to induce the expression of Wnt3a.
Taken together, these results show that the activity of each construct is
maintained upon differentiation and that they are able to induce transgene
expression after treatment with 4'-OHT. Treatment with 800 nM 4'-OHT for
48 hours was found to be the optimal conditions for induction ofWntl, Dkkl
and Wnt3a transgenes in EBs in our system.
4.2.2 TCF Driving Red Fluorescent protein-reporter ES cell line
(TOP-Red2)
Although expression of Wnt genes indicates their possible function during
neural differentiation of ES cells, it does not formally demonstrate that Wnt
signalling is active. We built a reporter construct which directly reports
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canonical Wnt signalling by activating red fluorescent protein (RFP). RFP
expression is driven under the control of a promoter that contains multiple
LEF/TCF consensus binding motifs upstream from a cFos minimal promoter.
The transgene, TOP-Red2, is a derivative of TOPFLASH (TCF binding sites
driving luciferase) whose expression is dependent on the formation of
nuclear TCF/LEF-fi-catenin complexes (Korinek et al., 1998). TOPFLASF1 is a
well established method of quantifying canonical Wnt signalling. Induction
of Wntl in C57MG cells has been shown to increase luciferase activity which
indicates the activation of TCF reporter construct in response to Wnt signal
(Korinek et al., 1998).
A fragment containing the multiple LEF/TCF-binding sites was excised from
pTOPFLASH vector (a gift from Prof Hans Clevers, Korinek et al., 1997) and
inserted upstream of the DsRed2 coding region in pDsRed2-l vector.
pDsRed2-l is a promoterless vector that encodes Discosoma sp. red
fluorescent protein or DsRed (Matz et al., 1999). DsRed2 is a DsRed variant
which contains six amino acids substitutions that allow more rapid
maturation of red fluorescent protein (Yarbrough et al., 2001). According to
the manufacturer (Clontech), red emitting cells can be detected by
fluorescence microscope within 24 hours of transfection. In addition, cells
expressing DsRed2 exhibit the same growth characteristic and morphology
as non-transfected control cells (BD living colors™ User manual volume II,
BD Biosciences).
Therefore, by using the system, we should be able to directly observe cells
that are actively responding to canonical Wnt signals during neural
differentiation assay, specifically in testing our hypothesis that Wnts may
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inhibit the formation of NPC but may also be promoting the differentiation
of these cells into neurons. The expression of TOP-Red2 during
differentiation would be helpful in confirming the activity of Wnt genes
during the process as had been suggested by the genes RNA expression
profiles. Furthermore, the availability of Soxl-GFP knock-in ES cells (46C ES
cell, chapter 3), which express GFP in NPC, has given us the opportunity to
specifically monitor Wnt responsive cells in neural precursor cells (NPC) as
well as other cells throughout the whole process of neural differentiation of
ES cells in vitro.
4.2.2.1 Construction of the pTOP-Red2 vector
In constructing the pTopRed vector, a 276 bp of Xbal-digested fragment from
TOPFLASH (Tcf Optimal Luciferase reporter construct) plasmid was first
cloned into a transitional vector [pBSIIKS(+)], due to limited cloning sites,
prior to cloning into a pDs-Red2-l vector (Figure 4.12). The nucleotide
sequence of the TCF binding sites and the cFos promoter was confirmed by
sequencing the TOPFLASH plasmid using TF1-SF and LuciTF-SS primers
(Appendix C). Subsequently, the Top/pBSIIKS(+) plasmid was digested with
Sacl and EcoRl to excise the Top fragment and cloned into the Sacl and EcoRl
sites in pDsRed2-l vector to generate pTopRed vector. Screening for the
correct plasmids was done by restriction enzyme digestions (Appendix E).
HEK 293 and ES cell lines were then transiently- and stably-transfected with
the vector and also the pDsRed2-l vector, respectively, as described in
chapter 2. The pDsRed2-l vector also contains a neomycin-resistance cassette
(.Neor) which allows for selection of stably transfected eukaryotic cells using
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4.2.2.2 Characterization of pTOP-Red2
In order to evaluate the ability of the pTOP-Red2 vector to respond to
canonical Wnt signalling, we transiently introduced the vector into Wntl-
HA-expressing HEK 293 cells (WnH-HA-HEK-TopRed cells) and HEK 293
cells (HEK-TopRed cells). These cells were also transiently transfected with
the control vector, pDsRed2-l. Analysis of WnH-HA-HEK-TopRed cells
revealed a slow rate of DsRed2 maturation. In the presence of constitutive
expression of Wntl, only a small number of cells expressing RFP was
detected 48 hours post-transfection (data not shown). More RFP was
detected 72 hours post-transfection (Figure 4.13B). In addition, no cells
expressing RFP were detected in the HEK-TOP-Red2 cells as well as in HEK
293 cells harbouring pDsRed2-l or pDsRed2-l-transfected Wntl-HA-
expressing HEK 293 cells (Figure 4.13C, D). These results therefore indicate
the absence of leaky expression from cFos promoter. The small number of
cells expressing RFP in WnH-HA-HEK-TopRed, however, was most likely
due to low number of cells expressing Wntl-HA in the stably-transfected-
Wntl-HA HEK 293 cells. Nevertheless, these results demonstrate the ability
of the pTOP-Red2 in driving the expression of RFP in the presence of Wnt
signals.
Based on these results, we then decided to use constitutively expressing
Wntl-HA (CAG-Wnf2-HA-Tp) and Wnt3a (CAG-Wnt3a-Tp) ES cell lines to
further analyse the functionality of TOP-Red2. These cells were transiently
transfected with pTopRed and pDsRed2-l. A reasonable number of cells
expressing RFP were observed 48 hours post-transfection (approximately
25%) with more of these cells being observed after 72 hours of transfection





Figure 4.13: Transient transfection of HEK 293 and Wnt1-HA-HEK 293 cells with
pTOP-Red2 and pDsRed2-1. Expression of RFP was not detected in HEK 293
transfected with pTOP-Red2 (A) and DsRed2-1 (C), and also in Wnt1-HA
overexpressing HEK 293 cells transfected with pDsRed2-1 (D). The expression of
RFP was detected in Wnt1-HA expressing HEK 293 cells 3 days post-transfection
indicating the ability of pTopRed in expressing the RFP in the presence of Wnt
signals. Scale bar is 50 pm.
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pDsRed2-l-transfected cells. In addition, we also tested the functionality of
the construct in response to LiCl that mimics Wnt signalling. Non-Wnt-
expressing ES cells (R26CT2S) were treated with lOmM LiCl for 20 hours
before visualizing the expression of TOP-Red2. After two days in culture,
expression of RFP was observed in the cells treated with LiCl but not in
untreated cells (Figure 4.14B). Taken together, these results demonstrate the
ability of TOP-Red2 in inducing the expression of RFP in ES cells and as a
reporter gene in response to Wnt signals.
4.2.2.3 Detection ofWnt responsive cells in EBs during neural
differentiation process of ES cells in vitro
In order to monitor the cells that were actually responding to endogenous
Wnt signals during neural differentiation assay, stably transfected-pTopRed
(46C-TR) and -pDsRed2-l (46C-Ds) 46C ES cells were generated by selection
using G418. Out of 20 clones that were picked, only 7 clones survived the
selection and were screened for their ability to induce RFP expression in the
presence of Wnts. The screening was conducted by treating the clones with
5-20 mM of lithium chloride (LiCl). Based on the screening, we found lOmM
LiCl was the optimal concentration to activate reporter gene expression (data
not shown). Two clones of each 46C-TR and 46C-Ds ES cells were chosen
and subjected to neural differentiation process through the formation of EBs
followed by the addition of ATRA (4-/4+ protocol). A positive control
condition was also included, in which the clone was treated with 10 mM LiCl
on DO for 48 hours. 46C-Ds cells were used to represent negative control
condition.
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On D4, a small number of EBs expressing RFP were observed in the positive
control cells but not in the LiCl-untreated 46C-TR and 46C-Ds cells (data not
shown). The GFP expression was not observed (as expected) at this stage.
These results most likely indicate the absence of Wnt signals at D4 of neural
differentiation process.
On D6, very few EBs expressing faint RFP were detected from the LiCl-
untreated 46C-TR cells (Figure 4.15A) while the positive control cells
continued expressing RFP (data not shown). No RFP expression was
observed in the 46C-Ds cells. As expected, at this stage, almost all of the EBs
in all culture conditions expressed GFP, indicating the presence of neural
precursor cells.
Due to technical problem, analysis on the RFP and GFP expression of the
positive and negative control cells was done on D7 instead of D6 EBs. On
D7, expression of GFP was observed from both 46C-Ds and LiCl-treated 46C-
TR cells (Figure 4.16). No RFP expression was observed in the negative
control cells indicating the specificity of TOP-Red in response to Wnt signal.
To our surprise, higher level of red fluorescence was observed from the
positive control cells indicating the stability of the integrated pTOP-Red2
construct upon differentiation.
On D8, more EBs expressing RFP were detected in the LiCl-untreated 46C-TR
cells (Figure 4.15B). Unlike D6 EBs, higher levels of fluorescence were
observed in these cells. At this stage, almost all EBs were still expressing
GFP even though the percentage of cells expressing GFP in each EBs was
reduced. Expression of RFP alone, however, was never observed in any EBs
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Ill
Figure 4.15: Expression of RFP and GFP in stably-transfected 46C ES cells (46C-
TR) with pTOP-Red2. A and B are the EBs on D6 and D8 of neural differentiation
process of 46C-TR cells, respectively. The expression of GFP was observed in all
EBs both on D6 (A, ii) and D8 (B, ii) EBs. A very faint expression of RFP was
observed on D6 EBs (A,iii, arrow). More EBs expressing brighter expression of
RFP were observed on D8 EBs (B, iii). Ai, Bi show the bright field of the respective
EBs. This is most likely to indicate the late presence of Wnt signals during neural
differentiation process of ES cells in vitro. Scale bar is 50 pm.
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Figure 4.16: Expression of GFP and RFP in D7 EBs treated with 10mM LiCI. A,C,E show
EBs derived from stably-transfected 46C cells with pTOP-Red2 (46C-TR). B,D,F show EBs
derived from stably-transfected 46C cells with empty pDs-Red2-1 vector (46C-Ds). Both cell
lines expressed GFP (A,B) showing Sox1GFP expression. Treatement with LiCI results in
expression of RFP expression (C) in 46C-TR cells but not in 46C-Ds cells (D), clearly
indicating that the Wnt responsive (pTOP-Red2) construct is working. E,F show the merge
between RFP and GFP. Scale bar is 50 pM.
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(Figure 4.15). Interestingly, co-localization of these proteins seemed to occur
in the EBs that have less number of cells expressing GFP (Figure 4.18B ii, iii).
We were then still interested to locate the cells that were only expressing RFP
in the EBs. We optically sectioned two selected EBs (5pm/stack) and
discovered that RFP expression was always co-localized with GFP, but
clearly no expression of RFP alone was ever detected (Figure 4.17).
However, the expression of GFP alone could be observed (Figure 4.17C).
Unfortunately, due to slow maturation of DsRed2 as described before, the
exact time for the presence of Wnt signals could not be determined.
However, it might be worth noting that the expression of RFP, albeit at a
very low level of fluorescence and in very few number of EBs, was first
detected on D6 of neural differentiation assay.
4.3 Discussion
4.3.1 Inducible ES cell expression system
Combining two techniques, Cre/loxP-based genetic recombination and
ligand-dependent activation of Cre, we have generated transgenic ES cell
lines that allow for the temporal control of expression and activity of Wnt
genes and a Wnt antagonist. Using this system, expression of Wntl-HA,
Dkkl, and Wnt3a from respective transgenic ES cell lines, driven by a strong
promoter, CAG, have been achieved in response to a nondetrimental dose of
the synthetic oestrogen, 4'-OHT.
Our system was characterized by the activation of the transgene both in
undifferentiated and differentiated ES cells indicating the stability of the
integrant and its transcriptional activity in ES cells as well as upon
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Figure4.17:ColocalizationfRFPndGexpressiononD8EBf46C-TRc lls.Opticaldiss ct n(5m/ tack)ol c edD8EBs (A,brightfield)ofneuraldiff r ntiationassayvealedcoloc lizationfRFPanG .EBw hnlexp essionsb erved(C)buttheexpressionofRFPalonewasneverobserved(B).ia dishowthgr nrfluor centi l ,p tively,ftnco d stackofthep:i alsection,iiandvhowtgr enanrfluorescentfi l ,rspectively,ft ve thackopti als tion theselectedEBs.vshowsov rlayfb th.Scalei50pm.
differentiation. In agreement with a previous study in which tamoxifen-
regulated expression of human alkaline phosphatase in differentiated
derivatives was lower than that of undifferentiated ES cells (Vallier et al.,
2001), the same phenomenon was also observed in our system. The system
however is also capable of producing about the same induction level of
transgene expression in undifferentiated ES cells and their differentiated
derivatives. The high expression of the transgene in differentiated
derivatives of ES cells is most likely due to the strong CAG promoter, which
has been shown to be capable of maintaining strong transcriptional activity
upon prolonged culture (Kosuga et al., 2000; MacKay et al., 2005). The
promoter which consists of a human CMV immediate-early enhancer, a
chicken S-actin transcription start site together with intron sequences from
rabbit fi-globin, has been shown to produce high level of gene expression in
numerous in vivo studies (Miyazaki et al., 1989; Niwa et al., 1991; Nitta et al.,
2005).
The system also produced very low background activity of Cre-ERT2 (almost
not detected) indicating an efficient repression of the genes downstream of
the floxed-neo-stop cassette in the absence of 4'-OHT. The repression is most
likely due to the selectable gene marker (neor) and the multiple
polyadenylation sites for strong termination sequence inserted between the
loxP sites in the pCAG-floxed-neopA. Selection in G418 would eliminate the
cells that spontaneously delete the floxed-neopA cassette because of
background activity of Cre-ERT2, and the strong termination sequence would
prevent the leakiness of transgene expression prior to treatment with 4'-
OHT.
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With double selection marker cassettes (floxed-neopA and IRES-pac), our
system also provides a more reliable screening method for transgenic clones
with high inducing transgene activity. Puromycin selection after treatment
with 4'-OHT on clones that survived neomycin (G418) selection positively
selects the clones with full length expression construct; the most stable and
integrated clones. The IRES-pac coding region downstream of the gene of
interest inserted in the pCAG-floxed-ncopA vector allows for the selection in
puromycin upon excision of the floxed-neo-stop cassette. The puromycin
selection thus is able to eliminate the clones with truncated coding region of
the gene of interest as only intact integrated clones survive the selection.
Induction of transgene expression is highly sensitive to 4'-OHT. We have
observed the induction of expression following the treatment with as low as
200 nM of 4'-OHT after as short as 10 hour-treatment (data not shown). The
sensitivity of the system is probably a result of the use of Cre-ERT2
recombinase that has been shown to be more sensitive to 4'-OHT induction
than the original Cre-ER™ (Feil et al., 1997; Indra et al., 1999; Vallier et al.,
2000). Besides being able to induce the expression of the transgene in a
temporally controlled manner, the system also offers the production of
constitutively expressing transgenic ES cells whenever required. One of the
biggest problems with constitutive expression of Wnt genes and some other
genes is the selective growth advantage of untransfected cells or cells that are
spontaneously lost Wnt expression over cell expressing Wnts resulting in
elimination of the cells which are constitutively expressing Wnt upon
prolonged culture. As opposed to conventional approach, our system
therefore offers greater advantage in that it is continuously capable of
producing constitutive gene expression whenever required. The cells that
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are constitutively expressing the gene of interest are easily selected by
puromycin.
The transgenic ES cell lines established will be very useful for inducing
ectopic expression of the genes at any specific time point during neural
differentiation assay in vitro, thus allowing us to examine the consequences
of overexpression during the process. We have demonstrated the ability of
these cell lines in inducing the expression of transgene in undifferentiated ES
cells and, more importantly, in differentiated derivatives of ES cells in vitro.
Additionally, the production levels of transgene expression upon treatment
with 4'-OHT should be enough for a biological effect to occur as has been
shown in previous studies such as in the effect of forced expression of sFRP2
on differentiation of 46C cells (Aubert et al.r 2002). The study showed the
amplification of both endogeneous and introduced sFRP2 sequences by RT-
PCR where the production levels of the amplified gene were similar to our
RT-PCR results for our induced transgene expression (data not shown). The
system thus gives us the opportunity to examine the effects of
overexpressing Wnt genes, specifically Wntl and Wnt3a, on neural
development in vitro. In addition, the effect of inhibiting Wnt signalling, by
overexpression of Dkkl, during neural differentiation process could also be
analysed.
4.3.2 Wnt responsive reporter gene expression system (TOP-Red2)
In this part of study, we have generated a Wnt responsive red fluorescent
reporter gene expression in ES cells (TOP-Red2). The expression of the RFP
was driven by the binding activity of multiple LEF/TCF binding sites in
response to the presence of Wnt signals or activation of canonical Wnt
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signalling. TOP-Red2 was found to be stably-integrated into the genome in
undifferentiated and differentiated ES cells.
The system offers two advantages. First, it offers a direct visualization of the
fluorescent protein in the living cells that are actually responding to Wnt
signals, thus avoiding the use of other substrates in analysing the presence of
the signal as required in other reporter gene system. For example, the use of
vital substrates needed to visualize fi-galactosidase in LacZ reporter system
or the use of Renilla plasmid in detecting the luciferase activity in Luciferase
reporter system (such as TOPFLASH). Second, it allows for the detection of
co-localization of proteins using spectrally different fluorochomes. RFP
which is spectrally distinct form GFP and its blue, cyan and yellow variants
would therefore be useful as an additional indicator.
However, the system which uses DsRed2 as the RFP has some drawbacks.
Despite attempts in improving the problems with slow and incomplete
maturation, and obligate tetramerization (Baird et al., 2000; Verkhusha et al.,
2001a,b; Terskikh et al., 2002) with DsRed, we found that the new version of
DsRed, DsRed2, still has these problems. We believe that the system is still
able to monitor the cells that are responding to Wnt signals but not the time
point of the occurrence. A recent Ds-Red-derived monomeric RFP1 (mRFPl)
has been shown to reduce these problems. A study by Long et al., 2005 has
shown the ability of mRFPl to produce high levels expression of monomer
RFP that are constitutively maintained in ES cells in vitro and in transgenic
mice. Hence, a better TOP-Red2 might be produced if mRFPl were to be
used instead of DsRed2.
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In this limited study, we discovered that only cells at the late stages of neural
differentiation process were most likely to respond to canonical Wnt signal
activity. However, the system was not able to exactly indicate the time for
the occurrence of the signals. Nevertheless, this may suggest the presence of
Wnt activity during late stages of neural differentiation process of ES cells in
vitro.
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Chapter 5: Manipulation ofWnt signalling during
neural differentiation of mouse ES cells in vitro
5.1 Introduction
Based on numerous studies, Wnt signalling is now known to regulate
multiple functions during animal development especially during the
development of the CNS (Chapter 1). A number of in vivo and ex vivo studies
of mouse embryos have strongly suggested the activity of Wnt to be stage-
dependent, in which depending on the cell-intrinsic properties at a particular
time point during neural development switches its role from, for example,
promoting cell proliferation to cell differentiation (Chapter 1). Several in
vitro studies also have implicated different roles of Wnts during neural
differentiation of ES cells. It has been observed that Wnt signalling seems to
inhibit the differentiation of these cells into neural precursor cells (Aubert et
al., 2002; Kielman et al., 2002; Haegele et al., 2003) and may also stimulate the
formation of neurons from these precursor cells (Hirabayashi et al., 2004;
Muroyama et al., 2002, 2004; Watanabe et al., 2005). In accordance to this, our
results (Chapter 3) also demonstrated some interesting dynamic RNA
expression profiles for a number of Wnt genes, which might indicate
functional properties of the genes during neural differentiation. However
due to the nature of Wnt, isolation of an active form of its protein has been
extremely difficult and only recently being managed to be purified (Willert et
al., 2003). Only purified Wnt3a and Wnt5a-HA have ever been used (Schulte
et al., 2005). Other in vivo studies in mouse embryos are mostly done by
injecting the mouse ventricles with retroviruses overexpressing the Wnt gene
of interest (Viti et al., 2003; Hirabayashi et al., 2004). Most in vitro studies in
analysing the functions of Wnt genes during mouse neural development
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used Wnt conditioned medium (Castelo-Branco et al., 2003) or recently
purified Wnt5a (Schulte et al., 2005) treated on selected mouse embryo
explants.
Studies involving analysis of Wnt function during neural differentiation of
ES cells in vitro mostly used Wnt conditioned medium (CM, Haegele et al.,
2003; Watanabe et al., 2005; ) or constitutive overexpression of a particular
Wnt gene (Aubert et al., 2002). Unfortunately, Wnt CM does not represent
the whole effect of purified active form of Wnt protein since other
extracellular factors contained in the medium may underscore the function of
Wnt compared to if the purified Wnt protein is used (Willert et al., 2003).
Willert and colleagues (2003) have discovered that Wnt3a CM promotes
differentiation of HSCs while purified Wnt3a protein stimulates self-renewal
of these cells. Constitutive overexpression of Wnt, on the other hand, does
not allow for temporal function ofWnt at a specific time point to be analysed.
Hence evaluation of stage-dependent Wnt function is hampered.
Here an inducible ES system would be an invaluable tool in monitoring the
effect of inducing or deleting specific Wnt gene in a temporally-controlled
manner in culture conditions. In accordance to this, we have established an
ES cell inducible system (chapter 4) that would allow us to directly test the
hypothesis that Wnt signalling may inhibit the differentiation of ES cells into
NPCs and then may also function in stimulating the differentiation of these
NPCs into neurons. The system offers a greater advantage compared to
previous studies such as the study by Aubert et al., 2003 which only analysed
the effect of constitutive expression of Wntl during neural differentiation of
ES cells. Our system, as far as the study is concerned, is the first system to
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be described that uses a tightly controlled overexpression of Wnt in a
temporally-controlled manner in analysing its effects during neural
differentiation of ES cells.
By using the system, this study was aimed to examine the effects of
stimulating or inhibiting Wnt signalling at specific time points during neural
differentiation of ES cells in culture. Based on the expression profiles
determined in previous chapter and due to time limitations, we were able to
overexpress only two Wnt genes (Wntl and Wnt3a) and one Wnt antagonist
(.Dkkl) during the differentiation process. The neural differentiation process
was carried through the formation of EBs and RA induction (4-/4+ protocol,
Bain et al., 1995; Li et al., 1998a). Specifically the aims were to see whether
activation of Wnt signalling by overexpressing a particular Wnt gene (Wntl
or Wnt3a) or inhibiting certain Wnts activities, specifically the canonical Wnt
signalling by overexpressing Wnt antagonist, Dkkl, at a specific time point
during the process would lead to the inhibition or promotion of the
differentiation processes. This was targeted to see whether the formation of
NPCs and neurons were inhibited or stimulated in the cultures stimulated by
RA through the formation of EBs.
Induction of these genes at different time points during the process was
conducted using the optimized inducible ES cell system as described in
chapter 4. The ubiquitous Cre-expressing ES cell line, R26CT2S, was stably-
transfected with a pCAG-floxed-neopA vector carrying the gene of interest or
empty vector. We have established stably-transfected Wntl-HA (CAG-
iloxed-neopA-Wntl-HA), Wnt3a (CAG-(loxed-neopA-Wnt3a), Dkkl (CAG-
iloxed-neopA-Dkkl) and empty vector (CAG-floxed-neopA) ES cell clones.
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The transgene was induced at three time points (Figure 5.1). At the first time
point, the gene expression was induced in undifferentiated ES cell clones by
treatment with 500 nM 4'-OHT for 2 days prior to selecting the cell
expressing the particular gene in 1.0 pg/ml puromycin (as described in
Chapter 4). This puromycin resistant ES cell line is constitutively expressing
the particular transgene. The second point of induction took place on D2 and
finally, the third induction point was on D7 of neural differentiation process
and exposed for 48 hours. As described in the previous chapter, the highest
RNA expression of transgenes in EBs was detected after 48 hours of
treatment with 4'-OHT. Treatment with 4'-OHT on D2-4 of neural
differentiation process therefore was presumed to give enough time for the
expression of the particular transgene to give any cellular effect on Wnt
signalling during early stages of the process particularly prior to the
formation of NPCs (before the addition of RA, Figure 5.1). In addition,
treatment of 4'-OFlT on D7-9 was intended to give enough time for the
expression of transgene to have effects on Wnt signalling at late stages of the
process specifically after the addition of RA, during the presence NPCs.
In summary, the effect of overexpressing Wnt gene and Wnt antagonist at the
early stages of the process should give us the opportunity to examine the
ability of the early stage EBs of neural differentiation process to differentiate
into NPCs and later on the ability of these precursors to differentiate into
neurons. The effect of overexpressing the genes at the late stages of the
process, in addition, gives us the opportunity to analyse the ability of NPCs
to form neurons. Moreover, constitutive expression of the transgene gives us
the opportunity to analyse the ability of ES cells to differentiate into NPCs
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Figure 5.1: Schematic representation of neural differentiation assay of ES cells in
vitro. Temporal sequence of all induction for Wnt1, Wnt3a and Dkk1
overexpression by treatment with 4'-OHT (as indicated in red). Analysis for the
formation of NPCs is done 1-2 hours post-plating by ICC and FACS using Nestin.




5.2.1 Effects of 4'-OHT on ES cells during neural
differentiation
To examine the potential cytotoxic effect of 800 nM 4'-hydroxytamoxifen (4'-
OHT) on the cells during neural differentiation process, CAG-floxed-neopA
ES cell line was used. The ability of these cells to differentiate into NPCs was
compared between non-treated and treated EBs on D2-4 with 800 nM 4'-OHT
(Figure 5.2). Neural induction was then followed by adding 1.0 pM all-trans
retinoic acid (ATRA) into the EB culture medium for four days (D4-8) prior
to dissociation of D8 EBs onto PDL/laminin-coated plates and grown in
DMEM-F12/N2 medium. 1-2 hours post-plating the cells were either fixed in
4% PFA for immunocytochemistry or trypsinized for FACS analysis. Both
sets of cells were stained with a marker for uncommitted neural precursor
cells, nestin. As compared to non-treated cells, treatment with tamoxifen on
D2 EBs did not affect the ability of CAG-floxed-neopA ES cells to differentiate
into NPCs (Figure 5.2). In agreement with this, FACS profiles also show no
significant difference in the percentage of the cells expressing nestin (Figure
5.2D, H) between non- and treated cells. There was also no significant
difference between the percentage of nestin positive cells between FACS
analysed and manually counted results (Figure 5.3A, C). In addition, there
was no significant difference between the number of nestin non-expressing
cells between non- and treated cells (Figure 5.3B, C), indicating that
tamoxifen does not affect the survival of either non- or neural cells in culture.
Thus, tamoxifen at a concentration of 800 nM does not affect the ability of
EBs to form neural precursor cells in the presence of RA in vitro, in other
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- 4'-OHT 50.17 ±9.99 49.83 ± 5.65 48.83 ± 4.37 600 43.07
+ 4 -OHT on D2 48.83 ±11.09 52.17 ±6.53 45.53 ± 6.38 606 42.83
Figure 5.3: Quantification of nestin expressing cells from 4'-OHT non- and treated
CAG-floxed-neopA ES cells. The cells stained for nestin as shown in Figure 5.2
were counted, plotted and tabulated. A) The percentage of nestin positive cells
over total number of cells were manually counted and analysed by FACS. Results
from both analyses were then plotted. The results demonstrate that tamoxifen
does not affect the percentage of nestin positive cells for both conditions. B)
Average cell number of nestin positive and negative cells per field was counted
and compared between non- and treated cells. The results clearly show that
tamoxifen at 800 nM does not effect the survival of nestin positive and negative
cells during neural differentiation process of ES cells in vitro. C) Data for A and B
were tabulated. Error bars are mean ± SEM (n=6 fields) from single experiment
with duplicate wells. Tamoxifen at a concentration of 800 nM does not seem to
have any effect on the ability of ES cells to differentiate into NPCs and also the
survival of non-neural precursor cells.
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words, 4'-OHT neither promotes nor inhibits the differentiation of ES cells
into NPCs.
We were then interested to know whether tamoxifen treatment affected the
ability of CAG-floxed-neopA cells to differentiate into neurons when the cells
were treated on D2 and also on D7 during neural differentiation assay. After
dissociation on D8, the cells were stained for neuronal marker, class III fi-
tubulin, 48 hours post-plating. Immunocytochemistry (ICC) with fi-tubulin
shows no significant difference on the ability of non- and treated cells to
differentiate into fi-tubulin positive cells (Figure 5.4 A, D, G). In addition,
tamoxifen also does not affect the survival of fi-tubulin negative cells (Figure
5.4 B, C, E, F, H, I). For quantification, total cells and cells stained with 6-
tubulin were manually counted, plotted (Figure 5.5A, B) and tabulated
(Figure 5.5C). The percentage of fi-tubulin positive cells was about the same
with no significant different between non- and treated cells (Figure 5.5A, C).
Similar to ICC with nestin, there was no significant difference between fi-
tubulin negative and positive cells per field beween non- and treated cells
(Figure 5.5 B, C), indicating that tamoxifen does not affect the survival of
non- and neuronal cells. Taken together, these results show that tamoxifen at
800 nM does not affect the ability of CAG-floxed-neopA ES cells to
differentiate into NPCs (nestin-expressing cells) or neuronal cells (fi-tubulin-
expressing cells). It also has no affect on the survival of both non- or neural
and non- or neuronal cells. The same phenomenon was observed when the
experiment was repeated using another clone of CAG-floxed-neopA cells
(data not shown). Therefore, 800 nM 4'-OHT does not seem to have any
cytotoxity effect on neural and neuronal differentiation process through the
formation of EBs in the presence of RA.
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Class III B-Tubulin T0PR03 Merge
CAG-floxed-neopA ES cells : -4'-OHT
CAG-floxed-neopA ES cells : + 800 nM 4'-OHT on D2
CAG-floxed-neopA ES cells : + 800 nM 4'-OHT on D7
Figure 5.4: The effect of 4'-OHT on R26CT2S cells stably-transfected with pCAG-
floxed-neopA on the formation of neurons in vitro. D8 EBs were trypsinized and plated
on PDL/laminin-coated plate before the cells were stained for neuronal marker, class
III B-Tubulin, 48 hours post plating. A, D and G show immunocytochemistry with class
III S-Tubulin for non-treated cells, cells treated with 800 nM tamoxifen on D2 and on
D7, respectively. Nuclei stained with TOPR03 for each respective treatment is shown
in B, E and H. C, F and I show the merge between TOPR03 and class III B-Tubulin
for each respective treatment. Tamoxifen at 800 nM does not have any effect on the
formation and survival of both non- and neuronal cells. White arrows indicate the B-
tubulin negative cells. Scale bar is 50 pm.
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- 4'-0HT 47.62 ±6.18 85.00 ± 10.42 35.79 ± 1.73 1061
+ 4'-0HT (D2) 51.62 ± 3.36 90.87 ± 6.62 36.49 ± 1.96 1140
+ 4'-0HT (D7) 51.25± 1.94 89.12 ±2.91 36.52 ± 1.12 1123
Figure 5.5: Quantification analysis of B-tubulin expression in untreated and
treated (on D2 and D7) CAG-floxed-neopA ES cells. The cells stained for B-
tubulin 2 days post-plating were manually counted. Percentage of B-tubulin
positive cells were plotted (A) and tabulated (C). Total number of B-tubulin
positive and negative cells per field were also plotted (B) and tabulated (C).
There was no significant difference on the formation of neurons between non- and
treated cells. Error bar is the mean ± standard error of mean (SEM, n=8 fields)
from single experiment with duplicate wells.
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5.2.2 Effects of Wntl-HA overexpression during neural
differentiation of ES cells
To examine the effect of overexpressing Wntl on neural differentiation of ES
cells in vitro, stably-transfected Cre-expressing ES cells (R26CT2S) with
pCAG-floxed-Wnfd-HA construct (CAG-floxed-neopA-Wnff-HA ES cells)
were used. In this part of study, we wanted to determine the effect of
inducing Wntl-HA at early stages of differentiation (on D2-4 EBs, just before
the addition of ATRA) as well as constitutive expression of Wntl-HA on the
formation of NPCs and neurons. We also wanted to know the capability of
the cells overexpressing Wntl-HA during the late stages (on D7-9 EBs) of
differentiation process to differentiate into neurons. Wntl-HA was induced
by treating CAG-floxed-neopA-Wnff-HA cells at indicated time points with
800 nM 4'-OHT for 48 hours. In all cases, dissociated D8 EBs were plated at a
density of 3 x 105 cells/cm2. The formation of NPCs was determined by the
presence of cells expressing nestin, while neuronal cells were confirmed by
the presence of the class III fi-tubulin-expressing cells. In all cases, the
number of cells expressing these antibodies was manually counted and the
percentage of the positive cells expressing the antibody was calculated. In
some cases the percentage of positive cells expressing these antibodies were
confirmed by FACS analysis. Results from three independent experiments
on two separate clones of CAG-floxed-neopA-Wnfl-HA ES cells will be
presented.
5.2.2.1 Constitutive expression of Wntl-HA
1-2 hours post-plating, most cells expressing nestin have a spindle-shaped
morphology in untreated CAG-iloxed-neopA-Wntl-HA cells (Figure 5.6A, D)
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CAG-floxed-neopA-Wnt1-HA:-4' OHTCAG-floxed-neopA-WbM-HA:+' T(D2)Constitutiv lyexpressi g
Wnt1-HA(CAG-Wnt1-HA-Jp)
Figure5.6:NestinxpressioninWnt1-HAe ressingEScelll n .Cre- singll(R26CT2S)wast b ytransf ct d withpCAG-floxed-neopA-lMnff-HAconstruct.ICCascarr doutfintermedia efila epr t i ,nes ift r1-2hou spl g onthecellsreat dwithA)no4'-OI-TrBHoD2,andCconst utivelyexpr ssingWnt1-HAc lls.,Ea dFsh wth mergebetweennucleistainingwithT0PR03andN stfoaresp tivetreat nt.Sc lbi50p .
as shown by ICC results. However the number of nestin-expressing cells
was reduced in the cells constitutively expressing Wntl-HA with no
appearance of the spindle-shaped morphology (Figure 5.6C, F). In
agreement with this, FACS profiles also demonstrates a lower percentage of
cells expressing nestin in these cells compared to untreated cells (Figure
5.7C,G). ICC results also show a significant decrease in the percentage of
nestin-expressing cells as well as the number of nestin-positive cells per field
compared toWntl-HA non-overexpressing cells (control, Figure 5.8A,C,E).
A number of in vivo and in vitro studies have suggested the role of Wntl in
promoting the proliferation rate of precursor cells during the development of
mouse embryonic brain (McMahon and Bradley, 1990; Thomas and
Capecchi, 1990; Castelo-Branco, et al., 2003; Panhuysen et al, 2004). We were
interested to see if the same phenomenon would be observed in our system.
We wanted to examine whether the number of nestin-expressing cells would
be increased 24 hours after plating the dissociated D8 EBs on PDL/laminin-
coated plates. To our surprise, after 24 hours post-plating, both FACS (Figure
5.7D,H) and ICC results demonstrate an increase of nestin-expressing cells in
Wntl-HA constitutively expressing cells compared to the control cells (Figure
5.8).
A significant reduction of 6-tubulin expressing cells was observed after 48
hours post-plating from these cells compared to that of the control cells as
analysed by ICC and FACS (Figure 5.9, 5.10). Interestingly, as observed by
Aubert and colleagues (2002), we also found that constitutive expression of
Wntl-HA directed the differentiation of ES cells into non-neuronal cells and
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Figure 5.7: FACS analysis on Wnt1-HA expressing cell lines stained for
nestin 1-2 (A,C,E,G) and 24 (B,D,F,H) hours post plating. (A, B) Non-
treated CAG-floxed-neopA-Wnff-HA cells stained with only secondary
antibody (PE). This acts as control cells for setting up the M1 gate. (C,D)
untreated CAG-floxed-neopA-Wnff-HA cells, (E,F) the cells treated with
800 nM 4'-OHT on D2 and (G,H) constitutively expressing Wntl-HA cells
(CAG-HW7-HA-Tp). The percentage of nestin positive cells is shown in
parentheses.
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86.46 ± 3.76 53.56 ±2.15 3909 70.50
Figure 5.8: Quantitative analysis of Nestin expression of Wnt1-HA expressing lines from
ICC by manual counting and FACS 1-2 (A,C,E) and 24 (B,D,F) hours post-plating.
Percentage (A,B) and number (C,D) of Nestin positive cells from CAG-floxed-neopA-WWf-
HA cells treated with no 4'-OHT and 800 nM 4'-OHT on D2, and CAG-Wnt1-HA-Tp cells.
(E,F) tabulated data of results from A-D. Manually counted results for NPCs (Nestin) 1-2
and 24 hours post plating were from three independent experiment from two clones (n=8
fileds) and single independent experiment with duplicate wells (n=21 fields), respectively.
FACS results were from single independent experiment from one clone. ** indicates highly




Figure 5.9: R-tubulin expression in Wnt1-HA expressing cells. The effect of
overexpressing Wnt1-HA on D2 (D,E,F) and D7 (G,H,I), and constitutively
overexpressing Wnt1-HA (J,K,L) compared to uninduced (A,B,C) cells was
analysed by ICC (A,B,D,E,G,H,J,K) and FACS (C,F,I,L). D8 EBs were trypsinized
and plated on PDL/laminin-coated plates in N2 medium before the cells were
stained for neuronal marker, class III R-Tubulin, 48 hours post plating. A, D, G
and J show immunocytochemistry with class III R-Tubulin. Merge of R-tubulin
staining and nuclei stained with T0PR03 for each respective treatment is shown
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6-tubulin-negative cells was observed when compared to the fi-tubulin-
negative cells formed from untreated cells (the control cells, Figure 5.10B,K,
cells in circle and rectangular shape). Quantitative analysis also revealed a
significant decrease in the percentage of fi-tubulin positive cells as well as the
number of B-tubulin-expressing cells per field from these cells (Figure 5.11).
Interestingly enough, neural differentiation of these cells (CAG-Wntl-HA-
Tp) also led to the similar formation of non-neuronal cells or B-tubulin-
negative cells even in the absence of RA (Figure 5.12J-L) compared to that of
the control cells as well as early and late induction of cultures without RA
treatment (Figure 5.12A-I).
In summary, constitutive expression of Wntl-HA during the differentiation
process may inhibit the formation of NPCs. Constitutive expression of Wntl-
HA also may inhibit neuronal differentiation of ES cells into neurons.
5.2.2.2 Overexpression of Wntl-HA at early stages
The formation of nestin-expressing cells was reduced in the cells where the
overexpression of Wntl-]HA was induced at the early stages of neural
differentiation process when analysed 1-2 hours post-plating. The number of
cells with spindle-shaped morphology was also decreased (Figure 5.6B,E).
Unlike constitutive expression of Wntl-HA, overexpression of Wntl-HA
induced at the early stages of the process did not seem to increase the
number of nestin-expressing cells when analysed 24 hours post-plating
(Figure 5.7E,F; 5.8). However, the analysis revealed a significant decrease in
the percentage of nestin positive cells as well as the number of nestin positive
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MergeClass III R-Tubulin T0PRQ3
CAG-floxed-neopA-Wn»-HA: - 4'-OHT
CAG-floxed-neopA-Wntf-HA: + 4'-OHT on D2
CAG-floxed-neopA-Wnrt-HA: + 4'-OHT on D7
CAG-Wnt1-HA-Tp:Constitutively expressing Wnt1-HA (tp)
Figure 5.10: The effect of overexpressing Wnt1-HA on the formation of non-neural cells. W1-
HA expressing lines were subjected to neural differentiation and stained for class III B-Tubulin
as described before (Figure 5.12). A, D, G and J show ICC with class III B-Tubulin for CAG-
floxed-neopA-l/VWf-HA cells without 4-OHT treatment (AB,C) and the cells after treatment with
800 nM 4'-OHT on D2 (D,E,F) and on D7 (G,H,i), and constitutively overexpressing Wnt1-HA
CAG-Wnt1 -HA-Tp cells (J,K,L). Nuclei stained with T0PR03 for each respective treatment is
shown in B,E,H,K. C,F,I,L show the merge between T0PR03 and class III B-Tubulin for each
respective treatment. Scale bar is 50 gm. Note the presence of less B-Tubulin negative cells in
cells treated with 4'-OHT on D2 (E,F) and D7 (H,l) compared to untreated cells (B,C). Cells in
circle showing non-neural cells present in non-induced cells for comparison. Cells in
rectangular shape showing different morphology formed in Wnt1-HA-overexpressed cells.
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- 4'-OHT 52.51 186.75 ± 15.27 202.85 ± 19.75 48.69 ± 2.31 7792
+ 4-OHTon D2 89.42 214.05 ± 15.68 54.32 ±7.45 80.37 ± 2.38 5099





28.30 24.75 ±3.81 156.83 ± 11.95 14.37 ±2.31 2179
Figure 5.11: Quantification analysis on the expression of class III G-tubulin in
Wnt1-HA expressing cell lines by ICC. After each indicated treatment, no 4'-
OHT, 800 nM 4'-OHT on D2 and D7, and constitutively expressing Wnt1-HA
(Tp), the cells stained for G-tubulin 2 days post-plating were manually counted
and analysed by FACS. Percentage of 6-tubulin positive cells were plotted (A)
and tabulated (C). G-tubulin positive and negative cells were also plotted (B) and
tabulated (C). Error bar is the mean ± standard error of mean (SEM, n=20 fields)
from three independent experiment with duplicate wells. ** indicates highly
significant to non-treated cells, T-test, p<0.001. Note the agreement between
manually counted and FACS analysed results.
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Figure 5.12: Effect of overexpressing Wnt1-HA in neural differentiation process
without retinoic acid (RA). Untreated CAG-floxed-neopA-Wnff-HA cells together
with the cells treated with 800 nM 4'-OHT on D2 and D7, and CAG-Wnt1-HA-Tp
cells were subjected to neural differentiation in the absence of RA. In all
conditions the formation of proper neurons was hampered. A,D,G,J show
immunocytochemistry with class III B-Tubulin, 48 hours post-plating, for each
treatment conditions, respectively. Nuclei stained with TOPR03 for each
respective treatment is shown in B,E,H,K. C,F,I,L show the merge between
T0PR03 and class III R-Tubulin for each respective treatment. Scale bar is 50
pm. Note the formation of non-neural cells as observed in constitutively
expressing Wnt1-HA (CAG-Writf-HA-Tp) cells in the presence of RA (Figure 5.12
and 5.13).
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cells per field when analysed at 1-2 and 24 hours post-plating compared to
that of the control cells (Figure 5.8).
Analysis of the expression of fi-tubulin in these cells 48 hours post-plating
revealed a significant increase in the percentage of fi-tubulin-positive cells
(Figure 5.11A) but only a slight increase in the average formation of fi-
tubulin-positive cells per field (Figure 5.1 IB) when compared to that of
control cells. A great decrease of non-neural cells was also observed in these
cells (Figure 5.11B) which resulted in the increase of the percentage of fi-
tubulin positive cells. In other words, fewer fi-tubulin-negative cells were
observed in these cells compared to that of the control cells (Figure 5.9D,E;
Figure 5.10D,E,F). FACS analysis demonstrated the same phenomenon, the
percentage of S-tubulin-positive cells was higher in the cells when Wntl-HA
was induced on D2 (Figure 5.9F, 5.11A).
In summary, overexpression of Wntl-HA induced on D2 may inhibit the
formation of NPCs. The number of neurons formed as determined by the
expression of fi-tubulin increased slightly with significant increase in the
percentage of fi-tubulin-positive cells hence the presence of overexpressing
Wntl-FfA cells during the late stages of the differentiation process of ES cells
may enhance the percentage of neurons formed at the expense of non-
neuronal cells.
5.2.2.3 Overexpression of Wntl-HA at late stages
When the overexpression of Wntl-HA was induced at late stages of the
differentiation process (on D7-9), the percentage of 6-tubulin-positive cells
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increased significantly while the number of fi-tubulin-positive cells increased
slightly compared to that of the control cells, as demonstrated by ICC and
FACS analysis (Figure 5.9G,H,I) 48 hours post-plating. Similar to the
overexpression of Wntl-HA at early stage, overexpression at the late stage
significantly decreased the number of fi-tubulin-negative cells (Figure 5.11B)
which explained the higher percentage of fi-tubulin-positive cells in the
culture as compared to the expression of fi-tubulin in the control cells. Figure
5.10G,H,I clearly show the absence of fi-tubulin-negative cells when Wntl-
HA was overexpressed at the late stage of the differentiation process.
In summary, overexpression of Wntl-HA at late stages of the neural
differentiation process of ES cells may enhance the percentage of fi-tubulin-
positive cells at the expense of non-neuronal cells (fi-tubulin-negative cells).
5.2.3 Effects of Wnt3a overexpression during neural
differentiation of ES cells
To examine the effect of overexpressing Wnt3a on neural differentiation of ES
cells, CAG-floxed-tteopA-Wnf3a ES cells was used. Due to limitations of time,
results from a single experiment with duplicate wells will be presented.
Albeit preliminary, they were interesting observations with potential for
expansion. Wnt3a was induced by activation of Cre-recombinase with 750
nM tamoxifen on D2 and D7 EBs for 48 hours. ES cells constitutively
expressing Wnt3a (CAG-Wnf3a-Tp) were also used. The analysis of the
effects of overexpressing Wnt3a on neural differentiation of ES cells was
carried out as described for that of Wntl-HA overexpression.
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5.2.3.1 Constitutive overexpression of Wnt3a
Unlike constitutive expression of Wntl-HA, more nestin-expressing cells
with the spindle-shaped morphology were observed in CAG-Wnl3fl-Tp cells
even though the total number of cells expressing nestin was actually reduced
in these cells (Figure 5.13G,H,I) when compared to that of the 4'-OHT-
untreated CAG-floxed-neopA-Wnt3a cells (control cells). In agreement with
this, FACS profiles on the cells expressing nestin in these cells also revealed
the same phenomenon (Figure 5.14 F). In addition, quantitative analysis also
demonstrates that the percentage of nestin positive cells as well as the total
number of nestin positive cells per field decreased significantly when Wnt3a
was constitutively overexpressed (Figure 5.15).
Constitutive overexpression of Wnt3a also resulted in a decreased percentage
of cells expressing fi-tubulin as demonstrated by FACS analysis (Figure
5.16L; Figure 5.17A,C) compared to that of the control cells. Unfortunately,
due to technical problems in the binding specificity of the secondary
antibody, we had to discard the quantification analysis from ICC (Figure 5.16
J,K). However, it was clear that the formation of neuron-like cells was
inhibited in these cells.
In summary, constitutive overexpression of Wnt 3a may inhibit the
formation of NPCs and may also perturb the ability of ES cells to
differentiate into neurons.
207
Nestin Propidium iodide Merge
CAG-floxed-neopA-Wnf3a clonel : - 4'-OHT
»•**•
I* «
<1 - * *» » [ ^ ♦ H«
CAG-floxed-neopA-Wnt3a clonel : + 4'-OHT on D2




» * » . v< ..* *x
. f * % 1 * |
■y
•» *
, " " -J l
• * ** *%• % • ' J
* t * *
£ * «
* * ' - K *




. "C .» \ • - A T * 4
CAG-Wnf3a-Tp clone 1 : Constitutively expressing Wnt3a (Tp)
Figure 5.13: Expression of Nestin in WnfcJa-expressing ES cell lines. ICC was
carried out for intermediate filament protein, Nestin, 1-2 hours post plating on
CAG-floxed-neopA-Wnt3a cells treated with (A,B,C) no 4'-OHT or (D,E,F) with 750
nM 4'-OHT on D2, and (G,H,I) constitutively expressing Wnt3a-HA (CAG-Wnt3a-
Tp) cells. (B,E,H) nuclei staining with propidium iodide (PI) and (C,F,I) the merge
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Nestin: Constitutivelv expressing Wnt3a (Tp)
Figure 5.14: FACS analysis on CAG-floxed-neopA-Wnt3a cells stained for nestin
1-2 hours post plating. A, B and C are untreated CAG-floxed-neopA-l/Vnf3a cells
that were either unstained, stained with primary antibody only or stained with
secondary antibody only, as controls used to setup the M1 gate. D, E and F are
the FACS profiles for nestin staining for non-treated CAG-floxed-neopA-l4/nf3a
cells, the cells treated with 750 nM 4'-OHT on D2 and constitutively expressing
Wnt3a (CAG-Wnf3a-Tp) cells, respectively. The percentage of nestin positive
cells is shown in parentheses.
209
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- 4'-OHT 87.25 ± 1.57 7958 88.62
+ 4 -OHT on D2
63.64 ±3.11 7311 79.22
Constitutively expressing Wnt3a (Tp) 70.93 ± 3.83 9566 72.07
Figure 5.15: Quantification of nestin expression in U7r?f3a-expressing cells. The
analysis was done on untreated CAG-floxed-neopA-l/VW3a cells or the cells
treated with 4'-OHT on D2 and constitutively overexpressing Wnt3a (CAG-
Wnt3a-Tp) cells at 1-2 hours post plating. A) Percentage of nestin positive cells
counted manually (ICC from 4-well plate) and analysed by FACS. Note both
results demonstrate decrease in percentage of nestin positive cells in the
presence of Wnt3a. B) Number of nestin positive cells per field. Note the
number of nestin positive cells were decreased when treated with Wnt3a. C)
Tabulated data of results from A and B. Manually counted results for npc 1-2
post plating were from single experiment with duplicate wells. FACS results
were from single experiment from one clone. ** indicates highly significant to
non-treated cells, T-test, p<0.001. Error bar is the mean ± standard error of
mean, SEM (n=7 fields).
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CAG-floxed-neopA-Wnt3a + 4'-OHT on D7
CAG-WnOa-Tp: Constitutively expressing Wnt3a (Tp)
Figure 5.16: Class III B-tubulin expression in Wnt3a-overexpresing cell lines. Neural
differentiation was carried out as described previously. ICC and FACS analyses were done on
CAG-floxed-neopA-tVnt3a treated with no 4'-OHT (A,B,C), with 750 nM 4'-OHT on D2 (D,E,F)
and D7 (G,H,I), and on CAG-Wnf3a-Tp cells (J,K,L) two days post-plating for neuronal marker,
class III B-Tubulin. A,D,G,J show staining with class III S-Tubulin, B,E,H,K. show the merge
between TOPR03 and class III B-Tubulin and C,F,I,L show the FACS profiles of the cells in
each respective treatment. Scale bar, 50 pM.
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Non -treated 140.5 ± 13.15 54. 67 ± 11.13 73.35 ± 2.32 1171 77.95
Treated on D2 EBs 28.67 ± 5.37 5.83 ± 3.39 - 207 44.50
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Figure 5.17: Quantification of B-tubulin expression in Wnt3a-expressing cell
lines. The analysis was done on CAG-floxed-neopA-Wnt3a cells with treatment
as indicated above and on CAG-Wnf3a-Tp cells. Percentage of positive cells
were plotted (A) and tabulated (C). B-tubulin positive and negative cells were
also plotted (B) and tabulated (C). ** indicates highly significant to non-treated
cells, T-test, p<0.001. * indicates highly significant to non-treated cells, T-test,
p<0.005. Error bar is the mean ± standard error of mean (SEM, n=6 fields) from
single experiment with duplicate wells.
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5.2.3.2 Induction of Wnt3a overexpression at early stage
A significant decrease in the percentage of nestin-positive cells as well as the
number of nestin positive cells per field was observed when the
overexpression of Wnt3a was induced on D2 of the differentiation process as
demonstrated by ICC (Figure 5,13 D,E,F; Figure 5.15) and FACS (Figure5.14
E, 5.15 A) analyses 1-2 hours post-plating, when compared to that of the
control cells and also of the cells that constitutively overexpressing Wnt3a. In
addition, the spindle-shaped morphology was still observed in a few cells
that were expressing nestin (Figure 5.13D,F).
48 hours post-plating, the number of fi-tubulin-expressing cells per field was
significantly decreased as observed from ICC (Figure 5.16D,E,F) in these
cells. Unfortunately due to a technical problem, quantitative analysis of this
result had to be discarded since for unknown reasons, the fi-tubulin-negative
cells were lost during the ICC procedure. Fortunately, FACS analysis
reliably demonstrates that the percentage of fi-tubulin-expressing cells was
reduced when compared to that of the control cells (Figure 5.16 F; Figure
5.17A).
In summary, overexpression of Wnt3a induced on D2 of the neural
differentiation process may inhibit the formation of NPCs. The formation of
neurons may also be inhibited from these cells.
5.2.3.3 Induction of Wnt3a overexpression at late stage
In constrast to Wntl-HA, the induction of Wnt3a expression on D7
significantly increased the formation of fi-tubulin-positive cells (Figure 5.16
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G,H). Supporting this, FACS analysis agreed with the ICC result,
overexpression of Wnt3a at late stage of the process increased the percentage
of cells expressing fi-tubulin (Figure 5.161, 5.17A). The number of fi-tubulin-
expressing cells was also increased significantly (Figure 5.17B) even though
the percentage of fi-tubulin-positive cells only increased slightly compared to
that of the control cells as quantitatively analysed from ICC results (Figure
5.17A).
In summary, overexpression of Wnt3a during the late stages of neural
differentiation of ES cells may promote the formation of neurons.
5.2.4 Effects of Dkkl overexpression during neural
differentiation of ES cells
As discussed in chapter 3, a number of Wnts are expressed during neural
differentiation of ES cells. Hence, it is always difficult to be clear about the
effects of overexpressing a single Wnt gene during the process. In constrast,
by overexpressing Dkkl, which is presently known to antagonise the
canonical Wnt signalling, we hoped to be able to block activity of multiple
Wnts, specifically the ones that are involved in activating the canonical
pathway. A dynamic RNA expression profile for Dkkl during neural
differentiation process has also been observed. To examine the functional
properties of the gene in the process, CAG-lloxed-neopADkkl ES cells were
used. Similar procedures, as described for Wntl-HA and Wnt3a, were
carried out in order to analyse the effects of overexpressing Dkkl during the
process, except for FACS analysis. Due to a technical problem, the FACS
analysis had to be discarded. Dkkl expression was induced with 800 nM 4'-
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OHT on D2 and D7 for 48 hours. Results from two independent experiments
using one CAG-floxed-neopA-Dkkl ES cells will be presented.
5.2.4.1 Constitutive overexpression of Dkkl
Similar to constitutive overexpression of Wntl-HA, 1-2 hours post-plating a
significant decrease of nestin-expressing cells with spindle-shaped
morphology was observed in cultured cells constitutively overexpressing
Dkkl (Figure 5.18 G,H,I) compared to the control cells. Quantitative analysis
from ICC also revealed a significant decrease in the percentage as well as the
total number of nestin-positive cells per field in these cells compared to that
of the control cells (Figure 5.19). Interestingly, constitutive overexpression of
Dkkl did not seem to affect the viability of nestin-negative cells as compared
to the control cells (Figure 5.19B).
A recent study by a group of Japanese researchers demonstrates that
treatment with Dkkl protein into ES cell cultures directs the differentiation of
the cells into telencephalic precursor cells, as determined by an increase of a
transcription factor Foxgl expression, which is specifically expressed in the
VZ and SVZ of the telencephalon (Watanabe et al, 2005). We were also
interested to see if constitutive overexpression of Dkkl would affect the
expression of Foxgl in our cultures, unlike in Watanabe et al.'s culture
condition, in the presence of RA. In the presence of RA, more than 50% of
the cells in this condition from all selected field analysed expressed Foxgl
(Figure 5.20G,H,I). Interestingly, a number of these cells only expressed
Foxgl but not nestin (Figure 5.20H,I, arrows). This is likely to explain that
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CAG-D/ckf-Tp: Constitutively expressing Dkk1 (Tp)
Figure 5.18: Nestin expression in Dkk1-expressing ES cell lines. Expression of
Nestin in CAG-floxed-neopA-D/ckf cells treated with 800 nM 4'-OHT on D2 (D,E,F)
and constitutively expressing Dkk1 (CAG-Dkkf-Tp) cells (G,H,I) was compared to
the un-treated cells (A,B,C). B,E,H show nuclei staining with T0PR03 while C,F,I
are the merged images for each respective treatment. Scale bar is 50 pm.
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- 4'-OHT 162.12 ±22.36
49.62 ± 12.33
77.71 ± 3.10 1698
+ 4'-OHT on D2






66.50 ± 3.48 1093
Figure 5.19: Quantification of nestin expression in 4'-OHT untreated and treated
CAG-i\oxed-neopA-Dkk1, and CAG-Dkk1-Jp cells from ICC. (A) Percentage of
nestin positive cells counted manually (ICC from 4-well plate). (B) Number of
nestin positive cells per field. (C) Tabulated data of results from A and B.
Manually counted results for npc 1-2 post plating were from single experiment with
duplicate wells. ** indicates highly significant to non-induced, t-test, p<0.01. *
indicate significant to non-induced, t-test, p<0.05. Error bar is the mean ±
standard error of mean, SEM (n=8 fields).
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CAG-floxed-neopA-DWrf: - 4'-OHT
CAG-floxed-neopA-Dkkf: + 4'-OHT on D2
CAG-DWrf-Tp : Constitutively expressing Dkk1 (Tp)
Figure 5.20: Effects of overexpressing Dkk1 on expression of Foxgl during neural
differentiation of ES cells. After 1-2 hours post plating, untreated and treated
CAG-floxed-neopA-Dkkf (with 4'-OHT) and CAG-Dkkf-Tp cells were stained for
Foxgl. A,D,G show the cells stained for Foxgl. B,E,H show double staining for
nestin and Foxgl for the respective treatments. C, F and I show the merge
between T0PR03, Nestin and Foxgl, for the respective treatments. Arrows point
the cells stained for Foxgl but not nestin (F and I). Scale bar is 50 pm.
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shown that differentiated neuronal cells outside the VZ also express the
gene. Thus this might explain the reduced number of nestin-expressing cells
when Dkkl is constitutively expressed. Notably, the majority of these cells
expressed Foxgl both in the cytoplasm and in the nucleus (Figure 5.201).
Quantitative analysis from ICC also show a significant increase in the
percentage of Foxgl positive cells in these cells compared to the control cells
(Figure 5.21).
On the other hand, 48 hours post-plating, constitutive overexpression of
Dkkl seemed to inhibit neuronal differentiation of ES cells. Notably, high
percentage of non-neuronal cell death was observed resulting in the survival
of neuronal cells, although fewer neuronal cells survived, compared to the
control cells (Figure 5.22 A,B,C,J,K,L). Consequently, as also revealed by
quantitative analysis, a high percentage of 6-tubulin positive cells was
observed (Figure 5.23A). The analysis, however, also revealed a significant
decrease in the total number of both fi-tubulin-negative and -positive cells
per field compared to that of the control cells.
In summary, constitutive overexpression of Dkkl may have directed the
differentiation of ES cells into more regional specialized type of precursor
cells (telencephalic cells). Consequently, it may also result in generation of
more specific type of neurons.
5.2.4.2 Induction of Dkkl expression at early stage
1-2 hours post-plating, overexpression of Dkkl induced at early stages (on
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Figure 5.21: Quantification of Foxgl expression from untreated and treated CAG-
floxed-neopA-DWc7 with 4'-OHT and CAG-D/dc7-Tp cells. The cells were stained
for Foxgl 1-2 hours post plating and were manually counted. A) Percentage of
Foxgl positive cells were counted manually (ICC from 4-well plate). B) Tabulated
data from A. Results were from single experiment with duplicate wells. **
indicates highly significant to non-induced, t-test, p<0.01. Error bar is the mean ±
standard error of mean, SEM (n=4 fields).
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Class III B-Tubulin T0PR03
CAG-floxed-neopA-Dkkl: -4'-OHT
CAG-floxed-neopA-Dfcfcl: + 4'-OHT on D2
CAG-floxed-neopA-Dfcfcf: + 4'-OHT on D7
CAG-Dfckf-Tp : Constitutively expressing Dkk1 (Tp)
Figure 5.22: Expression of class III R-Tubulin in Dkk1-expressing ES cell lines.
Expression of R-Tubulin in CAG-floxed-neopA-DWc/ cells treated with 800 nM 4'-OHT
on D2 (D,E,F) and D7 (G,H,I), and constitutively expressing Dkk1 (CAG-DWcf-Tp)
cells (J,K,L) were compared to the un-treated cells (A,B,C). B,E,H,K show nuclei
staining with T0PR03 while C,F,I, L show the merged images for each respective
treatment. Scale bar is 50 pm.
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- 4-OHT 213.5± 16.16 226.9 ± 24.88 49.19 ± 1.60 4404
+ 4-OHTon D2 245.2 ± 29.26 92.9 ±15.72 73.46 ± 1.25 3381
+ 4'-OHT on D7 82.5 ± 10.66 28.8 ±4.14 72.87 ± 3.76 1113
Constitutive expression of
Dkk1 (Tp)
62.6 ± 5.21 27.9 ± 3.25 69.70 ± 1.99 905
Figure 5.23: Quantification analysis of B-tubulin expression in Dkk1-expressing
cells. Cells expressing 6-tubulin from CAG-floxed-neopA-Dkk1 treated with no
4'-OHT or treated with 800 nM 4'-OHT on D2 and D7, and CAG-Dkk1-Tp were
manually counted. Percentage of positive cells was plotted (A) and tabulated (C).
Total number of B-tubulin positive and negative cells per field were also plotted
(B) and tabulated (C). Error bar is the mean ± standard error of mean (SEM,
n=10 fields) from two independent experiment with duplicate wells. ** indicates
highly significant to non-induced, t-test, p<0.001
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nestin-expressing cells with spindle-shaped morphology (Figure 5.18D,E,F).
This condition significantly increased the number of nestin-positive cells per
field and slightly increased the percentage of nestin-positive cells compared
to that of the control cells (Figure 5.19).
When the cells were stained for Foxgl (1-2 hours post-plating), only a few
fields among all selected field analysed displayed expression of this gene.
(Figure 5.20D,E,F). In comparison to the control cells, in which no expression
of Foxgl was ever observed in any of the selected fields, we believe that
overexpression of Dkkl at early stages of differentiation process may also
have some effect on the formation Foxgl-expressing cells even though only in
small number of cells. Quantitative analysis on the selected field revealed
around 30% of the cells expressed Foxgl (Figure 5.21). Similar to constitutive
expression, overexpression of Dkkl at this stage also generated cells
expressing Foxgl in the cytoplasm as well as in the nucleus (Figure 5.20F).
Unlike constitutive expression, the majority of these cells expressed both
nestin and Foxgl (Figure 5.20E).
As expected, more fi-tubulin-positive cells were observed 48 hours post-
plating in this condition (Figure 5.22D,E,F). Quantitative analysis also
revealed a significant increase in the percentage of fi-tubulin-expressing cells
as well as an increase in the total number of fi-tubulin-positive cells when
overexpression of Dkkl was induced at early stage (Figure 5.23).
In summary, induction of Dkkl overexpression at early stages of neural
differentiation process may promote differentaion of ES cells into NPCs as
well as the formation of neurons.
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5.2.4.3 Induction of Dkkl expression at late stage
Similar to constitutive overexpression, less number of fi-tubulin-expressing
cells with very few number of 6-tubulin-negative cells were observed when
the culture was analysed 48 hours post-plating (Figure 5.22 G,H,I).
Quantitative analysis from ICC also demonstrates a reduction in the total
number of both S-tubulin-positive and -negative cells per field in this
condition compared to the control cells as well as when Dkkl was
overexpressed at early stage (Figure 5.23B). Consequently, a significant
increase in the fi-tubulin-positive cells was revealed (Figure 5.23A).
In summary, late induction of Dkkl may inhibit differentiation of ES cells into
certain type of neurons and may, on the other hand, enhance the percentage
of those particular neurons at the expense of non-neuronal cells.
5.3 Discussion
In this study the effects of Wntl, Wnt3a and Dkkl overexpression on neural
differentiation process of ES cell in vitro were demonstrated. Using an
optimized inducible ES cell system (as described in chapter 4), we were able
to test the functional properties of these genes, as they have been shown to
exhibit dynamic RNA expression profiles (Chapter 3), during neural
differentiation process in EB cultures stimulated by RA. More importantly,
the system has enabled us to induce the overexpression of each gene in
temporally-controlled manner. This is an advantage over previous studies
where only constitutive expression of Wnt gene or component of Wnt
signalling were used in examining the functions of these genes during neural
differentiation of ES cells (Aubert et al., 2002; Kielman et al., Haegele et al,
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2003). Specifically, we have analysed the effects of overexpressing each of
these genes at the early stages of the differentiation process (D2-4), at the
time before neural enrichment by treatment of RA (D6-8) takes place in the
EBs, on the ability of these EBs to differentiate into NPCs and also on
neuronal differentiation of ES cells. Overexpression of each of these genes
was also induced during late stages of the process (D7-9), and its effects on
neuronal differentiation of ES cells was also analysed. Together with that,
we also monitored the effect of the constitutive overexpression of Wntl-,
Wt3a- and Dkkl. In all cases, due to time limitations, we only managed to
show the presence of NPCs by nestin positive cells. Nestin is the
intermediate filament protein that marks neuroepithelium but also somatic
mesoderm (Lendahl et al, 1990; Sejersen, 1993; Sejersen and Lendahl,
1993Lendahl, 1997; Lee et al., 2000). We have also attempted to monitor the
differential expression of Pax6 (a paired-box transcription factor expressed in
dividing NPCs throughout embryonic neural tube, Walther and Gruss, 1991;
Tanabe and Jessell, 1996) and RC2 (marker for radial glial cells) between non-
and induced cells, however failed to do so due to technical problems.
Therefore, our analysis on the presence of NPCs was dependent on nestin
expression. We presumed the comparison to the percentage of nestin
positive cells in the control cells would be enough to indicate the effect of
Wnt genes or Dkkl on the formation of precursor cells, even may not all be
NPCs. The formation of neurons was indicated only by the expression of
class III fi-tubulin, which marks post mitotic neurons.
Using the inducible system, our study has demonstrated the stage-specific
effect of Wnt signalling as well as their multiple functions during neural
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Figure 5.24: Summary of the observations made on the effects of
overexpression of Wnt1-HA, Wnt3a and Dkk1 on neural differentiation of ES
cells at the indicated time point of induction. The arrows indicate an increase
t or a decrease | in the formation of NPCs or neurons as determined by the
expression of nestin or class III S-tubulin, respectively.
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Patapoutian and Reichardt, 2000; Kleber and Sommer, 2004; Wang and
Wynshaw-Boris, 2004). Most of the in vivo and in vitro studies described
point to the roles of Wnt signalling in cell-fate determination especially in
instructing cell proliferation or differentiation in ensuring proper
development of the vertebrate CNS or neural lineage specification of ES cells
(also described in Chapter 1-references therein). One general observation
made is that inhibition of Wnt signalling is required during the early
patterning of neural tube (around E6.5 mouse embryo) and during later
stages of its development requires the activity ofWnt signalling (after E8). In
addition, many studies also have strongly suggested the involvement of Wnt
in promoting proliferation of precursor cells during early stage of brain
development, and during later stage of the development, Wnt has been
implicated in promoting the formation of neurons (Dickinson et al., 1994;
Chenn and Walsh, 2002; Muroyama et al., 2002; Castelo-Branco et al. 2003;
Hirabayashi et al., 2004; Panhuysen et al., 2004; Schulte et al., 2005). Based on
these studies, we have analysed the effect of stimulating and inhibiting Wnt
signalling on neural differentiation of ES cells.
5.3.1 The effects of stimulatingWnt signalling
In the present study, Wnt signalling was stimulated by overexpressing Wntl-
HA and Wnt3a. The inducible system allowed us to induce the
overexpression of these genes at three specific time points. Hence permitting
us to examine the stage-dependent effect of Wnt activity, as being described
in vivo, in culture conditions. The effect of stimulating Wnt activity at the
early stage of development in vivo was recapitulated by inducing the
expression of these genes on D2-4, the stage which is believed to be similar to
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that of E4-6 of mouse embryo (as discussed in chapter 3). Its effects on the
ability of EBs to differentiate into NPCs and neurons together under the
influence of RA was evaluated. Additionaly, inducing the expression of
these genes on D7-9 may recapitulate the stimulation of Wnt activity at late
stages of mouse embryo, and gave us the opportunity to analyse its effect on
the ability of the NPCs to differentiate into neurons. Constitutive
overexpression, on the other hand, may recapitulate the effect of Wnt activity
during preimplantationn stage of mouse embryo, and led us to the analysis
of constitutively overexpressing these genes on the ability of ES cells to
differentiate into NPCs and neurons.
5.3.1.1 Wnts inhibit the formation of NPCs
Our limited study discovered that constitutive and early induction of
overexpression of Wntl and Wnt3a in ES cells significantly inhibited the
formation of NPCs. Recent study on ES cells in vitro by Aubert and
colleagues (2002) has shown that constitutive overexpression of Wntl
suppressed neural differentiation of ES cells in response to RA. We also have
repeated their work in using Wntl-constitutively overexpressing ES cells. In
our work, however, constitutively expressed Wntl-EIA was used instead of
non-tagged Wntl construct. The same results were observed indicating no
effect of HA epitope-tagged on Wntl expression. By contrast, Hirabayashi
and colleagues (2004) discovered that HA epitope tag interfered with the
activity of Wnt7a in their work. Thus, to be on the safe side, we have used
non-tagged Wnt3a and Dkkl in our study.
Other studies have found that stimulation of Wnt signalling inhibits the
formation NPCs from ES cells. In study by Haegele et al. (2003), expression
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of nestin and Soxl were reduced in APC-deficient (component of Wnt
signalling) and fi-catenin-overexpressed ES cells in vitro, suggesting Wnt
signalling in inhibition of NPCs. Another study with APC-mutated ES cells
also showed inhibition of neural lineages in vivo and in vitro (Kielman et al,
2002). Taken together these studies and our studies strongly suggest the
inhibition role of Wnt signalling in differentiation of ES cells into NPCs.
In addition, treatment of Wnt3a protein into early stages of RA- and serum-
free EB cultures also suppressed the number of cells expressing Soxl, a
marker for NPCs (Watanabe et al., 2005). In agreement to that, our study also
shows that exposure of Wnt3a on the early stages of EBs and ES cells, even
though in the presence of serum and RA, inhibit the formation of NPCs. The
study by Watanabe and co-workers and our study suggest that Wnt
signalling could work independent of serum and RA to inhibit neural
differentiation of ES cells.
Although many studies have shown the effect of Wnt signalling, especially
through the canonical pathway, in inhibiting neural differentiation, many
studies have also demonstrated its role in enhancing proliferation of NPCs.
Expansion of cortical precursor cell number was observed in cells with
expression of a stabilized form of S-catenin (Chenn and Walsh, 2002).
Similarly, the same phenomenon was observed in this study where
constitutively overexpressing Wntl-HA cells significantly produced higher
number of nestin positive cells after 24 hours post-plating suggesting the role
of Wntl in promoting proliferation of nestin-positive cells. Immunostaining
with marker for proliferating neural precursor cells, such as Soxl, or cell
proliferation assay with BrdU labelling on these nestin-positive cells would
229
have confirmed this. However, we believe nestin was also marking non-
NPCs in these cells. Previous study has suggested that overexpression of
Wnt signals led to differentiation of non-neural cells (Haegele et al., 2003).
Hence, immunostaining with appropriate markers for non-neural cells
would have led us to some explanations. This might also indicate the role of
Wnts in differentiation into non-neural lineage despite of neural enrichment
of RA. On the other hand, induction of Wntl-HA overexpression on D2 did
not increase the number of nestin-expressing cells 24 hours post-plating.
Thus, the different effect on the proliferation of nestin-expressing cells from
these two conditions may strongly suggest the stage-dependence of Wnt
activity during neural differentiation process. It is most likely to signify the
communication between components of the molecular mechanisms of Wnt
signalling, specifically Wnt/fi-catenin, in ES cells. Recent study has
demonstrated that convergence of Wnt/fi-catenin and LIF on STAT3 delays
differentiation of ES cells in the presence of serum (Hao et al., 2006). This
might explain our observations on the initial low number of nestin-positive
cells in constitutively overexpressing Wntl-HA cells when analysed 1-2
hours post-plating, but later increased its number 24 hours post-plating.
Thus, immunostaining these cells with a marker for undifferentiated ES cells
1-2 post-plating may explain the situation.
5.3.1.2 Late stage Wnts promote the formation of neurons
We also observed an increase of fi-tubulin-expressing cells when both Wntl-
HA and Wnt3a were overexpressed at late stage of neural differentiation.
Similar phenomena have been demonstrated when comparing the effect of
ectopic expression of a stabilized form of fi-catenin on different stages of
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mouse neocortex development (Hirabayashi et al., 2004). In the study, more
neurons were produced from older aged neocortex in response to the
expression of stabilized 6-catenin. This study may suggest stimulation of
canonical Wnt signalling during late stages of neural differentiation
stimulates neuron formation. Indeed, late induction of Wntl-HA and Wnt3a
overexpression, which are known to activate the canonical pathway,
significantly increased in the percentage of fi-tubulin-expressing cells. The
same results were observed when Wnt3a conditioned medium (CM) was
added into newly formed neurospheres from dissociated telencephalon of
mouse embryo day 11.5 (Muroyama et al., 2004). In addition, their study
showed enhanced neuronal differentiation when dissociated neurospheres
plated on adhesive substratum was treated with Wnt3a CM. Similar results
were observed in our study. Late induction of Wnt3a during neural process
promoted differentiation of ES cells into neurons. The results also indicate
that the pCAG-floxed-neopA-Wnf3a construct is inducible and capable of
expressing Wnt3a with the same functional activity as Wnt3a CM.
In addition, an increase of the number of neurons was observed when Wntl-
HA overexpression was induced on D2. Not only that we also discovered
that the percentage was enhanced as a result of positive selection on
neuronal cells and elimination of fi-tubulin-negative cells. On the contrary to
Wntl, our results showed inhibition of neuronal differentiation when Wnt3a
was induced at early stages of neural differentiation. This may imply
functional stage-specifity of individual Wnt gene in addition to their
redundant function during differentiation process.
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Forced differentiation to non-neural lineage in constitutively overexpressing
Wntl-HA cells in this study was clearly seen with the reduced percentage of
class III S-tubulin-expressing cells two days post-plating. With this result,
we have confirmed the study by Aubert et al. (2002). In addition to their
study, we also discovered non-neural differentiation from these cells in the
absence of RA. This might indicate the role of Wntl in cell fate decision
during differentiation of ES cells in vitro.
5.3.2 The effects of inhibitingWnt signalling
In this study, Wnt signalling was inhibited by overexpressing Dkkl at the
specific time points as described above. Dkkl is believed to inhibit canonical
Wnt signalling pathway (Semenov et al., 2001). At early stages of developing
mouse embryo, inhibition of Wnt by Dkkl expression is required for proper
patterning of vertebrate axis (Glinka et al., 1998; Hashimoto et al., 2000;
Mukhopadhyay et al., 2001). Overexpression of this gene has resulted in
embryos with enlarged heads (Glinka et al., 1998; Hashimoto et al., 2000).
Indeed, an increased number of NPCs and also 6-tubulin-positive cells
observed when overexpression of Dkkl was induced on D2 suggesting that
Wnt signalling is inhibiting neural differentiation of ES cells. It may also
indicate that the developmental process in vivo has been recapitulated in
culture condition as overexpression of Dkkl in vivo has been shown to
enlarge embryos head in zebrafish and Xenopus (Glinka et al., 1998;
Hashimoto et al., 2000) when injected at early stage of development. A study
by Watanabe and colleagues (2005) also demonstrated that treatment with
Dkkl protein into their EB cultures increasesd the formation of Soxl-positive
cells as well as Foxgl-expressing cells. In accordance to this, exposure to
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overexpression of Dkkl in ES cells as well as in early-stage EBs also increased
the formation of Foxgl-expressing cells in our culture, even in the presence
of RA. This may indicate that overexpression of Dkkl at these specific stages
overrides the caudalizing effect of RA. However, the reduced number of
nestin-positive cells in Dkkl -constitutively expressed ES cells in our system
may indicate the antagonistic effect of Dkkl on other Wnt signalling
pathway. A recent study has shown that Dkkl could activate the
noncanonical PCP-like pathway (Pandur et al, 2002). Through other
pathway, overexpression of Dkkl in ES cells may have promote the Wnt
activity acting through the canonical pathway and inhibit neural
differentiation of ES cells as observed in this study and previous studies.
Overexpression of Dkkl during late stages of neural differentiation
significantly increased the percentage of fi-tubulin-expressing cells while the
total number of positive cells per field was reduced significantly. This
highly suggests that overexpression of Dkkl is blocking Wnt signals which is
required in promoting the formation of neurons. It may also indicate that
overexpression of Dkkl during the late culture period has specifically select
the differentiation into a specific type of neuron. Indeed, when Watanabe
and colleagues (2005) treated their culture with Dkkl during late stages of
neural differentiation, less number of Pax6-expressing cells was detected in
their Foxgl-positive cells, indicating that inhibition of Wnt activity through
overexpression of Dkkl has perturbed the differentiation into certain type of
neurons. Alternatively, the reduced number of neurons in Dkkl-
overexpressing ES cells might also be due to its proapoptotic activity (Shou et
al., 2002). These results, therefore, demonstrate that the specific induction
time is critical for the role played by Dkkl during neural differentiation.
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Early induction of Dkkl overexpression seems to promote neuronal
differentiation while late induction seems to inhibit formation of neurons.
However, the presence of Dkkl in ES cells which seems to have similar effect
as inducing overexpression of Dkkl during late stages on the formation of
neurons highly suggest the complexity of Wnt signaling as well as the role
played by Dkkl during the process.
5.4 Conclusion
In summary, using an inducible system we have analyzed the effects of
stimulating and inhibiting Wnt signalling by overexpressing Wnt (Wntl-HA
and Wnt3a) and Wnt antagonist (Dkkl), respectively, at specific time points
during neural differentiation of ES cells in culture conditions; in the presence
of serum and RA. Taken together, the results generally indicate the role of
Wnt signalling in inhibiting differentiation of ES cells in to NPCs, but also
promoting the differentiation into neurons, when induced at particular time.
Stage-specific effect of Wnt signalling was demonstrated. Early induction of
Wntl and Wnt3a overexpression resulted in inhibition of NPCs, while early
induction of Dkkl overexpression promoted the formation of NPCs.
Exposure to overexpression ofWntl and Wnt3a during late period of culture
promoted neuron formation, and decreased the number of neurons when the
culture was exposed to overexpression of Dkkl during that stage.
Constitutive expression of all genes during the process, interestingly,
decreased the formation of NPCs as well as neurons. These results, hence,
demonstrate the complexity of the roles played by Wnt signalling during
neural differentiation of ES cells in vitro as it is in vivo.
234
Chapter 6: Final Discussion
6.1 Conditional activation and inhibition of Wnt signalling
during neural differentiation of ES cells.
In an effort to understand the roles of Wnt signalling during neural
differentiation of ES cells, we began by screening the expression profiles of
all 19 Wnt genes during the process. Results from RT-PCR as well as qRT-
PCR demonstrated the expression of almost all Wnt genes with a few genes
exhibiting interesting dynamic RNA expression pattern, suggesting possible
functions of the gene in the process. However, heterogeneity of cell
population of EBs does not identify the specific cell type(s) in which the
Wnts are expressed. Analysis of RNA expression from SoxlGFP-positive cells
versus the negative cells would have given us some closer explanations.
This could have been carried out by using homogeneous GFP-positive and -
negative cells sorted by FACS. Differential expression from these sorted
populations as well as from population of stage 1 (undifferentiated ES cells)
and stage 2 (young EBs before neural enrichment by RA) of neural
differentiation would tell us more specifically the Wnt genes and Wnt
antagonists that are actually expressed during neural lineage commitment.
Expression of TOP-Red2, despite its technical limitations, also suggested
involvement of the canonical Wnt activity particularly during the late stage,
which is an agreement with most of Wnt RNA expression profiles.
Functional analysis of selected Wnt genes and Wnt antagonist was then
carried out with a focus on the roles of Wnt signalling in inhibiting
differentiation of ES cells into NPCs and stimulating differentiation of NPCs
into neurons as our hypothesis using an inducible expression system.
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Using an inducible expression system in ES cells, we have discovered that
Wnt signalling plays broader functions than just affecting cell proliferation
and differentiation in cell fate determination during different stages of
neural differentiation of ES cells. The system has allowed us to examine in
more detail the function of Wnt activity, as proposed by Aubert and
colleagues (2002), in inhibiting or stimulating neural determination of ES
cells. Constitutive overexpression of Wntl and Wnt3a seem to inhibit the
ability of ES cells to differentiate into NPCs and neurons when analysed 1-2
hours after plating on PDL/laminin-coated plates (Figure 5.24), suggesting
inhibition of Wnt signalling may be required to stimulate the production of
NPCs. On the other hand, constitutive overexpression of Dkkl tells a
different story. Instead of promoting the generation of nestin-positive cells,
a higher percentage of Foxgl-positive cells with fewer cells expressing
nestin were observed. This may indicate that inhibition of Wnt activity,
specifically of the canonical pathway, does not stimulate the production of
NPCs but instead directs the differentiation of ES cells into more region
specific cells. Additionally, the inhibition of Wnt signalling may positively
regulate cell cycle exit which might explain the decreased number of nestin-
positive but higher number of Foxgl-nestin cells. A high percentage of fi-
tubulin-positive with lower number of B-tubulin-negative cells observed
may also suggest positive selective towards neuronal cells rather than non-
neuronal cells.
Inhibition ofWnt signalling by overexpressing Dkkl induced at early stages
of differentiation stimulated the generation of NPCs and also neurons,
implying the inhibition effect ofWnt signalling in the process. In agreement
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with this, overexpression ofWntl and Wnt3a induced at early stages inhibit
the differentiation of ES cells into NPCs. These results indicate that early
stage of this process may be the critical time point where stimulation or
inhibition of Wnt signalling will influence cell-fate decision. Similarly, the
significant increase of 6-tubulin-positive cells seen when Wnt signalling is
stimulated by overexpressing Wntl and Wnt3a at late period of
differentiation may also indicate that this time point is important in
promoting differentiation of ES cells into neurons.
In summary, in an effort to understand the functions of Wnt signalling
during neural differentiation of ES cells, we began this study by showing the
presence of RNA expression (RT-PCR and qRT-PCR) of Wnt genes and Wnt
antagonists during the process. Based on the expression profiles in addition
to expression of Wnt reporter gene (TOP-Red2), it is believed that the
regulation of Wnt activity during this process is highly stage-dependent.
Finally we have examined the effects of stimulating and inhibiting,
particularly the canonical Wnt signalling, by overexpressing Wntl and
Wnt3a, and Dkkl at three different time points. Using the inducible
system, we discovered that Wnt signalling might plays multiple complex
functions during neural differentiation of ES cells.
6.2 Limitations of study and future work
One major drawback of this study is the limited set of markers used for
NPCs and neurons. The study only used nestin as a marker for NPCs which
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in broader terms may not only represent proliferating neural precursors.
Dahlstrand et al. (1994) found that there are few exceptions to the expression
of nestin that marks the proliferating CNS progenitor cells. There are a few
differentiated regions of the CNS (the intermediate zone of E15.5
telencephalon) and cells of non-CNS origin (muscle cells) that expressed
nestin were detected in the study. Therefore, in addition to nestin, the use of
other markers for neural progenitors particularly the SRY-related
transcription factor Soxl (marks dividing neural progenitors and
neuroepithelium of the neural plate, Pevny et al., 1998) and the paired-box
transcription factor Pax6 (expressed mainly in the ventral region of the
neural tube, Walther and Gruss, 1991) might be useful in confirming the
presence of NPCs or nestin-positve non-neural precursor cells.
One of the main functions proposed by this study is the role of Wnt
signalling in inhibition of differentiation of ES cells into NPCs. There are
many factors that might contribute to the decreased in the number of NPCs
or specifically nestin-expressing cells when Wnt gene is overexpressed or the
increased of these cells whenever Wnt signalling is inhibited. This could be
due to changes in mitotic rate, cell survival or proapoptotic factor, or cell fate
choice on whether to re-enter cell cycle or to differentiate. One way of
addressing these possibilities is by looking at the proliferation or death rate
of these cells in response to stimulation or inhibition of Wnt signalling at
various specific time points.
This study also found that Wnt signalling might be stimulating the formation
of neurons. A variety of distinct neuronal cell types is generated during
development of mammalian CNS and have been reproduced in vitro using
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various protocols from ES cells. Several extracellular factors such as platelet-
derived growth factor, PDGF (Erlandsson et al., 2001), insulin growth factor 1
(Arsenijevic and Weiss, 1998), brain-derived neurotrophic factor (Ahmed et
al., 1995), bone morphogenetic protein (Li et al., 1998b) have been implicated
during neurogenesis in vivo, and RA, FGF, EGF and BMP have been
demonstrated to be involved in neural development of ES cells in vitro (Ying
et al., 2003a; Irioka et al., 2005; Watanabe et al., 2005; Conti et al., 2005). It
will be interesting to determine which types of neurons are generated upon
activation or inhibition ofWnt signalling and also to examine the interactions
of this pathway to these factors, particularly, in the generation of regional
specific neurons.
Wnt also has been implicated to play a role in the self-renewal of ES cells
(Sato et al., 2004). The decrease in the formation of neurons when Wntl and
Wnt3a were overexpressed in ES cells might suggest the effects of
overexpressing Wnts on self renewal of ES cells that might result in
inhibition of differentiation process of the cells. It therefore would be
interesting to examine the effects of overexpressing Wnts as well as Dkks on
this mechanism.
Over the years, considerable progress has been made in understand the role
of Wnt signalling especially during development in vivo. Progressive evident
is pointing to probable functions of this signalling molecule during
differentiation of ES cells in culture conditions. Multiple functions of Wnt
signalling addressed in this study demonstrate the complexity of Wnt signal
transduction mechanisms. One of the biggest problems with Wnt signalling
is the understanding the interaction of Fzd/Wnt interaction and the role of
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specific Wnt gene in activating the different pathways. Inducible expression
system may provide invaluable tool especially in trying to unravel the
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Appendix A: List of Antibodies used for Immunoblotting and Immunocytochemistry
"may use different Alexa conjugate from described above, ab = antibody












Rat IgGl 1:1000 - - -
Mouse Dkkl
(R&D System: AF 1765)







(R&D System: MAB 1324)






(R&D System: AF 645)
Goat IgG 1:500 Donkey anti-goat
IgG-HRP
(1:20,000)






Goat IgG 1:200 Donkey anti-goat
IgG-HRP
(1:20,000)




































































Appendix B: Cloning and Subcloning strategies
A) Construction of Wntl-HA/pCAG-floxed-neopA
Confirmed by restriction enzyme digestion with:
Cla1, BamH1, Acc1, Xho1, EcoR1, EcoRV, Sail, Nae1
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Ref: Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J.
Transformation by Wnt family proteins correlates with regulation of beta-



























B) Construction of Dkkl/pCAG-floxed-neopA
i/Dkk1/pGEMT-Easy
Confirmed by restriction enzyme digestion with:
Cla1, BamH1, Acc1, Xho1, EcoR1, Sail, Asp718
270
B-i) pGEM-T Easy + BamH l-Dkk 1-BamH I
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Confirmed by restriction enzyme digestion with:
Xho1, Sail, Sac1, Not1, Hindlll




+ I pCAG-floxed neopAl
Xho1 Xho1
/// l(Vhf5a/pCAG-floxed neopA
Confirmed by restriction enzyme digestion with:






















































































































































—j— J pCAG-floxed neopA|
Xho1 Xho1
Hi/ l/Wjf7a/pCAG-floxed neopA
Confirmed by restriction enzyme digestion with:





































































































TF1-pBS II KS (+)
3239bp




















Appendix C: List of primers












95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 50 seconds^








95°C - 3 minutes
95°C - 30 seconds
58°C - 30 seconds
72°C - 50 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^







95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 50 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 50 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^








95°C - 3 minutes
95°C - 30 seconds
55°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
54°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 45 seconds^









95°C - 3 minutes
95°C - 30 seconds
55°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
59°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
59°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^








95°C - 3 minutes
95°C - 30 seconds
55°C - 30 seconds
72°C - 45 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds__








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^









95°C - 3 minutes
95°C - 30 seconds
58°C - 30 seconds
72°C - 45 seconds^









95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^
>- 30 cycles
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95°C - 3 minutes
95°C - 30 seconds
55°C - 30 seconds
72°C - 40seconds








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^








95°C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 40 seconds^








95 °C - 3 minutes
95°C - 30 seconds
62°C - 30 seconds
72°C - 45 seconds^




Gene Primer name-Sequence Size (bp)/annealing
Temperature
ft-Actin G-ActinF2-forward: 5' CCTGTCAGCAATGCCTGGGT 3'
G-Actinr2-reverse: 5' CCAGCCTTCCTTCTTGGGTA 3'
150/58°C
Dkkl Dkkl-LCF-forward: 5' AGTGCGGCTCTGACGAGTAC 3'
Dkkl-LCR-reverse: 5' GGTCAGAGGGCATGCATATTC 3'
165/58°C
GAPDH GAPDH-lF-forward: 5' TGGTGAAGCAGGCATCTGAG 3'




NeoF-forward: 5' ATCAGGATGATCTGGACGAA 3'













Wnt2b-R-reverse:5' TCAGTCCGGGTGGCGTGGCG 3' 290/54°C
Wnt3a Wnt3aLC-F-forward: 5' TGAACCGTCACAACAATGAG 3'
Wnt3aLC-R-reverse: 5' CCAGCAGGTCTTCACTTCC 3'
107/55°C
Wnt4
Wnt4-F-forward: 5' GGCGTAGCCTTCTCACAGTC 3'
Wnt4-R-reverse: 5' TGCATTCCGAGGCACCAGCG 3' 300/58°C
Wnt5a
Wnt5aFl-forward: 5' TCCTATGAGAGCGCACGCAT 3'
Wnt5aRl-reverse: 5' CAGCTTGCCCCGGCTGTTGA 3' 230/58°C
Wnt5b
Wnt5bFl-forward: 5' CAGCTTGCCCTGGCGGGTGA 3"
Wnt5bRl-reverse: 5' TCGGAGGAGCAGGGCCGAGC3' 230/58°C
Wnt6
Wnt6- F-forward: 5' ATGGATGCGCAGCACAAGCG 3'
Wnt6-R-reverse: 5' TTTGCCGTCGTTGGTGCCCA 3' 310/58°C
Wnt7a
Wnt7a-F-forward: 5' CAAGGCCAGTACCACTGGGA 3'
Wnt7a-R-reverse: 5' GGCTCCACGTGGACGGCCTC 3' 310/55°C
Wnt7b
Wnt7b-F-forward: 5' CAAGGCTACTACAACCAGGC 3'
Wnt7b-R-reverse: 5' CACCTCCACCTGCACCGCTG 3' 310/58°C
Wnt8a
Wnt8aFl-forward: 5' GCAGCGACAACGTGGAGTTC 3'
Wnt8aRl-reverse: 5' GCTTCCTGAGATGCCATGAC 3' 170/58°C
Wnt9a (14)
Wntl4-F2-forward: 5' CAGCACTACCAATGAAGCCA 3'
Wntl4-R2-reverse: 5'CCTCGGCCACAACAAATACT 3' 220/58°C
WntlOb
WntlOb-Fl-forward: 5' CGGCTGCCGCACCACAGCGC 3'
WntlOb-Rl-reverse: 5' CAGCTTGGCTCTAAGCCGGT 3' 180/58°C
Wntll
Wntll-Fl-forward: 5' GCCATGAAGGCCTGCCGTAG 3'
Wntl 1-R1-reverse: 5' GATGGTGTGACTGATGGTGG 3' 160/58°C
286
iii/ Sequencing primers
Name of Plasmid Sequence
TopFLASH TFl-SF-forward: 5' TTCAGTCGACCCCAGTGA 3'
LuciTF-SS-reverse: 5' CTGACGCAGGCAGTTCTA 3'
Ds-Red2-1 Ds-Red2-lF-forward: 5' AGCTGGACATCACCTCCCACAACG
3'
Ds-Red2-lR-reverse: 5' GTACTGGAACTGGGGGGACAG 3'
pCAG-floxed pCAGF-Fl-forward: 5' TCATGTCTGGATCTCCCG 3'
pCAGF-Rl-reverse: 5' AAGACGGCAATATGGTGG 3'
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Appendix D: Consistency of fi-actin expression during neural


















Internal controls: Gapdh vs Beta Actin




Comparison between expression of fi-Actin and Gapdh during neural
differentiation of ES cells was carried out in order to examine the consistency
of their expression during the process. It was discovered than expression of
6-Actin was more consistent than Gapdh, hence was used as an internal
control for quantitative analysis of RT-PCR (qRT-PCR, Chapter 3). Results
were from two independent experiments. Error bars are mean ± range
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Appendix F: Manual Cell Counting







cells ToPRO-3 Nestin +
Nestin % +ve
cells
f1 121 48 73 39.66942 98 61 37 62.2449
f2 90 53 37 58.88889 73 28 45 38.35616
f3 90 45 45 50 98 41 57 41.83673
f4 81 29 52 35.80247 108 64 44 59.25926
f5 152 96 56 63.15789 60 12 48 20
f6 66 30 36 45.45455 169 87 82 51.47929









Nestin +ve 48.82887 45.529391
Nestin
Positive 50.16667 48.833333
std dev 10.70388 15.6215201
Nestin
negative 49.83333 52.166667
SEM 4.36984 6.37745887 Std dev + 24.4738 27.154496
Flocytometry 43.07 42.83 Std dev - 13.84798 15.992707
T-test SEM + 9.991385 11.085777
% no 4'-OHT to + 4'-0HT on D2
0.67857566 SEM - 5.653416 6.5289952
B) pCAG-floxed-neopA : B-tubulin


























fi 183 67 116 36.61202 165 43 122 26.0606 129 47 82 36.43411
f2 151 51 100 33.77483 112 39 73 34,8214 130 46 84 35.38462
f3 46 16 30 34.78261 161 66 95 40.9938 150 54 96 36
f4 173 60 113 34.68208 141 46 95 32.6241 141 52 89 36.87943
f5 115 38 77 33.04348 156 60 96 38.4615 141 62 79 43.97163
f6 107 32 75 29.90654 165 59 106 35.7576 131 45 86 34.35115
f7 118 55 63 46.61017 123 54 69 43.9024 157 53 104 33.75796
f8 168 62 106 36.90476 117 46 71 39.3162 144 51 93 35.41667














Average % B-tubulin +ve 35.7896 36.49222 36.52445
Average 13-
Tubulin + 47.625 51.625 51.25
std dev 4.89104 5.530963 3.179687
Average fl-
Tubulin - 85 90.875 89.125
SEM 1.72925 1.955491 1.124189 Std dev +ve 17.476 9.516 5.496752
T-test SEM +ve 6.1787 3.3644 1.943395
% untreated to 4'-OHT D2
0.7917
Std dev -ve 29.4812 18.712 8.219098
% untreated to 4'-OHT D7
0.7269
SEM -ve 10.4232 6.6156 2.90589
290
C) CAG-floxed-neopA-l/y/7f7-HA: NPC 1-2 hours after plating














f1 277 231 46 83.3935 243 123 120 50.617 171 99 72 57.8947
f2 247 194 53 78.54251 272 174 98 63.971 111 49 62 44.1441
f3 307 258 49 84.03909 270 156 114 57.778 170 96 74 56.4706
f4 245 217 28 88.57143 356 208 148 58.427 108 47 61 43.5185
f5 311 269 42 86.49518 339 171 168 50.442 161 86 75 53.4161
f6 302 231 71 76.49007 284 103 181 36.268 107 50 57 46.729
f7 323 241 82 74.613 295 179 116 60.678
f8 233 180 53 77.25322 259 151 108 58.301
Total 2245 1821 424 2318 1265 1053 828 427 1255












f1 252 185 67 73.4127 125 96 29 76.8
- 4'-OHT
3915
f2 184 141 43 76.63043 282 173 109 61.348
+ 4'-OHT on D2
3892
f3 207 173 34 83.57488 170 109 61 64.118
Tp
828
f4 183 143 40 78.14208 181 115 66 63.536
f5 217 174 43 80.18433 172 94 78 54.651
f6 162 121 41 74.69136 211 136 75 64.455
f7 249 219 30 87.95181 189 100 89 52.91
f8 216 183 33 84.72222 244 122 122 50













%Non-induced to Induced on D2
Average 80.54 59.222 50.362 pos 197.5 138.125 71.1667 6.6E-10
std dev 4.997 8.9506 6.3573 std dev 31.02 26.292 25.0393
%Non-induced to Tp
2E-10






# pos.cells Non-induced to Induced on
D2 0.00018
FACS 61.73 54.59 40.09
# pos cells Non-induced to Tp
1.5E-06
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D) CAG-floxed-neopA-Wnff-HA: Nestin after 24 hrs plating







+ Nestin - % +ve
229 67 162 29.25764 117 25 92 21.36752
264 78 186 29.54545 185 29 156 15.67568
261 81 180 31.03448 194 32 162 16.49485
206 45 161 21.84466 226 42 184 18.58407
303 112 191 36.9637 252 35 217 13.88889
226 46 180 20.35398 298 31 267 10.40268
261 49 212 18.77395 291 24 267 8.247423
229 42 187 18.34061 277 27 250 9.747292
214 35 179 16.35514 265 20 245 7.54717
190 26 164 13.68421 219 13 206 5.936073
169 30 139 17.75148 179 20 159 11.17318
210 22 188 10.47619 229 20 209 8.733624
317 128 189 40.37855 221 41 180 18.55204
321 127 194 39.56386 187 32 155 17.1123
274 88 186 32.11679 219 31 188 14.15525
243 72 171 29.62963 218 49 169 22.47706
293 86 207 29.35154 295 41 254 13.89831
269 96 173 35.68773 287 32 255 11.14983
440 130 310 29.54545 305 42 263 13.77049
377 117 260 31.03448 276 29 247 10.50725
215 55 160 25.5814 164 16 148 9.756098
199 49 150 24.62312 160 9 151 5.625
138 33 105 23.91304 187 13 174 6.951872









+ Nestin - % +ve
Nestin
positive 69.125 28.25 86.45833
150 94 56 62.66667
Nestin
negative 181.6667 199.5417 76.41667
180 81 99 45





196 78 118 39.79592 std dev 34.74918 10.35983 18.40127
192 68 124 35.41667 SEM +ve 7.093146 2.114692 3.756144
162 83 79 51.23457 std dev 40.7342 47.72929 23.22277
167 82 85 49.1018 SEM -ve 8.314835 9.742701 4.740328
162 84 78 51.85185





199 108 91 54.27136 % Nestin 26.33845 12.63867 53.56444
166 84 82 50.60241 std dev 7.827768 4.622236 10.54133
138 78 60 56.52174 SEM 1.597836 0.94351 2.15174
158 28 130 17.72152
146 78 68 53.42466 T-Test
149 87 62 58.38926 % Non-induced to induced on D2 0.0000000042
162 94 68 58.02469 % Non-induced to Tp 4.8555E-13
154 94 60 61.03896 T-test non-induced +ve cells to D2's 1.49541E-06
201 123 78 61.19403 T-test non-induced +ve cells to Tp's 0.03605404
174 101 73 58.04598
197 107 90 54.31472
111 75 36 67.56757
140 87 53 62.14286
148 92 56 62.16216
144 86 58 59.72222
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E) pCAG-floxed-neopA-Wnt1-HA: ft-Tubulin
















f1 a 417 195 222 46.7626 152 126 26 82.89474
f1 b 452 172 280 38.0531 216 163 53 75.46296
f1 c 241 138 103 57.2614 118 109 9 92.37288
f2a 255 118 137 46.2745 230 126 104 54.78261
f2b 334 168 166 50.2994 278 161 117 57.91367
f2c 295 154 141 52.2034 232 195 37 84.05172
Total 1994 945 1049 1226 880 346
Clonel
f 1 a 435 211 224 48.5057 345 264 81 76.52174
f1 b 636 407 229 63.9937 376 295 81 78.45745
f1c 648 242 406 37.3457 277 268 9 96.7509
f2a 367 204 163 55.5858 388 307 81 79.12371
f2b 419 159 260 37.9475 364 266 98 73.07692
f2c 613 199 414 32.4633 377 320 57 84.88064
Total 3118 1422 1696 2127 1720 407
Clone2
f1 a 181 102 79 56.3536 175 154 21 88
f1 b 353 118 235 33.4278 225 195 30 86.66667
f1c 274 107 167 39.0511 304 254 50 83.55263
f1 d 373 143 230 38.3378 193 158 35 81.86528
f2a 382 224 158 58.6387 370 304 66 82.16216
f2b 362 213 149 58.8398 228 207 21 90.78947
f2c 413 244 169 59.0799 251 195 56 77.68924
f2d 342 217 125 63.4503
Total 2680 1368 1312 1746 1467 279
Total 7792 5099
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Clonel + 4'-OHT on D7 Constitutive expression (Tp)
G- G- G- 6-
ToPRO- Tubulin Tubulin % +ve ToPRO- Tubulin Tubulin % +ve
f 1 a 3 + - cells 3 + - cells
f 1 b 252 110 142 43.6508 203 54 149 26.60099
f1c 113 56 57 49.5575 214 19 195 8.878505
12a 132 72 60 54.5455 221 11 210 4.977376
12b 330 212 118 64.2424 139 17 122 12.23022
12c 202 141 61 69.802 171 29 142 16.95906
Total 274 163 111 59.4891 191 6 185 3.141361
Clonel 1303 754 549 1139 136 1003
f1 a
f1 b 420 301 119 71.6667 121 27 94 22.31405
f1c 304 166 138 54.6053 181 34 147 18.78453
f2a 376 190 186 50.5319 147 40 107 27.21088
12b 319 229 90 71.7868 214 19 195 8.878505
12c 430 334 96 77.6744 236 23 213 9.745763
Total 141 18 123 12.76596
Clone2 1849 1220 629 1040 161 879
f1a
f1 b 270 171 99 63.3333
f1c 297 187 110 62.963
fid 564 331 233 58.6879
f2a 322 223 99 69.2547
f2b 293 190 103 64.8464
f2c 281 158 123 56.2278
f2d 278 140 138 50.3597




OHT on D2 on D7 Tp No 4'-OHT on D2 on D7 Tp
Ave 48.6938 80.36923 61.05192 14.3739 pos 186.75 214.0526 189.95 24.75
std
dev 10.3106 10.37669 9.095819 8.01667 neg 202.85 54.31579 115.79 156.8333
SME 2.30551 2.380575 2.086724 2.31421
std
dev 68.30032 68.33616 75.989 13.18487
SEM 15.27242 15.67739 17.433 3.806145
No 4'-OHT on D2 on D7 Tp
neg 202.85 54.31579 115.78947 156.8333
stddev 88.30585 32.49111 42.045714 41.40231
SEM 19.74579 7.453973 9.6459484 11.95182
T-test
T-test
% untreated to 4'-OHT D2 1.54E-11
#pos untreated to 4'-OHT D2
0.220063
% Untreated to 4'-OHT D7 0.000327
#pos untreated to 4'-OHT D7
0.890719
% Untreated to Tp 6.37E-11 # pos Untreated to Tp 5.15E-09
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F) CAG-floxed-neopA-lVnf3a: Nestin














f1 864 63 927 93.2 895 229 1124 79.63 687 113 800 85.88
f2 735 76 811 90.63 956 152 1108 86.28 784 121 905 86.63
f3 952 61 1013 93.98 864 323 1187 72.79 920 155 1075 85.58
f4 993 111 1104 89.95 686 360 1046 65.58 724 183 907 79.82
f5 834 88 922 90.46 334 242 576 57.99 989 149 1138 86.91
f6 895 79 974 91.89 441 204 645 68.37 753 124 877 85.86
f7 1181 80 1261 93.66 564 220 784 71.94 870 123 993 87.61
Total 6454 7012 92.04 4740 6470 73.26 913 113 1026 88.99














(Tp) 7275 7662 94.95





std dev 1.663 9.24831 2.5267 neg 79.7143 247.143 131.889
std
pos 141.32 240.3223 120.104
SEM 0.6286 3.49553 0.8422
SEM
pos 53.4139 90.83329 40.0347
T-test % control to untreated on D2
1E-04
std
neg 16.79 71.29383 25.2064
T-test % control to Tp
1E-04
SEM




on D2 TP T-test #pos untrested to D2 0.039
Flowcytometry 88.62 79.22 72.07 T-test #pos untrested to Tp 0.104
G) CAG-floxed-neopA-tyhf3a: R-tubulin















f1 a 141 188 47 75 53 53 0 100
f2a 133 184 51 72.2826 24 24 0 100
f3a 190 289 99 65.7439 33 45 12 73.3333
Total A 464 661 197 70.1967 110 122 12 90.1639
f4b 156 228 72 68.4211 16 36 20 44.4444
f5b 92 114 22 80.7018 21 23 2 91.3043
f6b 131 168 37 77.9762 25 26 1 96.1538
Total B 379 510 131 74.3137 62 85 23 72.9412
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f2a 340 477 137 71.2788 112 141 29 79.4326
f3a 187 218 31 85.7798 93 133 40 69.9248
Total A 261 359 98 72.7019 95 149 54 63.7584
f4b 788 1054 266 74.7628 300 423 123 70.922
f5b 363 481 118 75.4678 54 85 31 63.5294
f6b 200 246 46 81.3008 95 133 38 71.4286
Total B 311 421 110 73.8717 62 116 54 53.4483
874 1148 274 76.1324 211 334 123 63.1737
H) CAG-floxed-neopA-D/f/c7: Nestin
No 4'-OHT 4'-OHT on D2
Nestin + Total Nestin - %+ve Nestin + Total
Nestin
%+ve
fl 143 158 15 90.506329 159 207 48 76.811594
f2 167 229 62 72.925764 219 275 56 79.636364
f3 174 220 46 79.090909 270 318 48 84.90566
f4 307 432 125 71.064815 280 330 50 84.848485
f5 96 140 44 68.571429 257 312 55 82.371795
f6 127 185 58 68.648649 219 258 39 84.883721
f7 144 169 25 85.207101 165 201 36 82.089552
f8 139 161 22 86.335404 202 240 38 84.166667
Total 1297 1694 397 1771 2141 370
Constitutive expresion (TP)
Nestin + Total Nestin - %+ve
f1 70 133 63 52.631579
f2 87 136 49 63.970588
f3 100 177 77 56.497175
f4 68 102 34 66.666667
f5 93 124 31 75
f6 97 157 60 61.783439
f7 85 104 19 81.730769
f8 118 160 42 73.75
Total 718 1093 375
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No 4'-OHT 4'-OHT on D2 Tp No 4'-OHT 4'-OHT on 02 Tp
% Nestin
+ve 77.7938 82.46423 66.503777 pos 162.125 221.375 89.75
sd dev
8.692113





pos 63.232988 45.55354 16.298554
T-test SEM pos 22.356237 16.105608 5.762409
% Non-induced to D2 0.1719495
std dev
neg 34.883224 7.7228788 19.134393
% Non-induced to Tp 0.0290243 SEM neg 12.333082 2.73045 6.7650296
T-Test
# pos Non-treated to D2 0.0494832
# pos Non-treated to Tp 0.0073078
I) CAG-floxed-neopA-DWc7:Foxg1
No 4'-OHT 4'-OHT on D2 Constitutive expression (Tp)
Foxgl + Total %+ve
Foxgl
+ Total %+ve Foxgl + Total %+ve
f1 26 72 36.111111 76 189 40.21164 31 70 44.285714
f2 13 97 13.402062 61 173 35.260116 39 77 50.649351
f3 3 264 1.1363636 1 152 0.6578947 41 60 68.333333
f4 1 236 0.4237288 50 136 36.764706 47 78 60.25641






Average 12.768316 28.223589 55.881202
Std dev 16.663122 18.493641 10.583409
SEM 8.3315608 9.2468204 5.2917044
T-test
% untreated to D2 0.2606755
% untreated to Tp 0.0047289
J) CAG-floxed-neopA-D/c/tf: R-tubulin





cells Btub -ve % +ve B-tub +ve Total cells Btub -ve % +ve
f1 291 548 257 53.102 178 265 87 67.17
f2 175 329 154 53.191 237 306 69 77.451
f3 149 269 120 55.39 223 300 77 74.333
f4 265 532 267 49.812 336 487 151 68.994
f5 134 285 151 47.018 327 448 121 72.991
f6 255 625 370 40.8 170 226 56 75.221
f7 211 462 251 45.671 156 201 45 77.612
f8 192 395 203 48.608 172 220 48 78.182
f9 236 548 312 43.066 438 637 199 68.76
f10 227 411 184 55.231 215 291 76 73.883
Total 2135 4404 2269 48.479 2452 3381 929 72.523
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cells Btub -ve % +ve B-tub +ve
Total
cells Btub -ve % +ve
f1 56 109 53 51.38 64 97 33 65.97938
<2 93 144 51 64.58 58 94 36 61.70213
f3 63 80 17 78.75 44 71 27 61.97183
f4 148 175 27 84.57 86 113 27 76.10619
f5 57 86 29 66.28 89 132 43 67.42424
f6 79 104 25 75.96 59 80 21 73.75
f7 35 60 25 58.33 44 60 16 73.33333
f8 74 89 15 83.15 77 117 40 65.81197
f9 121 148 27 81.76 47 58 11 81.03448
f10 99 118 19 83.9 58 83 25 69.87952
Total 825 1113 288 74.12 626 905 279 69.17127
- 4'-OHT D2 D7 Tp T-test
Average 49.189 73.46 72.8656 69.699 Non-induced to induced on D2 (+ve cells) 0.356
std dev 5.077 3.9628 11.8915 6.2979 Non-induced to induced on D7 (+ve cells) 2E-06
SEM 1.6055 1.2531 3.76041 1.9916 Non-induced to Tp (+ve cells) 5E-08
T-test% non-induced to induced D2 5.6E-10
T-test % non-induced to induced D7 1.7E-05








Average + 213.5 245.2 82.5 62.6
Average - 226.9 92.9 28.8 27.9
std + 51.1 92.536 33.712 16.48
SEM + 16.159 29.262 10.6607 5.2115
std -ve 78.69 49.709 13.0792 10.279
SEM -ve 24.884 15.719 4.13602 3.2505
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Appendix G: FACS analysis
CAG-floxed-«eopA: Nestin







X Parameter: FL2-H (Log)
Marker Events % Gated % Total Mean Geo Mean Median
All
">2 ' ' " 1,1,13 ' M1
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X Parameter: FL2-H (Log)












X Parameter: FL2-H (Log)





















X Parameter: FL2-H (Log)





















X Parameter: FL2-H (Log)















4'-OHT on D2 -Nestin/PE
FACS analysis on nestin expression in stably-transfected R26CT2S cells with pCAG-floxed-
neopA empty vector was carried out using controls as described above (for setting up the R1
andMl gate). The same procedure was used for all antibodies staining analysed by FACS.
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